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Abstract 
     Over the past two decades, there has been increasing attention in medical 
research and literature into ‘metabolic syndrome’ due to the important role it plays 
in the aetiology and clinical course of non-insulin dependent diabetes and coronary 
heart disease. However, due to large individual differences seen in treatment 
outcomes of metabolic syndrome factors, which currently include lifestyle and 
pharmacological interventions, it has been proposed that other underlying risk 
factors are involved in the aetiology and pathogenesis of metabolic syndrome. The 
Hypothalamus-Pituitary-Adrenal cortex (HPA) axis dysregulation hypothesis 
posits that psychological factors place additional stressors on the endocrine 
system, which in turn may elevate the results of the biological indicators of 
metabolic syndrome in individuals. Therefore, both physical and psychological 
factors may be important in the development and maintenance of metabolic 
syndrome, and this has implications for targeted interventions and treatment. This 
study aimed to further expand on the current body of research of interrelationships 
between physical and psychological symptomatology and to determine predictive 
relationships between Depression, Anxiety and/or Stress and metabolic syndrome 
in farm men and farm women, a cohort that is known to have poorer health 
outcomes and to experience unique psychological stressors. The results revealed 
that the prevalence of metabolic syndrome is greater in farm men and women than 
the general population, and that Depression is related to the emergence of 
metabolic syndrome, whilst both Depression and Anxiety are involved in its 
maintenance. It is concluded that psychological evaluation and interventions 
should be included in the detection and treatment of metabolic syndrome. 
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Overview 
      Metabolic syndrome can best be described as a clustering of metabolic, 
anthropometric and haemodynamic abnormalities that play an important role in the 
aetiology and clinical course, and increased risk of, morbidity and mortality from 
Type II diabetes and cardiovascular disease (Eckel, Grundy & Zimmet, 2005; 
Reaven, 1993). The word ‘syndrome’ is used as the term defines a group or 
recognizable pattern of symptoms or abnormalities that indicate a particular trait or 
disease (International Diabetes Foundation (IDF), 2006). Whilst metabolic 
syndrome is currently used as a clinical tool to identify and inform treatment for 
individuals who are at significantly increased risk of cardiovascular disease or 
Type II diabetes, the aetiology and pathogenesis of metabolic syndrome is still 
unclear, partially due to large individual differences in the magnitude of 
intervention and treatment effects.  
 
     A variety of factors have been suggested to play a role in the aetiology and 
pathogenesis of metabolic syndrome including genetic influences, insulin 
resistance, environmental factors and Hypothalamic-Pituitary-Adrenal cortex 
(HPA) Axis dysregulation. Increasingly, research findings suggest that there is a 
complex interrelationship between these factors and that the interaction between 
physical and mental ill health places individuals at increased risk of developing 
and maintaining metabolic syndrome. As current interventions target the physical 
metabolic syndrome factors, if a relationship between physical and mental ill 
health can be identified it is possible to expand on current interventions to reduce 
the burden of disease and achieve better health outcomes. This thesis investigates 
these issues. It evaluates the role of Depression, Anxiety and Stress in the 
pathogenesis of metabolic syndrome as well as the reverse relationship, using a 
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sample of Australian farm men and farm women, a population known to have 
poorer physical health outcomes and to be susceptible to unique and sometimes 
catastrophic individual, financial and environmental stressors.  
 
     Chapter 1 begins with a description of the conceptualisation, definitions and 
criteria of metabolic syndrome. A review of the prevalence, course, burden of 
disease and opportunity for recovery from metabolic syndrome is presented. 
Aetiological models are discussed, and the HPA axis dysregulation hypothesis of 
metabolic syndrome is reviewed.  
 
     Chapter 2 provides a review and evaluation of research into the link between 
metabolic networks and mood disorders. The co-occurrence of metabolic 
syndrome and Depression, and evidence of the predictive values of each of these 
factors in determining poorer outcomes is reviewed and the limitations within the 
current body of research are discussed.   
 
     Chapter 3 reviews the status of rural physical and mental health in Australia, 
provides an overview of Australian farm men and women, and the determinants of 
poorer health outcomes amongst this population explored.  
 
     Chapter 4 details the aims of the proposed study, including details about the 
program from which the data was drawn from. Chapter 5 details the methodology 
used to achieve the research aims. It also describes the setting and participant 
demographics for this project.  
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     Chapter 6 outlines the results of the cross-sectional study conducted on data 
collected at the commencement of the program, including comparisons to results 
from previous research. Results pertaining to metabolic syndrome and its 
individual factors, Depression, Anxiety and Stress, and the relationships between 
these are also presented.  
 
     Chapter 7 outlines the results of the longitudinal study conducted 
approximately 12 months later. Results pertaining to predictive relationships 
between Depression, Anxiety and Stress and metabolic syndrome, as well as the 
role of Depression, Anxiety and Stress in the maintenance of metabolic syndrome 
are also presented.  
 
     Chapter 8 discusses the results of the project and examines key findings. 
Significant relationships between Depression, Anxiety and metabolic syndrome 
are explained and the role of the HPA axis dysregulation hypothesis and 
environmental factors are reviewed. Limitations of the study and recommendations 
for future research are explored, followed by the implications of the findings and 
concluding remarks.  
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Chapter 1: Metabolic Syndrome Research 
1.1 Conceptualisation of Metabolic Syndrome 
     Over the past two decades, 'metabolic syndrome' has gained increasing 
attention in medical research and literature due to the important role it plays in the 
aetiology and clinical course of non-insulin-dependent diabetes and coronary 
heart disease (Eckel et al., 2005; Reaven, 1993). Also known as ‘Syndrome X’, or 
‘The Insulin Resistance Syndrome’, it can best be described as a clustering of 
metabolic, anthropometric and haemodynamic abnormalities that, when occurring 
together, significantly increase the risk of morbidity and mortality from Type II 
diabetes and cardiovascular disease (CVD). The word ‘syndrome’ is used as the 
term defines a group or recognizable pattern of symptoms or abnormalities that 
indicate a particular trait or disease (IDF, 2006). However, whilst metabolic 
syndrome is currently used as a clinical tool to identify and inform treatment for 
individuals who are at significantly increased risk of cardiovascular disease or 
Type II diabetes, it is not predictive of these events. 
 
     Metabolic syndrome is not a new condition. As early as 1923 a Swedish 
physician, Kylin, described a condition associated with the presence of 
hyperglycaemia, hypertension and gout (Ford & Giles, 2003; Zimmet, Alberti & 
Shaw, 2005). During the 1940s, it was noted that Type II diabetes and CVD were 
often observed in those with upper body adiposity (male-type or android obesity) 
(Eckel et al., 2005; Zimmet et al., 2005). However, it was not until 1988 that real 
interest was generated when Gerald M. Reaven, a Medical Doctor with the 
Department of Medicine at Stanford University, noted that several metabolic and 
hemodynamic abnormalities including hyperglycaemia, hypertriglyceridemia, 
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hypertension, abdominal obesity and low high-density lipoprotein cholesterol 
concentration, commonly cluster together in individuals with diabetes or coronary 
heart disease, (Gami et al., 2007; Reaven, 1993). In an effort to emphasise these 
relationships and to assist in understanding their importance in the aetiology and 
clinical course of coronary heart disease, high blood pressure and non-insulin-
dependent diabetes, Reaven called this clustering of risk factors Syndrome X 
(Grundy, Brewer, Cleeman, Smith & Lenfant, 2004; Reaven, 1993).  
 
     Reaven (1993) also postulated that the primary defect associated with the risk 
factors of this syndrome was insulin-resistance. Insulin is a hormone produced by 
the pancreas which assists the body’s use of glucose for energy. A simplified 
explanation of insulin resistance is that it is a condition in which the body’s liver, 
muscle and fat cells do not respond properly to the uptake of insulin, usually due 
to an overabundance of circulating fatty acids derived from adipose tissue; thus 
the body requires more insulin to help glucose enter cells. The pancreas must 
therefore work harder to produce more insulin and eventually fails to keep up with 
the body’s requirements. This results in excess glucose building up in the 
bloodstream which significantly increases the chance of developing Type II 
diabetes and cardiovascular disease (Eckel et al., 2005; Groop, 2000; National 
Institute of Diabetes and Digestive and Kidney Diseases, 2011). 
 
     In the context of the increasing global burden of ‘diseases of modern 
civilization’ (e.g. obesity, Type II diabetes, hypertension, high cholesterol and 
cardiovascular disease), it was suggested by Reaven (1993) and subsequently 
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others, that the pathogenesis of Syndrome X was embedded in interactions 
between genetic factors, diet, and a sedentary lifestyle.  
 
     Due to the amplified risk of morbidity and mortality associated with the 
clustering of metabolic syndrome factors, the increased clinical interest and 
research in metabolic syndrome, and the need to allocate research and health care 
resources, a standard definition of metabolic syndrome risk factors was required. 
In 1997, the American Diabetes Association (1998) proposed that the ‘insulin 
resistance syndrome’ comprised a number of risk factors including central 
obesity, glucose intolerance and dyslipidaemia; however no specific thresholds or 
definitions were proposed (Gami et al., 2007). In 1999, the World Health 
Organization (WHO) proposed a unifying definition of these risk factors and 
chose to call it ‘metabolic syndrome’ rather than ‘insulin-resistance syndrome’, 
partly due to the fact that the underlying cause of the factors had not been 
established (Groop, 2000). This definition included the WHO’s perception of the 
components of metabolic syndrome and associated cut-off criteria, including high 
blood pressure, elevated plasma triglyceride levels, low HDL cholesterol, high 
BMI and/or high waist-hip ratio, and overnight urinary albumin excretion. 
However, it was discovered that the proposed cut-off for waist-hip ratio alone 
would classify 80-90% of the population as obese and therefore disagreement 
continued amongst the different international healthcare stakeholders (including 
the WHO, the National Cholesterol Education Program – Adult Treatment Panel 
III (ATP-III), the European Group for the Study of Insulin Resistance (EGIR), and 
International Diabetes Federation) in reaching a consensus on the unique 
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components of metabolic syndrome and threshold values that should be assigned 
(Eckel et al., 2005; Gami et al., 2007; Groop, 2000).   
 
     In 2001, an expert panel was convened to provide a new working definition for 
metabolic syndrome which, in 2006, was the most widely used in the United 
States to identify and research metabolic syndrome (Sierra-Johnson et al., 2006). 
The proposal by the third report of the National Cholesterol Education Program-
Adult Treatment Panel III (ATP-III) suggested that three or more of the following 
5 criteria must be met to identify metabolic syndrome in individuals: high waist 
circumference, hypertriglyceridemia (elevated levels of triglycerides), low High-
Density Lipoprotein (HDL) cholesterol, high fasting glucose, and high blood 
pressure. Table 1 (below) provides a list of the criteria and threshold values of the 
ATP-III criteria.  
 
Table 1.   
ATP III Metabolic Syndrome Criteria* 
Criteria Values (Male) Values (Female) 
Waist Circumference >102cm >88cm 
Hypertriglyceridemia ≥150mg/dL 
(1.69mmol/L) 
≥150mg/dL 
(1.69mmol/L) 
Low High-Density 
Lipoprotein (HDL) 
Cholesterol 
<40mg/dL (1.04mmol/L) <50mg/dL (1.29mmol/L) 
High Fasting Glucose ≥110mg/dL (6.1mmol/L) ≥110mg/dL (6.1mmol/L) 
High Blood Pressure ≥130/85 mmHg ≥130/85 mmHg 
*Three or more of the above criteria must be met for a diagnosis of metabolic syndrome 
 
5 
 
     In 2003, the ATP III cut-off point for fasting glucose level was modified to ≥ 
100mg/dL (5.6 mmol/L) to refocus the primary cause of metabolic risk factors as 
insulin resistance (Grundy et al., 2005). 
 
     Whilst there is a general consensus amongst various stakeholders that the 
factors shown in Table 1 are appropriate for the diagnosis of metabolic syndrome, 
there is still some contention as to cut-off values for each of the risk factors due to 
the effects on prevalence rates and also the risk of under-identification of 
individuals or ethnic sub-groups who are at risk of cardiovascular disease and 
diabetes. For example, within the United States of America (USA) a comparison 
of the WHO criteria and the ATP-III criteria resulted in substantially different 
prevalence estimates for African-American men; 24.9% & 16.5% respectively 
(Ford, Giles & Dietz, 2002). Further, research into the diagnostic accuracy of 
ATP-III criteria for the metabolic syndrome among asymptomatic Caucasian 
adults (N = 256) has shown that this criteria set provides good specificity but low 
sensitivity for the identification of insulin resistance amongst this cohort, and that 
waist circumference alone appears to provide greater overall diagnostic accuracy 
than the combined components of metabolic syndrome (Sierra-Johnson et al., 
2006).  
 
     In 2006, the International Diabetes Foundation (IDF) (2006) released what it 
termed the ‘worldwide definition of metabolic syndrome’ to address both clinical 
and research needs. This definition does not rely on measurements only available 
in research settings, and it includes a comprehensive list of additional criteria for 
use in epidemiological studies and other research. Table 2 provides a list of the 
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IDF criteria. Central to this definition is central obesity (defined as waist 
circumference), plus any two of the four factors of raised triglycerides, reduced 
HDL cholesterol, raised blood pressure and raised fasting plasma glucose.  
 
Table 2. 
 IDF Metabolic Syndrome Criteria 
Central obesity (defined as waist circumference* with ethnicity specific values) 
plus any two of the following four factors: 
Raised serum triglycerides ≥150mg/dL (1.7mmol/L)  
or specific treatment for this lipid abnormality 
Reduced (HDL) serum 
Cholesterol 
<40mg/dL (1.03mmol/L) in males 
<50mg/dL (1.29mmol/L) in females  
or specific treatment for this lipid abnormality 
Raised  Blood Pressure Systolic BP ≥130 or diastolic BP ≥85 mmHg 
or treatment of previously diagnosed 
hypertension 
Raised Fasting Plasma 
Glucose 
(FPG) ≥100mg/dL (5.6 mmol/L),  
or previously diagnosed type 2 diabetes 
If above 5.6 mmol/L or 100 mg/dl, Oral Glucose 
Tolerance Test is strongly recommended but is not 
necessary to define presence of the syndrome. 
*If BMI is >30kg/m2, central obesity can be assumed and waist circumference does not need to be 
measured.       
 
     Table 3 (below) provides the IDF ethnic group specific values for waist 
circumference. This is an important inclusion as previous research has shown 
significant differences in the prevalence rates of metabolic syndrome between 
ethnic groups when using the ATP III criteria for research purposes (Ford et al., 
2002) and accommodates the anthropometric differences between ethnic groups 
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(Magliano, Shaw & Zimmet, 2006). The IDF also recommends that these ethnic 
group specific cut-off criteria should be used for members of the same ethnic 
group no matter where they are residing. Therefore, the criteria recommended for 
South Asian populations should also be used in expatriate South Asian 
communities for research and clinical purposes. As a result of these 
improvements, the IDF definition is increasingly being used in research. 
 
Table 3.  
IDF Ethnic Specific Values for Waist Circumference 
Country/Ethnic group Waist circumference 
Europids* 
In the USA, the ATP III values (102cm 
male; 88cm female) are likely to continue 
to be used for clinical purposes 
Male 
 
Female 
≥ 94cm 
 
≥ 80cm 
South Asians 
Based on a Chinese, Malay and Asian-
Indian population 
Male 
 
Female 
≥ 90cm 
 
≥ 80cm 
Chinese Male 
 
Female 
≥ 90cm 
 
≥ 80cm 
Japanese** Male 
 
Female 
≥ 90cm 
 
≥80cm 
Ethnic South and Central Americans Use South Asian recommendations 
until more specific data are available 
Sub-Saharan Africans Use European data until more specific 
data are available 
Eastern Mediterranean and Middle East 
(Arab) populations 
Use European data until more specific 
data are available 
*In future epidemiological studies of populations of Europid origin, prevalence should be given 
using both European and North American cut-off points to allow better comparisons. 
**Originally different values were proposed for Japanese people but new data support the use of 
the values shown above. 
      
     In 2009, representatives from the International Diabetes Federation Task Force 
on Epidemiology and Prevention held discussions in an attempt to resolve 
differences in the definitions of Metabolic Syndrome (Alberti et al., 2009). It was 
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agreed that the categorical cut-off points for triglycerides, HDL, blood pressure 
and fasting blood glucose would remain the same as for the IDF definition (see 
Table 2 above), and that meeting any three of the five criteria would establish a 
clinical diagnosis of metabolic syndrome. However, it was also recommended 
that, rather than the adoption of an International criteria, waist circumference 
would require further cross-sectional and longitudinal research to determine sex 
and ethnic differences, which would allow particular health systems to adopt local 
population cut-off points for economic and pragmatic reasons. 
 
     Although there are other definitions of metabolic syndrome, such as the WHO 
definition and the European Group for the Study of Insulin Resistance (EGIR) (a 
modified version of the WHO definition to be used with subjects without a 
diagnosis of diabetes) (Cameron, Magliano, Zimmet, Welborn & Shaw, 2007), a 
review of the literature demonstrates that the most widely used definitions in 
research within the USA and Australia are those of the ATP III and IDF.  
 
     Controversy around the definitions and specific values associated with 
metabolic syndrome appear to reflect the various conceptual aetiological 
frameworks (Magliano et al., 2006). Whilst initially proposed as a means of 
identifying insulin resistance, research has shown that not all of those meeting the 
criteria for Metabolic syndrome have insulin resistance which has, in turn, called 
into question the clinical usefulness of the syndrome (Cameron et al., 2007; 
Grundy et al., 2004; Khan, 2008).   However, as Khan (2008) notes, even amongst 
critics, there is no doubt that the combination of the metabolic syndrome risk 
factors for Type II diabetes and CVD are “found more often in combination than 
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chance alone would dictate” (p. 1892). Therefore, metabolic syndrome is an 
advantageous indicator in the research, and the identification and treatment of 
those individuals and populations at increased risk of CVD or Type II diabetes.  
 
1.2 Prevalence and Course of Metabolic Syndrome 
     Due to the relatively recent addition, and differing definitions of metabolic 
syndrome, prevalence data are somewhat limited.  However, the available data are 
alarming as they provide evidence that not only is metabolic syndrome highly 
prevalent, it is also rapidly increasing in prevalence. 
 
1.2.1 Prevalence 
     To initially estimate the prevalence rates in the USA, Ford et al. (2002) used 
data from the Third National Health and Nutrition Examination Survey 
(NHANES III), a cross-sectional, multistage, stratified sampling design survey 
conducted during 1988 and 1994 using a representative sample of the non-
institutionalized civilian population aged 20 years and older (N=8814). Using the 
ATP III criteria (see Table 1) the overall unadjusted and age-adjusted prevalence 
rates of metabolic syndrome were 21.8% and 23.7% respectively. From age 20 
through to 29 years, the prevalence rate of 6.7%, continued to increase over the 
life-span to 43.5% for participants aged 60 through 69 years. Little difference was 
found in the prevalence rates for men (24.0%) and women (23.4%).  
 
     Further research conducted by Ford, Giles and Mokdad (2004) that included 
data (N = 1677) from the NHANES 1999-2000 survey, found that the age-
adjusted prevalence rates had increased by 23.5% (p = 0.021) amongst women 
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and 2.2% among men (p = 0.831), with rises in waist circumference, high blood 
pressure and hypertriglyceridemia accounting for much of this increase.  
 
     In an attempt to understand world-wide prevalence of metabolic syndrome, 
Eckel et al., (2005) presented the findings from various countries using the ATP 
III criteria (Figure 1). Although these various studies differed in design, precise 
metabolic syndrome definitions used, sex and age structure of the populations, 
year they were undertaken and sample selection, Eckel et al. (2005) believe that 
certain inferences can be drawn about prevalence of metabolic syndrome in urban 
populations.  
 
Figure 1. World-wide Prevalence of Metabolic Syndrome from ATP III Definition 
 
     A comparison of four populations within the Asia-Pacific Region with 
distinctly different ethnic backgrounds (‘Asian’ for Japan and Korea; ‘Europid’ 
for Australia; and ‘Pacific Islander’ for Samoa) aged >35 years, also found 
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distinctly different prevalence rates of metabolic syndrome between countries 
(Lee et al., 2008). Table 4 (below) provides a summary of the age-adjusted 
prevalence rates using both the ATP III and IDF criteria. Lee et al. (2008) ensued 
that the inclusion of the ethnic specific waist circumference of the IDF definition 
appears to capture more of the at-risk population than the ATP III criteria would.  
 
Table 4.  
Summary of Age-Adjusted Prevalence (%) of Metabolic Syndrome in Adults Aged 
≥ 35years 
 Australia Japan Korea Samoa 
Male     
ATP III 35.7 8.1 12.5 39.2 
IDF 42.2 7.5 12.7 45.3 
Female     
ATP III 28.3 9.9 22.8 57.4 
IDF 33.3 11.3 28.9 59.5 
 
 
     Within Australia, research of the Australian adult population aged 25 years and 
over has estimated metabolic prevalence rates to be between 22.1% (95% CI, 
18.8-25.4) and 30.7% (95% CI, 27.1-34.3) using the ATP III and IDF criteria 
respectively (Cameron et al., 2007). A nationally representative, cross-sectional 
study of the Australian population (N = 11,247) by Cameron et al. (2007), using 
data collected in 1999-2000 for the Australian Diabetes, Obesity, and Lifestyle 
Study (AusDiab), also found that prevalence rates increased with age, with 
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estimates peaking amongst those participants aged 65-74 at approximately 43% 
and 52% using the ATP III and IDF criteria respectively. Gender differences were 
also found, with prevalence amongst males significantly greater than amongst 
females (APT III – 24.4% versus 19.9%, p < 0.001; IDF 34.4% versus 27.2%, p < 
0.001).  
 
     Another urban Australian cross-sectional study, using a representative random 
sample of predominantly European adults from Adelaide, South Australia (N = 
5,850) found that the rate of metabolic syndrome was 22.8% (15.7% women; 
26.4% men) using the IDF definition, and 15.0% using the ATP III definition 
(14.4% women; 19.4% men) (Adams et al., 2005). Congruent with findings from 
previous studies, the prevalence rate increased with age, with 45.7% (IDF 
definition) and 29.5% (ATP III definition) of men between the ages of 55 and 69 
meeting the criteria for metabolic syndrome. For women, those 70 years of age 
and over had the highest prevalence rates for both the IDF and ATP III 
definitions; 45.5% and 24.8% respectively.  
 
     Within rural Australia, the prevalence rates for metabolic syndrome are even 
greater than those of their urban counterparts and substantially higher than those 
reported in the 1999-2000 AusDiab survey. A study by Janus et al. (2007) 
conducted in rural areas of south-eastern Australia using a stratified random 
sample of the population aged 25-74 years (N = 806), found the prevalence of 
metabolic syndrome, as defined by ATP III, was 27.1% (95% CI, 22.7-31.6) in 
men and 28.3% (95% CI, 24.0-32.6) in women. When using the IDF definition, 
prevalence rates for men and women were 33.7% (95% CI, 29.0-38.5) and 30.1% 
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(95% CI, 25.7-34.5) respectively. Fundamental to the observed differences in 
prevalence rates was the incidence of central obesity using the IDF waist 
circumference criteria of ≥ 94cm for men and ≥80cm for women (as opposed to 
the ATP III criteria of ≥102cm for men and ≥ 94cm for women), which resulted in 
61.9% of men and 72.4% of women being classified as overweight or obese. It 
was also found that when using waist circumference as the criterion, prevalence of 
obesity ranged from 46.4% in regional centres to 49.8% in smaller towns. Of note 
was the comparison conducted by Janus et al. (2007) of their data with that of the 
1989 National Heart Foundation of Australia (NHFA) Risk Factor Prevalence 
Study, which found that whilst mean height had not increased in either sex, mean 
weight had increased by an average of 10kg for both sexes, and waist 
circumference had increased by an average of 12cm in men and 16cm in women. 
Janus et al. (2007) also reported that these increases were even greater than those 
of the 1999-2000 AusDiab study, which indicated an increase of 7cm in men and 
8cm when compared with the NHFA 1989 study. These findings are consistent 
with trends of increased central obesity and development of myocardial infarction 
and diabetes (Janus et al., 2007). 
 
1.2.2 Course 
     As noted above, those defined as having metabolic syndrome have a 
substantially elevated risk of developing Type II diabetes and CVD. This is not 
surprising as the different factors included in the definitions of metabolic 
syndrome are all risk factors for these diseases. Within a European population, 
relative hazard ratios for CVD outcomes in people with metabolic syndrome 
compared to those without it  ranged from 2 to 5 (Eckel et al., 2005). Prospective 
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studies of middle-aged persons have also shown that of all new-onset CVD cases, 
metabolic syndrome alone was able to predict around 25% of cases (Grundy et al., 
2004; Lakka et al., 2002).  
 
     In an attempt to quantify the impact of metabolic syndrome on early-onset 
coronary artery disease (CAD), Iribarren et al. (2006) conducted a case-controlled 
study of early-onset CAD subjects (N = 393) and individually matched control 
subjects (N = 393). It was found that after adjusting for external risk factors such 
as smoking, body mass index (BMI), educational attainment and alcohol 
consumption in men >46 years and women >56 years, the odds of early-onset 
CAD in the presence of metabolic syndrome by ATP III criteria was a 5-fold 
increase in the absence of diabetes and an 8-fold increase when combined with a 
diagnosis of diabetes.  
 
     A meta-analysis of 37 longitudinal studies that included 43 cohorts and 
172,573 individuals has also been conducted to assess the association between 
metabolic syndrome and cardiovascular events and mortality (Gami et al., 2007). 
This study found the overall pooled relative risk (RR) for cardiovascular events 
and death in people with metabolic syndrome was 1.78 (95% CI, 1.58-2.00). More 
interesting were the results of the pooled analysis of studies that simultaneously 
adjusted multivariate models for both metabolic syndrome and its components. 
This analysis demonstrated that patients with metabolic syndrome have around a 
50 per cent increased risk of cardiovascular disease beyond its individual 
components when compared with patients without metabolic syndrome (RR = 
1.54, 95% CI 1.32-1.79) (Gami et al., 2007). This finding has important 
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implications for both the clinical usefulness of metabolic syndrome and the 
identification, treatment and prevention planning of those at risk of CVD. 
 
     Several studies have also indicated the predictive value of metabolic syndrome 
in the development of Type II diabetes, which accounts for 90 per cent of all 
diabetes (Eckel et al., 2005; IDF, 2006). However, given that glucose intolerance 
was initially purported in the aetiology of metabolic syndrome, this association is 
not surprising. A British study that investigated outcome data from two 
prospective studies on non-diabetic individuals found that metabolic syndrome 
was associated with an increased risk of diabetes in elderly persons aged 70-82 
years (N = 5,804) (HR = 4.41, 95% CI, 3.33-5.84) and also in middle aged men 
aged between 40-59 years (N = 7735) (HR = 7.47, 95% CI, 4.90-11.46) (Sattar et 
al., 2008). However, Sattar et al. (2008) concluded that metabolic syndrome was 
not required to identify those at risk of developing Type II diabetes within the 
younger cohort as fasting glucose alone was able to predict the onset of Type II 
diabetes. Nevertheless, amongst the older cohort in their study, there was a 
significant association between meeting the criteria for metabolic syndrome and 
the incidence of diabetes (HR = 4.41, 95% CI, 3.33-5.84), whilst fasting glucose 
alone was only able to account for less than 50% of participants developing overt 
diabetes. No other individual risk factor alone was able to account for diabetes.  
 
     Beyond Type II diabetes and CVD, individuals with metabolic syndrome are 
purported to be susceptible to conditions such as polycystic ovary syndrome, sleep 
disturbances, some forms of cancer, fatty liver, cholesterol gallstones, and stroke 
(Grundy et al., 2004; Rosmond & Bjorntorp, 2000), although no causality has 
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been established. Again, the purporting of these associations is not surprising 
given that individual metabolic syndrome risk factors have been implicated in 
their aetiology previously. What has not been researched to date is the increased 
risk of these conditions when combined with meeting the criteria for metabolic 
syndrome. Nevertheless, the development of Type II diabetes and CVD, along 
with their respective complications, creates a global burden that impacts 
profoundly on healthcare systems. 
 
1.3 Burden of Disease and Negative Outcomes 
There are currently no figures available for the burden of disease related to 
metabolic syndrome, however the IDF (2006) provides the most comprehensive 
information regarding the burden of disease associated with the negative 
outcomes of metabolic syndrome: Type II diabetes (and associated complications 
such as amputation, blindness and kidney failure) and cardiovascular 
complications. It is predicted that by the year 2025, the incidence of diabetes will 
double, suggesting a comparable rise in cardiovascular-related morbidity and 
mortality.  
 
At present, it is conservatively estimated that diabetes in those aged between 
20 and 79 years of age has an annual global health care cost of 286 billion 
international dollars (ID) and that if the prevalence continues to rise as predicted, 
by 2025 this figure will increase to 396 billion ID, the equivalent of 13 per cent of 
the world’s healthcare budget (IDF, 2006). However, in countries where there is 
high prevalence of diabetes, this figure could be as much as 40 per cent of their 
healthcare budget. The IDF (2006) also specifies that these figures do not include 
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the co-morbid burden of CVD associated with metabolic syndrome where clinical 
diabetes is not yet present. Thus, the burden of disease from metabolic syndrome 
and associated risk factors is likely to be much greater than both the current 
figures and future estimates. However, there is an opportunity to reduce the risk 
factors associated with metabolic syndrome and possibly an opportunity for 
recovery. 
 
1.4 Opportunity for Recovery  
     The strength of the metabolic syndrome diagnosis is that it identifies the 
clustering of metabolic abnormalities that are associated with an increased risk of 
developing CVD or Type II diabetes. However, it has been suggested that once 
detected, this risk can be significantly reduced through relatively simple and 
inexpensive therapeutic lifestyle changes. 
 
     Core to the IDF’s definition, and included in the ATP III’s definition of the 
metabolic syndrome, is central obesity. Obesity alone is associated with higher 
CVD risk and contributes to high serum cholesterol, hyperglycaemia, 
hypertension and low HDL cholesterol and can lead to a decrease in insulin-
mediated glucose uptake (IDF, 2006; Reaven, 1993). Whilst metabolic syndrome 
can be found in non-overweight or non-obese individuals, suggesting that it is not 
solely determined by environmental factors but also genetic and endocrine factors, 
appropriate levels of habitual physical activity (at least 30 minutes of brisk 
walking per day) and weight management appear to be the cornerstone in any 
attempt to reduce risk factors associated with metabolic syndrome (Eckel, Khan, 
Robertson & Rizza, 2006; Ford et al., 2002; Grundy et al., 2005; Lakka & 
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Laaksonen, 2007; Reaven, 1993). Indeed, research has demonstrated that an 
increase in physical activity when combined with dietary modifications improves 
insulin sensitivity, reduces insulin resistance, decreases blood pressure, increases 
high-density lipoprotein (HDL) cholesterol, decreases triglyceride levels, and may 
prevent or delay the onset of Type II diabetes, CVD and premature mortality.  
These reductions can often occur independent of weight loss (Ford et al., 2002; 
Grundy et al., 2004; Lakka & Laaksonen, 2007; Shaw & Chisholm, 2003). An 
uncontrolled study on sedentary individuals with metabolic syndrome (N = 105) 
showed that after 20 weeks of aerobic exercise training around 30% (N = 32) no 
longer met the criteria for metabolic syndrome, with no sex or ethnic differences 
in the efficacy of this treatment (Katzmarzyk et al., 2003).  
 
     As epidemiological data suggest that many components of metabolic syndrome 
are modifiable through diet and exercise, primary interventions should aim to 
include healthy therapeutic lifestyle changes including moderate calorie restriction 
(to promote weight loss) and moderate increase in physical activity (Feldeisen & 
IDF, 2006; Lakka & Laaksonen, 2007; Shaw & Chisholm, 2003; Tucker, 2007).   
However, research has also shown large individual differences in the magnitude 
of the effect of regular exercise on metabolic syndrome (Lakka & Laaksonen, 
2007). There is also currently no consensus regarding the most appropriate dietary 
recommendations for metabolic syndrome, although it has been suggested that 
gene-diet interaction research may clarify this in the future and result in tailored 
dietary recommendations (Feldeisen & Tucker, 2007).  These conclusions appear 
to confirm that the underlying aetiological mechanisms and pathogenesis of 
metabolic syndrome are still ill-defined and that metabolic syndrome may have a 
19 
 
multifactorial aetiology, including genetic, environmental and endocrine factors 
which will, in turn, affect the pathogenesis for individuals. To be able to refine 
interventions and treatments it is important to understand the underlying risk 
factors and how metabolic syndrome may develop.  
 
1.5 Aetiological Models of Metabolic Syndrome 
     There are currently a number of proposed aetiological models for metabolic 
syndrome, with research suggesting that the development of the syndrome may be 
individualistic and dependent on a number of genetic and environmental 
influences. For example, a twin study using a sample of 125 monozygotic (MZ) 
twins and 178 dizygotic (DZ) twins aged between 55-74 years in Denmark found 
that, amongst the risk factors associated with metabolic syndrome, BMI, glucose 
intolerance and HDL cholesterol concordance rates were significantly higher 
amongst monozygotic (MZ) twins than dizygotic (DZ) twins (Poulsen, Vaag, 
Kyvik & Beck-Nielsen, 2001).  However, gender accounted for much of the 
differences observed, with glucose intolerance among male twins primarily 
explaining the different concordance rates and no evidence of any genetic 
influence on glucose intolerance amongst female twins. Conversely, the 
difference in concordance rates for HDL-cholesterol was only detected amongst 
female twins. Poulsen et al. (2001) also found no differences in concordance rates 
for abdominal obesity, triglycerides, hyperinsulinaemia or hypertension, 
suggesting these particular risk factors of metabolic syndrome are substantially 
environmentally influenced. Therefore, it is important to examine some of the 
major theoretical aetiology models to further understand some of the underlying 
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influences on metabolic syndrome and how these may affect the pathogenesis of 
the syndrome.  
 
1.5.1 Insulin Resistance 
     The original, and possibly most accepted, conceptualisation of metabolic 
syndrome and its pathophysiology is that of ‘insulin resistance’, as first suggested 
by Reaven in 1988 (Reaven, 1993). As stated earlier, insulin resistance occurs 
when the pancreas fails to keep up with the body’s increasing requirement of 
insulin (usually due to an overabundance of circulating fatty acids derived mainly 
from adipose tissue that interfere with the ability of the cells in the liver, muscle 
and fat to absorb insulin), resulting in a build-up of glucose in the bloodstream. In 
turn, these abnormalities increase lipid and glucose levels and elevate blood 
pressure, which significantly increases the risk of developing Type II diabetes and 
CVD. Whilst this is an overly simplified explanation of the mechanism of insulin 
resistance, it does clarify why, regardless of differing opinions on appropriate cut-
off levels, the five risk factors of metabolic syndrome (particularly central 
obesity) were chosen by the major stakeholders given the role that adipose tissue 
fatty acids play in the development of insulin resistance. 
 
     Nevertheless, insulin resistance does not occur in isolation and various 
theoretical models of the pathogenesis of insulin resistance over the years have 
included such factors as age, obesity, foetal malnutrition, genetic inheritance 
and/or abnormalities, and visceral adiposity (Cameron et al., 2007; Ford et al., 
2002; Groop, 2000). Also, whilst it is common for individuals with metabolic 
syndrome to have insulin resistance, a significant proportion do not (Ford et al., 
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2002), suggesting that insulin resistance is not the principal underlying factor of 
metabolic syndrome, even though it may play an important role in the clustering 
of risk factors and may contribute towards outcomes (Grundy et al., 2004; Khan, 
2008). 
 
1.5.2 Environmental Factors 
     As previously stated, the clustering of abnormalities associated with metabolic 
syndrome is associated with increased risk of glucose-intolerance, dyslipidaemia, 
high blood pressure and CVD, which have been referred to as ‘diseases of modern 
civilization’ (Reaven, 1993). It is possible that these diseases have become more 
prevalent in modern society due, in particular, to two environmental determinants: 
an increase in sedentary behaviour (such as watching television) and/or decrease 
in physical activity; and poor dietary habits, including higher caloric intake and 
saturated fat content and lower quality of nutritional intake, known as ‘empty 
calories’  (Eckel et al., 2005; Feldeisen & Tucker, 2007; Ford et al., 2002; Ford, 
Giles & Mokdad, 2004; IDF, 2006; Lakka & Laaksonen, 2007; Poulsen et al., 
2001).  
 
     These two environmental factors are well established as contributing to an 
overweight or obese status, which alone has been implicated in the elevation of 
risk factors in many fatal and nonfatal conditions including low HDL cholesterol, 
hypertension, hyperglycaemia, coronary heart disease, CVD, heart failure and 
stroke, even in the absence of glucose intolerance (Eckel et al., 2006; Grundy et 
al., 2004). There is also evidence of a correlation between abdominal obesity and 
other metabolic risk factors, including insulin sensitivity, although there is the 
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possibility of these factors being a coincidental expression of an unknown third 
factor (Groop, 2000; Grundy et al., 2004).  Nevertheless, obesity has been 
growing steadily in prevalence over the past three decades and has become a 
significant world-wide problem with no socio-economic, ethnic or racial group 
spared (Cameron et al., 2007; Eckel et al., 2006). Obesity is also a simple-to-
measure and modifiable risk factor that can be targeted by clinical and public 
health practitioners to decrease the associated risks (Janus et al., 2007; Magliano 
et al., 2006).  
 
     However, under the ATP III definition which does not require central obesity 
to be included in diagnosis, metabolic syndrome can also develop independently 
of obesity and sedentary activity (Reaven, 1993), and the evidence relating to 
genetic heritability of factors, and gender and age differences, cannot be ignored 
in the aetiology and pathogenesis of metabolic syndrome. Therefore, it appears 
that there is a complex interrelationship between genetic and environmental 
factors in the development of metabolic syndrome that is perhaps triggered by a 
third variable.   
 
1.5.3 Hypothalamic-Pituitary-Adrenal Cortex Axis Activity 
     More recently, Hypothalamic-Pituitary-Adrenal cortex (HPA) Axis activity has 
been implicated in the aetiology and pathogenesis of metabolic syndrome. 
Prolonged stress activates the hypothalamus which then induces the anterior 
pituitary gland to secrete adrenocorticotropic hormone (ACTH), which in turn 
stimulates the adrenal cortex to secrete cortisol, enhancing metabolic activity and 
elevating blood levels of glucose and other nutrients (see Figure 2 below) (Kalat, 
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2007). Compared to the autonomic nervous system, which prepares the body for 
the brief emergency ‘fight or flight’ responses, the HPA axis reacts more slowly 
and plays a central role in the homeostatic processes of the endocrine system 
(Nevid, Rathus & Rubenstien, 1998; Rosemond & Bjorntorp, 2000).  
 
Figure 2. The Hypothalamus-Pituitary-Adrenal Cortex Axis (Kalat, 2007, p. 377) 
 
     In non-stressful situations, cortisol levels should vary throughout the day in a 
circadian, pulsatile pattern of high and varying levels in the morning and 
decreasing between 1600 hours and midnight to less than 75% of the morning 
values (Rosemond & Bjorntorp, 2000; Tsigos & Chrousos, 2002). Whilst 
temporary increases in cortisol levels enhance immune system activity, in 
situations of high levels of prolonged stress the HPA axis becomes the dominant 
response, continually releasing elevated levels of cortisol at the expense of the 
immune system (Kalat, 2007; Nevid et al., 1998). Continued secretion of elevated 
cortisol levels may suppress the production of antibodies to fight illness and 
disease and has been linked to increased vulnerability to the common cold and 
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influenza, and increased risk of chronic diseases including cancer and heart 
disease (Kalat, 2007; Nevid et al., 1998).  
 
     Cortisol levels, as regulated by the HPA axis, also play an important role in 
lipid and glucose metabolism, with evidence of prolonged elevated levels leading 
to Type II diabetes, a redistribution of body fat as characterised by central 
adiposity, and hypertension. A study by Rosemond and Bjorntorp (2000) on men 
chosen from the National Population Register and born within the first six months 
of 1944 (N = 284), demonstrated that a pathological HPA axis function 
(determined by low cortisol variability) in men aged 51 years, was significantly 
inter-correlated with established anthropometric, metabolic and haemodynamic 
risk factors for CVD, Type II diabetes and stroke, including the metabolic 
syndrome risk factor variables, with the exception of low HDL cholesterol.  
 
     As metabolic syndrome risk factors and psychological stress share the same 
endocrine system, HPA axis pathology may be a moderating factor in the 
development of CVD and Type II diabetes (Rosmond & Bjorntorp, 2000; Weber-
Hamann et al., 2002).  There is evidence to suggest that HPA axis pathology 
associated with stress is a plausible underlying pathway to increased risk of 
metabolic syndrome as psychological characteristics such as anger, hostility, 
Depression and Anxiety also influence the risk of developing CVD and diabetes 
(Goldbacher & Matthews, 2007; Weber-Hamann et al., 2002). Evidence of the co-
occurrence of high levels of circulating cortisol and depressive symptoms, also 
known as hypercortisolemic Depression, has also supported this underlying 
pathway as a specific risk factor for metabolic syndrome. Research by Vogelzangs 
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et al. (2007) found a significant interaction between urinary cortisol, Depression 
and metabolic syndrome in an older population (N = 867, M = 74.1 years), with 
the odds of metabolic syndrome in persons with both urinary cortisol excretion in 
the highest tertile and depressed mood to be 1.84 (95% CI = 1.02-3.34, p = 0.003), 
when compared to persons without either condition. It was also found that an 
increased prevalence of metabolic syndrome was significantly associated with 
higher levels of depressive symptoms, which was partially mediated by urinary 
cortisol levels. Similarly, Weber-Hamann et al. (2002) found that when 
comparing post-menopausal female in-patients with a diagnosis of Major 
Depression (N = 22) to an aged-matched healthy control group (N = 23), cortisol 
concentrations were significantly higher in patients than in the control group (26.3 
± 9.9 vs. 10.5 ± 4.6 mmol/L, F(1,37) = 32.9, p < 0.001).  
 
     However, the above findings do not address the relationship between 
psychological distress and subsequent detrimental effects on positive health 
behaviours, including an increase in harmful behaviours and poor compliance 
with treatment regimes which, like metabolic syndrome, are also associated with 
insulin resistance and increased central adiposity (Goldbacher & Matthews, 
2007).   
 
1.6 Summary 
     In summary, metabolic syndrome is a clustering of metabolic, anthropometric 
and haemodynamic abnormalities. With increasing clinical and research interest 
over the past two decades, the definition of metabolic syndrome continues to 
evolve and currently the ATP III and IDF definitions are the most widely used. 
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Limited, global prevalence studies have found that the risk of developing 
metabolic syndrome increases with age, whilst gender differences appear to be 
related to ethnicity. The course of metabolic syndrome places an individual at 
increased risk of development of Type II diabetes and CVD which, along with 
their respective complications, creates a global burden that impacts profoundly on 
healthcare systems. It has been suggested that this risk can be significantly 
reduced through relatively simple and inexpensive therapeutic lifestyle changes 
such as diet and exercise; however large individual differences in the results of 
interventions have been found, suggesting a multifactorial aetiology of metabolic 
syndrome. The differences in intervention results may possibly be explained by 
the HPA axis pathology conceptualisation, which suggests that psychological 
factors may be placing additional stress on an endocrine system that is shared with 
the biological indicators of metabolic syndrome. It is important to understand this 
interrelationship between psychological and biological risk factors in the 
aetiology and pathogenesis of metabolic syndrome as the current treatment 
paradigm is focused on interventions aimed at reducing only physical 
symptomatology. Further understanding of the psychological factors associated 
with metabolic syndrome is imperative for determining those populations at 
higher risk of developing the syndrome and for guiding the development of more 
effective interventions and treatments. Psychological factors associated with 
metabolic syndrome will be examined and evaluated in the following chapters.  
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Chapter 2:  Psychological Factors Associated with Metabolic Syndrome 
2.1 Rationale for Increased Research Interest 
     Over the past decade there has been an increasing volume of research into the 
associations between cortisol, mood disorders (including Depression, Anxiety and 
Stress) and the component factors of metabolic syndrome.  From the literature 
reviewed, it appears that this shift has occurred for a number of reasons, including 
the inability to ascertain a direct cause and effect relationship between 
physiological factors and the pathogenesis of metabolic syndrome. The 
formulation of the HPA axis pathology hypothesis, which suggests that a shared 
endocrine system that is influenced by both physical and psychological factors is a 
plausible pathway in the aetiology of metabolic syndrome. This has led to a 
paradigm shift amongst psychologists and other health professionals towards 
developing an understanding of relationships between psychological factors (e.g. 
behaviours, attitudes, and beliefs) and health and illness.  
 
     Along with physical illnesses, Depression has been identified by the WHO as 
one of the top 10 worldwide health problems. It is responsible for the greatest 
proportion of burden attributable to non-fatal health outcomes, accounting for 
almost 12% of total years lived with disability worldwide (Muhtz , Zyriax, Klahn, 
Windler & Otte, 2009). In fact, it is estimated that by 2020 unipolar Depression 
will account for the second largest burden of disease worldwide, after ischemic 
heart disease (Viinamaki et al., 2009). Depression has also been associated with 
an increased risk of developing a number of physical illnesses, including 
cardiovascular disease (Whooley, 2006). A number of authors have suggested a 
link between metabolic and psychological factors and suggest the risk estimates 
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may be additive if a person has both metabolic syndrome and Depression. Recent 
explanatory theories, such as that of HPA axis activity (as discussed in Chapter 1), 
have also posited that alterations in metabolic networks mediate allostasis, that is, 
the process of achieving homeostasis through behavioural or physiological 
change. In the short term, they are essential for adaptation, maintenance of 
homeostasis, and survival (allostasis). Yet, over longer time intervals, they exact a 
cost (allostatic load) that can accelerate disease processes, such as metabolic 
derangements. Therefore, awareness of depressive symptoms could be important 
in the detection and clinical management of metabolic syndrome. This chapter 
will evaluate and discuss the research available on the relationship between 
psychological and metabolic risk factors, and identify those individuals or 
populations who are at increased risk of metabolic syndrome. 
 
2.2 Metabolic Networks and Mood Disorders 
     A systematic review by McIntyre et al. (2007) of 40 years of research 
conducted between 1966 and 2006 found evidence that disturbances in metabolic 
networks are implicated in depressive disorders in a number of ways, including 
pathophysiology (changes in the normal mechanical, physical and biochemical 
functions, caused by disease or resulting from an abnormal syndrome), brain 
volumetric changes, symptomatic expression (e.g., neurocognitive decline), and 
medical comorbidity. The authors also found a number of shared abnormal 
metabolic process overlaps between Major Depressive Disorder and Type II 
diabetes, suggesting shared pathophysiological mechanisms. In fact, the authors 
went as far as proposing that alternations in metabolic networks are such a 
defining component in pathophysiology, that a neuropsychiatric syndrome of 
29 
 
‘metabolic syndrome Type II’ be conceptualised as a basis for testing metabolic 
influence and therapies for mood disorders. Whilst initially this may appear a 
brave proposal, a study of 60 acute depressive adult inpatients found that those 
patients with metabolic syndrome (n = 15) had significantly higher triglyceride 
blood levels in acute Depression than those without metabolic syndrome (n = 45), 
t (56) = 4.83, p < 0.01) (Richter, Juckel & Assion, 2010). Richter et al. (2010) also 
found a significant positive correlation between meeting the criteria for 
hypertriglyceridemia and severity of Depression, as measured by the Clinical 
Global Impression Scale (CGI) score, as a characteristic of the group with 
metabolic syndrome (r = 0.65, p < 0.01). Richter et al. (2010) posited that 
Depression and elevated triglycerides may be linked by an assumed activation of 
the HPA axis, citing research by Glueck et al. (1993) as support for their 
argument. Glueck et al. (1993) suggested a reversible causal relationship between 
high triglycerides and symptoms of Depression as the authors found after a 54-
week single blind treatment with triglyceride-lowering diet and medication, a 
concurrent major shift toward amelioration or absence of depressive symptoms, as 
measured by the Beck Depression Inventory, was observed.  
 
     Whilst it would be pragmatic to suggest that Depression and/or metabolic 
syndrome could be treated by focusing on metabolic factors alone, it does suggest 
an interrelationship between the two, and provides some further support of the 
HPA axis hypothesis.  
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2.3 Co-occurrence of Metabolic Syndrome and Depression 
     Research on the co-occurrence of metabolic syndrome and Depression is 
typically undertaken using standard clinical means and measures for metabolic 
syndrome factors, and self-report questionnaires for psychological symptoms of 
Depression and Anxiety, such as the Beck Depression Inventory (BDI-21) or the 
Hospital Anxiety and Depression Scale (HADS), and the Kessler 10 measure of 
Psychological Distress (K10). Whilst self-report measures have their limitations, 
particularly the possibility of exaggeration or minimisation of symptoms 
depending on the motivation of the respondent, they are more economically viable 
for larger scale research than clinical interviews and their use is considered 
acceptable practice (Gregory, 2007).   
 
     Most studies have also used the ATP III definition of metabolic syndrome 
which has allowed for comparison between the studies. However, they may not 
have captured a significant proportion of those who may meet the criteria for 
metabolic syndrome under the more sensitive IDF definition, which could be 
considered a possible limitation of these studies.  
 
     Nevertheless, research supporting the co-occurrence of metabolic syndrome 
and Depression is growing. One study in Finland (Miettola, Niskanen, Viinamaki 
& Kumpusalo, 2008), using eight adult birth cohorts (N = 416) found the 
prevalence rate of metabolic syndrome was 37% (39% in men and 35% in 
women). The mean BDI-21 total score was 7.07 among the subjects with 
Metabolic Syndrome and 5.49 among the subjects without Metabolic Syndrome 
(mean difference −1.585 and 95% CI −2.917; − 0.253). Miettola et al. (2008) also 
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examined items within the BDI-21 and found that participants with metabolic 
syndrome were significantly worse off than those without on the items relating to 
irritability (p = 0.006), work inhibition (p = 0.003), fatigability (p = 0.011), weight 
loss (p = 0.013), and loss of libido (p = 0.014). Gender comparisons found that 
whilst men with metabolic syndrome scored significantly higher on all of the 
above items than those men without, for women the item ‘loss of libido’ was the 
only significant difference. Logistic regression analysis, using a BDI-21 cut-off 
point of 14/15, and adjusted for age, vocational education, marital status and 
working status, found significant associations between self-reported Depression 
and elevated blood glucose amongst men (OR = 1.697, 95% CI, 1.185-2.430, p = 
0.004) and large waist circumference amongst women (OR = 1.066, 95% CI, 
1.009-1.127, p = 0.024).  
 
     Another study conducted in France by Skilton, Moulin, Terra and Bonnet 
(2007) on 1598 patients (aged 30-80 years) referred to an outpatient centre on the 
basis of possessing at least one CVD risk factor, found metabolic syndrome 
present in 61.5% of the study population, Anxiety in 62.6% and Depression in 
24.5%, when using the Hospital Anxiety and Depression Scale (HADS) as the 
self-report measure. When comparing those with metabolic syndrome with those 
without, there was a significantly higher rate of Depression in men (22.5% vs. 
15.5%, p = 0.007) and women (38.6% vs. 23.3%, p < 0.001), which persisted after 
adjusting for age, prior cardiovascular disease, employment status and marital 
status, and was only slightly altered by the addition of smoking status, dietary 
score and physical activity. No gender differences were found when examining 
these associations. The association of metabolic syndrome and Depression was 
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consistently observed across BMI categories and was of a similar magnitude in 
both the youngest and oldest quartiles. Skilton et al. (2007) also found that the 
primary metabolic syndrome component associated with Depression was 
abdominal obesity, although the association was found to be markedly stronger 
among women than among men. Interestingly, no association was found between 
metabolic syndrome and Anxiety. However the prevalence of metabolic syndrome 
in those with both Anxiety and Depression was similar to those with Depression 
alone, suggesting a relatively greater association with Depression and metabolic 
syndrome than Anxiety and metabolic syndrome.  
 
     Similarly, an association with Depression, but not Anxiety or psychological 
distress in men and women from rural Australia aged 25-84 years (N = 1,345) was 
reported by Dunbar et al. (2008). When comparing those participants with 
metabolic syndrome using the ATP III criteria (n = 409, 30.4%) with those 
without, those with metabolic syndrome had higher scores for Depression (mean 
scores 3.41 vs. 2.95, p=0.013) and were more likely to have moderate to severe 
Depression (10% vs. 6.0%, p = 0.069). Two components of metabolic syndrome, 
waist circumference and HDL cholesterol, were independently associated with 
Depression. Of those participants with metabolic syndrome (n = 409), 338 did not 
have diabetes, however the same associations remained after controlling for this 
variable, which is important as diabetes has previously been shown to be 
independently associated with Depression (Lustman & Clouse, 2005).  Dunbar et 
al. (2008) also conducted the analyses using the IDF criteria for metabolic 
syndrome and found the association between Depression and metabolic syndrome 
was consistent across definitions.  
33 
 
     The above findings from the different studies not only support an association 
between metabolic syndrome and Depression, but also suggest possible gender 
differences in the pathophysiology or symptomatology of metabolic syndrome.  
 
2.4 Depression as a Predictor of Metabolic Syndrome 
     Much of the research to date assumed that Depression predicts the onset of 
metabolic syndrome, based presumably on the need to improve aetiological 
models for metabolic syndrome. Research conducted in Finland on a sub-group (n 
= 223) from a random general population sample (N = 3004), interviewed 
participants once a year for three years between 1998 and 2001 and then again in 
2005 (seven years from baseline) on self-reported measures of mental symptoms 
and the Structured Clinical Interview for DSM-IV (Viinamaki et al., 2009). 
Metabolic syndrome criteria were measured by health professionals at a medical 
laboratory. It was found that the overall prevalence of metabolic syndrome at the 
2005 follow-up was 32% (49% in men and 21% in women, p < 0.001). Viinamaki 
et al. (2009) also categorised participants into groups that self-reported either high 
mental symptoms (HMS) (n = 106) or low mental symptoms (LMS) (n = 117) 
based on the Hamilton Rating Scale for Depression (HDRS) and BDI, and 
conducting a Structured Clinical Interview for DSM-IV to confirm diagnoses of 
personality disorders and Major Depressive Disorder (MDD). Cumulative 
depression burden was then calculated by summing the BDI scores from the three 
previous assessments (1998, 1999 & 2001), and used as an estimate for symptom 
severity. Participants were also divided into categories (HMS or LMS) based on 
the median of the total burden score. It was found that those participants in the 
HMS group had significantly higher prevalence of metabolic syndrome than those 
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in the LMS group (46% vs. 27%, p < 0.001), and that those with metabolic 
syndrome presented overall with more signs of depressive symptoms and 
suicidality in the HDRS and BDI than those without. When analysed by gender, 
these associations were only statistically significant in men. When the pooled 
sample was observed, it was found that psychiatric diagnoses were not associated 
with metabolic syndrome, however a statistically significant association was 
found between the diagnosis of MDD and metabolic syndrome in men (30.4%, p 
= 0.02). Conversely, the frequency of metabolic syndrome amongst those with 
chronic Depression (total Depression burden score above the median) was 
markedly higher than those under the median (41% vs. 24%, p = 0.01). When 
analysed by gender, this difference was observed in men (61% vs. 36%, p = 0.01) 
but not in women (25% vs. 17%, p = 0.22). Further analyses found significant 
relationships between the different descriptors of mental illness in relation to 
fulfilled metabolic syndrome criteria for men were: glucose level and major 
depressive disorder (26.2%, p < 0.05) and BDI (8.8%, p < 0.05); Triglyceride 
level and HMS (71.4%, p < 0.05); suicidality (33.3, p < 0.01) and BDI (10.3%, p 
< 0.05); and HDL cholesterol and suicidality (20.8%, p <0.05). Amongst women, 
the only significant relationship was between HMS and glucose level (54.0%, p < 
0.05). Based on hypocortisolemic depression of the HPA axis activity theory, 
Viinamaki et al. (2009) suggest that these gender differences, whilst peculiar, 
could possibly be explained by some men reacting to long-term mental distress by 
developing a metabolic syndrome phenotype. Further research would be required 
to test this hypothesis, particularly as the authors do not report controlling for 
medication. However, the findings that cumulative scores above the means on 
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High Mental Symptoms and chronic Depression were associated with metabolic 
syndrome highlights the clinical importance of a relationship. 
 
     Similar results relating to the severity of Depression affecting metabolic 
syndrome emergence was found in a study conducted by Raikkonen, Matthews 
and Kuller (2007) on middle aged women (N = 432) who were followed for an 
average of 15 years from baseline. The potentially confounding factor of HRT on 
metabolic effects was statistically controlled for. Using the IDF criteria, it was 
found that 9.7% (n = 42) had metabolic syndrome at baseline, and this rose to 
38% (n = 164) by follow-up. In logistic regression models, ‘depressive symptoms’ 
and ‘severity of stressful life events’ were associated with the cumulative 
prevalence of metabolic syndrome (including those with metabolic syndrome at 
baseline), (OR 1.31, 95% CI 1.08-1.61; OR 1.71, 95% CI 1.15-2.54).  The 
analyses also demonstrated that each one standard deviation (SD) increase in 
depressive symptoms was associated with 1.21 to 1.43 fold increases in risk for 
developing metabolic syndrome over the follow-up period. 
 
     Another longitudinal study (N = 488) to evaluate the risk for developing 
metabolic syndrome when having depressive symptoms (as self-reported in the 
BDI) was conducted over seven years in Finland by Vanhala, Jokelainen, 
Keinanen-Kiukaanniemi, Kumpusalo and Koponen (2009). At baseline, 16 men 
(8.2% of the baseline study population) and 48 women (16.3%) had depressive 
symptoms. At the 7 year follow-up, logistic regression analysis showed a 2.5-fold 
risk (95% CI 1.2-5.2) for middle-aged women with depressive symptoms at 
baseline to develop metabolic syndrome after adjusting for age, physical activity, 
36 
 
education, smoking, alcohol use, marital status and the use of antidepressant 
medication and hormone replacement therapy. Whilst there was no significant 
finding for men, males reported less severe depressive symptoms when compared 
with females, suggesting symptom severity or gender differences may play a role 
in the reporting of depressive symptoms. However, symptom severity could also 
perhaps explain the findings of the research by Viinamaki et al. (2009) reported 
above, as the males in their study reported more severe symptoms when compared 
to females.  
 
2.5 Metabolic Syndrome as a Predictor of Depression 
     There has also been research examining whether metabolic syndrome is 
associated with the onset of depressive symptoms. Akbaraly et al. (2009) 
conducted a longitudinal study of middle-aged British civil servants (N = 5,232, 
mean age 49.5 ± 6.1 years) from the Whitehall II prospective cohort study.  This 
study was conducted over a six-year period and used the Depression subscale 
from the 30-item General Health Questionnaire to measure depressive symptoms. 
At baseline, prevalence of metabolic syndrome was 10.4% (n = 547) and those 
participants with metabolic syndrome were more likely to be men, non-white, 
have a low education level and to undertake low physical activity levels. Three 
years later, 428 participants (8.2%) had developed depressive symptoms and it 
was found to be more common amongst participants with metabolic syndrome 
than those without (13.5% vs. 10.2%, respectively). A higher rate of new-onset 
depressive symptoms was observed in those with high triglycerides (29.4% vs. 
24.9%), low HDL cholesterol (22.7% vs. 17.8%) and central obesity (14.3% vs. 
10.4%).  Multivariate models using data from both the three and six year follow-
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ups, and controlling for age, sex and ethnicity, found that the odds ratio of new-
onset depressive symptoms within those participants with metabolic syndrome 
relative to those without was 1.47 (95% CI = 1.09-1.99, p = 0.01), which 
remained statistically significant after further adjustment for health behaviour, 
coronary heart disease and other socio-demographic factors (OR 1.38, 95% CI = 
1.02-1.87, p = 0.04). Interestingly, none of the components of metabolic 
syndrome had a significant independent effect on the onset of depressive 
symptoms, however the percent attenuations between depressive symptoms and 
metabolic syndrome by individual components were 23.4% for low HDL, 37.5% 
for obesity, and 38.0% for triglycerides; together explaining 93% of the 
association. Notably, Akbaraly et al. (2009) also found no evidence to support 
bidirectional associations between depressive symptoms and metabolic syndrome, 
and suggested that depressive symptoms may be a consequence rather than a 
cause of metabolic syndrome, and that a combination of abnormal lipids and 
central obesity constitutes a risk factor for the onset of depressive symptoms. As 
nearly half of the participants with metabolic syndrome were overweight (49.8%), 
the authors offer a possible explanation of the obesity-depression relationship as 
being the experience of stigma and devaluation by overweight and obese 
individuals. These experiences may cause individuals to suffer from lower self-
esteem and higher levels of Depression and, whilst there are a number of studies 
to support this explanation, Akbaraly et al. (2009) note that the onset of 
depressive symptoms appears to be the product of the cumulative effect of central 
obesity, high triglycerides and low HDL components. The finding that high 
triglyceride levels are associated with depressive symptoms is similar to that of 
Richter et al. (2010) and provides further support for the HPA axis pathology 
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hypothesis. Interestingly, Akbaraly et al. (2009) found that participants with 
elevated fasting blood glucose levels were less likely to develop depressive 
symptoms at the six year follow-up, which suggests that insulin resistance may 
not be a core mechanism in the metabolic syndrome-depressive symptoms 
hypotheses.   
 
     Conversely, in a study that examined gender effects and the role of cortisol in 
the association between depressive symptoms (as measured by the Patient Health 
Questionnaire) and metabolic risk, Muhtz et al. (2009) found no association 
between depressive symptoms and metabolic syndrome as an entity (p > 0.3) in 
either men (n = 107) or women (n = 108). However, when the single components 
of metabolic syndrome were analysed using MANOVA, there was a significant 
effect for gender (F = 9.2, p < 0.01), and it was found that women with depressive 
symptoms had a larger waist circumference (F = 4.7, p = 0.03), higher fasting 
blood glucose (F = 7.9, p < 0.01), diastolic blood pressure (F = 5.7, p = 0.02), 
evening salivary cortisol, and lower HDL cholesterol (F = 5.0, p = 0.03) when 
compared to those without depressive symptoms. A significant effect of 
depressive symptoms on cortisol levels was also found in women (F = 2.7, p = 
0.03) and the adjusted regression analyses found that evening cortisol levels 
attenuated the association between depressive symptoms and fasting glucose, 
waist circumference, diastolic blood pressure and HDL cholesterol, and partially 
mediated the association between metabolic syndrome and depressive symptoms. 
No significant associations emerged for men. Whilst these findings partially 
support the HPA axis hypotheses of metabolic syndrome, it is unclear why this 
would be the case for only women.  
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2.6 No Evidence of a Relationship 
     There are also studies that have reported no association between Depression 
and metabolic syndrome. One study, conducted by Hildrum, Mykletun, Midthjell, 
Ismail and Dahl (2009) was cross-sectional in nature and generous in power (N = 
9,571). The researchers concluded there were no consistent associations between 
either Depression or Anxiety and metabolic syndrome. However, after adjusting 
for age and gender, a weak positive association was found for Depression (as 
measured by the HADS) as a continuous measure and metabolic syndrome as 
defined by IDF criteria (OR 1.07 per standard deviation increase in symptom load, 
95%CI = 1.02-1.12, p = 0.007). This finding would suggest a relationship between 
the number of factors of metabolic syndrome and the severity of depressive 
symptoms. Hildrum et al. (2009) also found a weak relationship between both 
Depression and comorbid Anxiety and Depression with central obesity and high 
triglycerides; two factors which are becoming regularly apparent in the 
association between Depression and metabolic syndrome. These findings suggest 
an integrated approach to the pathogenesis of metabolic syndrome is required to 
further understand the relationship between metabolic syndrome factors and 
depressive symptoms.  
 
2.7 Chronic Stress, Distress and Metabolic Syndrome 
     According to the HPA axis pathology hypothesis, chronic stress could also be 
an underlying factor in the aetiology and pathogenesis of metabolic syndrome, as 
stress is known to adversely affect the neuroendocrine system through 
sympathetic dysregulation that may result in metabolic and anthropometric 
changes over time (Kalat, 2007; Matthews & Kuller, 2002; Nevid et al., 1998; 
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Raikkonen, Tsigos & Chrousos, 2002; Rosemond & Bjorntorp, 2000). There is 
also a relatively large body of evidence to suggest a relationship between stress 
and CVD or CHD, diseases that those individuals with metabolic syndrome are at 
increased risk of developing (Vitaliano, Scanlan, Zhang, Savage, Hirsch & 
Siegler, 2002). Unfortunately, few studies have examined this relationship. As 
noted by Vitaliano et al. (2002), this may be because there is an absence of 
theoretical models to guide hypotheses formulation and research. However, with 
the inclusion and subsequent momentum of the HPA axis hypothesis, chronic 
stress and distress should be included as possible factors in the research around 
the aetiology and pathogenesis of metabolic syndrome.  
 
     In a longitudinal study of 425 middle-aged women aged 42-50 years at study 
entry, Raikkonen et al. (2002) measured metabolic syndrome factors and also 
psychological risk attributes using the BDI, the Framingham Tension Scale, the 
Spielberger Trait Anxiety Questionaire, the Cohen Perceived Stress scale, and the 
Spielberger Trait Anger Questionnaire at baseline. Participants were re-tested 
after 7.4 years, at which time, relative to those without metabolic syndrome, 
women who met the criteria for metabolic syndrome at baseline also had 
significantly higher scores seven years later on the BDI (p = 0.002), Trait Anxiety 
(p = 0.01), Tension (p = 0.02), and Trait Anger (p = 0.01), although perceived 
stress was found to be not significant (p = 0.16). Results also showed that women 
who were classified at baseline as having metabolic syndrome when compared to 
those who did not, experienced a greater increase in Anger (M = 1.37 vs. -0.67, p 
< 0.001) and Anxiety (M = 1.68 vs. -0.55, p < 0.001) at follow up.  Furthermore, 
the risk for developing metabolic syndrome during the 7.4 years was increased for 
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women who experienced an increase in Trait Anger from baseline to follow-up 
(OR = 2.02, 95%CI = 1.50 – 2.72). Statistical controls for physical activity and 
alcohol did not significantly alter associations, ruling them out as mediational 
influences.  
 
     In a further follow-up study on the same cohort at 15 years post baseline, 
Raikkonen et al. (2007) found that intense and frequent feelings of anger and 
tension predicted the risk of metabolic syndrome using both the IDF and ATP-III 
criteria. Using the WHO criteria for metabolic syndrome, global perceived stress 
was predictive of the risk for the development of metabolic syndrome. This 
finding highlights the important role of psychological risk factors in the 
development of metabolic syndrome and also the requirement of a global 
definition of metabolic syndrome, as results can differ according to the criteria 
used.  
 
     In response to the lack of theory linking chronic stress, psychophysiology and 
CHD, Vitaliano et al. (2002), used structural equation modelling to test a path 
model of chronic stress in the development of metabolic syndrome and CHD. The 
model was evaluated using a sample of caregivers whose partners had 
Alzheimer’s disease, as the course of this disease is a prototypic chronic stressor. 
Caregivers were categorised as older men, women using hormone replacement 
therapy (HRT), and women not using HRT. The authors controlled for HRT as its 
use in postmenopausal women is believed to reduce CHD risk factors and is 
associated with greater HDL cholesterol and lower LDL cholesterol, insulin 
resistance and central adiposity. Participants were measured for chronic stress, 
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personal resources, vulnerability (less controllable and relatively enduring 
influences), social resources, psychological distress (negative affect, burden, 
hassles and the absence of positive experiences in response to stress) and 
metabolic syndrome factors at time of entry (Time One) and 15-18 months later 
(Time Two). Vitaliano et al. (2002) also measured poor health habits during this 
time, as there is greater risk for some people to increase fat and caloric intake and 
engage in alcohol consumption, smoking, and sedentary behaviours during times 
of stress. The cross-sectional pathway between distress and metabolic syndrome 
was significant both at Time One and Time Two for men, at Time Two only in 
women not using HRT, and non-significant in women using HRT at either time 
point. Positive relationships between distress and metabolic syndrome were three 
to 12 times larger in men than in women overall in a follow-up of medical records 
that was conducted 27-30 months after study entry. It was also found that 
metabolic syndrome was positively associated with CHD prevalence in men at 
Time Two. In women not using HRT, cross-sectional analyses found that poor 
health habits were related to metabolic syndrome at Time One only, distress was 
related to metabolic syndrome at Time Two only, and psychological distress was 
related to poor health habits at both Times One and Two, suggesting both 
psychological attributes and health behaviours were important. The use of the two 
time points also showed that these relationships grew stronger over time and that 
some variables, such as health habits, may have lagged effects on the development 
of metabolic syndrome. Vitaliano et al. (2002) also measured anger and hostility 
in this study and found that whilst they contributed to distress, there was a more 
direct relationship over time between distress and metabolism as measured by the 
metabolic syndrome factors. Therefore, chronic stress appears to activate the 
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distress reaction, which may precipitate metabolic reactions and lead to 
cardiovascular events, particularly in males experiencing chronic stress and a 
negative change in health behaviours. However, the results also suggest that 
future metabolic syndrome cannot be directly predicted by prior psychological 
distress, although it may predict metabolic changes due to poor health habits in 
the 15 to 18 months before metabolic syndrome is detected.  
 
2.8 Limitations of Research Reviewed 
     Whilst there are a number of limitations amongst the reviewed research, 
including, in some cases, small sample sizes and predominantly Caucasian 
samples based in Europe, one of the major limitations of the research reviewed is 
the use of the HADS as a measure of Depression in participants. The HADS has 
been designed for, and validated on, medical patients and excludes many of the 
somatic symptoms of Depression that overlap with physical problems such as 
fatigue, sleep disturbance, psychomotor changes and loss of appetite and weight. 
Other measures, such as the PHQ and the BDI, are based on DSM-IV criteria for 
major Depression. As participants identified as having metabolic syndrome in 
these studies were generally not seeking or undertaking medical treatment for this 
clustering of risk factors, nor necessarily meeting the criteria cut-off for a major 
depressive episode, a large proportion of participants may have been experiencing 
sub-acute levels of Depression that were not recognised. Future research should 
consider the use of a measure that has been normed on a general population and is 
continuous in its measure to ascertain cut-off levels that include sub-acute 
experiences by participants. 
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     Most of the research has also used the ATP III definition of metabolic 
syndrome which, while allowing for comparisons between the studies, may not 
have captured a significant proportion of those who may meet the criteria for 
metabolic syndrome under the more sensitive IDF definition. This is also a 
possible limitation of these studies.  
 
2.9 Summary 
     In summary, over the past decade there has been a paradigm shift in research 
that has resulted in an increasing focus on associations between cortisol, mental 
health problems (particularly Depression) and the component factors of metabolic 
syndrome. Based on the HPA axis activity hypothesis, neuro-endocrine and 
metabolic networks mediate both homeostasis and allostasis; as such, disturbances 
within these networks have been implicated in the pathogenesis, and also recovery 
from, depressive disorders. In particular, elevated triglyceride levels, a risk factor 
of metabolic syndrome, have been shown to have a reversible relationship with 
depressive symptoms, although this can also be confounded by such factors as 
alcohol use and body weight. 
 
     There is a growing body of evidence to suggest the co-occurrence of metabolic 
syndrome and Depression; although it appears that gender differences occur not 
only in prevalence of both Depression and metabolic syndrome, but also the 
pathophysiology or symptomatology of metabolic syndrome. From the research 
reviewed, it appears that hypertriglyceridemia and waist circumference are more 
closely associated with Depression in men with metabolic syndrome. Amongst 
women with metabolic syndrome, the more closely associated indicators appear to 
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be low HDL cholesterol levels and waist circumference. A reciprocal relationship 
between metabolic syndrome and psychological attributes may also therefore be 
dependent on gender related physiological manifestations or self-perceived 
severity of symptoms.  
 
     There is also evidence that the greater the number metabolic syndrome factors 
met, the higher the likelihood of co-morbid depressive symptoms, particularly in 
men. Interestingly, one study in which these associations were found was 
undertaken in a semi-rural community in eastern Finland. It has also been 
observed that the mean score for metabolic syndrome and Depression was around 
two to three times higher in research conducted in rural regions of Australia when 
compared with other studies reviewed. These findings suggest that those living 
within rural areas are at increased risk of co-morbidity of metabolic syndrome and 
Depression.   
 
     Whilst it would be pragmatic to suggest a causal relationship between 
metabolic syndrome and mood disorders, the evidence at present suggests that, 
whilst there are associations between these factors, there is currently no consensus 
on direction or causation. However, awareness of symptoms of psychological 
distress could be important in the clinical management of metabolic syndrome, 
and vice versa.  
 
     When data from prevalence studies are incorporated with the findings from 
research into the co-occurrence of metabolic syndrome and mood disorders, it 
appears that certain characteristics may increase a person’s risk in developing 
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metabolic syndrome. These characteristics include middle-age, lower education 
level, low levels of physical activity, and higher levels of psychological distress. 
There are also gender differences amongst these characteristics as men are more 
likely report psychological distress as depressive symptoms or feelings of 
suicidality, whereas females report experiencing higher levels of Depression, 
Anxiety, tension and anger. In relation to the co-occurrence of psychological 
distress and metabolic syndrome factors, males are more likely to have a large 
waist circumference and have a greater number of other metabolic syndrome 
factors, particularly high triglyceride levels, whereas for women, a larger waist 
circumference is the most prominent co-occurring risk factor. 
 
     The finding of higher risk ratios for metabolic syndrome and Depression 
amongst those living in rural areas is of particular interest given that rural 
populations are often under-researched (as evidenced by only two studies of this 
population) and under-serviced, not least, within Australia, due to their lower 
population density when compared to their urban counterparts and their 
geographical distance from research institutions and health care providers. Those 
living in rural areas also generally experience poorer health as reflected in levels 
of disease, mortality and health risk factors, than those living in major cities. 
Living and working on the land also exposes people to psychological stressors 
that are unique to this cohort. Therefore, it is important to understand if those 
living in rural areas may be more at risk for the co-occurrence of metabolic 
syndrome and mood disorders, and how this relationship may affect the 
pathogenesis of metabolic syndrome. This shall be explored in the next chapter.  
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Chapter 3: Rural Health in Australia 
3.1 Health Issues in Rural Australia 
     The rural idyll has been depicted in novels, films, popular press and academic 
publications, and portrays the entrenched view of many that life in rural areas 
offers tranquillity, peace, open space, a sense of belonging, community integration 
(expressed in close-knit ties), reduced criminality and social disorganisation, 
fewer problems, low pollution and simplicity of life (Brumby, Chandrasekara, 
McCoombe, Kremer & Lewandowski, 2011; Sarantakos, 2000). In the words of 
one family, farm life is described as “Especially for the kids, because it's a great 
life for them. Yeah it's a good life. It's a hard life, but it's a good life.” 
(Department of Primary Industries, 2007).  
 
     However, the limited research available has found no significant differences 
between the subjective quality of life of farmers and metropolitan residents (Best, 
Cummins & Lo, 2000; Sarantakos, 2000). Furthermore, contrary to the agrarian 
myth described above of a healthy and peaceful way of life, an abundance 
research shows that people living in rural areas generally experience poorer health 
than their counterparts who reside in major cities as is reflected in levels of 
disease, mortality and health risk factors (AIHW, 2008a). For example, alcohol 
consumption, cigarette smoking, drink driving accidents, Depression and suicides 
are all significantly higher in rural communities (Wilson, 2007). Indeed, it is well 
established that farming is an occupation that is inherently stressful. High levels 
of Depression, Anxiety and stress have been acknowledged as significant 
psychological hazards associated with engagement in agricultural work (Fraser et 
al., 2005). Research also suggests that poor mental and physical health may in 
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turn impair the running of a farm business effectively (Gorgievski-Duijvesteijn, 
Giesen, & Bakker, 2000), leading to further stress. 
 
     Those residing in rural and remote communities are also 1.3 times more likely 
to report having diabetes, and 6% of all excess deaths each year are directly 
related to diabetes, not including for those deaths from diabetic complications 
(AIHW, 2008b). However many rural and remote residents may be unaware they 
have the condition as they are less likely to be tested than their metropolitan 
counterparts (AIHW, 2008b). Due to current methodological issues, the rates of 
cardiovascular disease in rural/remote and metropolitan residents are not directly 
comparable (AIHW, 2008b). 
 
      The poorer health status of rural residents when compared to their 
metropolitan counterparts may be occurring for a number of reasons. For 
example, rural communities often face many barriers to accessing health care 
services, not only because of the lack of availability of services within their 
community, but also because of transportation problems and/or associated costs of 
accessing health services located in another town or region (Berry et al., 2008; 
Heflinger & Christens, 2006). Consistent with the lower availability of general 
and specialist health professionals in rural and remote communities, it has also 
been found that people living in rural and remote areas are more likely to be 
admitted to hospital with potentially preventable conditions, such as skin and 
other cancers which can be detected early through screening (AIHW, 2008a), with 
a mortality rate 42% higher for those living outside major cities (ABS, 2011).  
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    Whilst there is a growing body of research surrounding health risk factors and 
barriers to accessing services in rural and remote areas, much of the research fails 
to differentiate between those who simply reside in rural and remote communities 
and those who work the land. There is currently very little research available on 
an important and unique cohort within this population: farm men and farm 
women.  
 
3.2 Overview of Australian Farm Men and Women 
     Farmers are an important asset to Australia and its population, with 125,594 
farms solely dedicated to agricultural production (NFF, 2009). Australian farms 
and closely related sectors generate approximately 12% of the Australian Gross 
Domestic Product (GDP), equating to approximately AUD$103 billion per year in 
production. Australian farms also produce around 93% of Australia’s domestic 
food supply, directly employ 317,730 people on the farms, and support jobs for 
approximately 1.6 million other Australians, or 17.2% of the national workforce 
(NFF, 2009). Farm men and women also possess a large transferable skill set. In 
comparison to the 17-18 skills that a factory worker may have, farmers have 
around 120 skills that are broadly based and can be transferred to different jobs or 
careers (Department of Primary Industries, 2007).  
 
     Despite these impressive figures and the positive aspects of farm life, the 
agricultural industry and particularly farmers, face unique challenges that could 
possibly have a number of repercussions, including physical, psychological, social 
and economic impacts. Agriculture has one of the highest mortality rates of any 
industry and exposes farm men and farm women to a range of physical and mental 
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health risks (McCurdy & Carroll, 2000). Farmers are now working longer and 
harder, are ageing and are increasingly relying on family members to provide 
extra labour on the farm (Brumby, Martin & Willder, 2006). Present-day 
circumstances such as increased economic distress, decline in family farming, a 
growing need for off-farm work, and a fall in both the number of farms and the 
income generated by farming activities, have been shown to be associated with a 
generally lower quality of life and wellbeing (Melberg, 2003).  In this time of 
difficult economic and climatic conditions currently being experienced by the 
Australian agricultural sector, it is becoming increasingly apparent that research 
into the mental health of farm men and women and associated physical health 
outcomes is necessary.   
 
3.3 Rural and Farmer Mental Health  
     As farm men and women are currently an under researched sub-population, it 
is necessary to defer to the research available for rural and remote Australian 
population mental health issues. One Australian cross-sectional population survey 
(n=1563) on the prevalence of psychological distress amongst people aged 
between 25-75 years living in the south-east of South Australia and the south-west 
and north-west of Victoria, found that 31.3% of men and women living in these 
area reported psychological distress (Kilkkinen et al., 2007). Kilkkinen et al., 
(2007) also found that 10% of the population surveyed reported elevated 
Depression and Anxiety, with the highest rates occurring in both men and women 
in the 45-54 year age bracket. Another report on rural, regional and remote health 
also found that males aged 45 to 65 years living in regional or remote areas were 
1.2 times more likely to report high to very high levels of psychological distress 
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and 1.4 times more likely to report Depression than their Major City counterparts 
(AIHW, 2008b). Conversely, the AIHW (2008b) found that there were no 
significant inter-regional differences in the prevalence of Depression or Anxiety, 
and that women aged 45-64 years living in rural and remote areas were 
significantly less likely to experience Anxiety when compared to their Major City 
counterparts. However, in a study of Australian farm men and women (N = 1813) 
the incidence of psychological distress using the K10 was 45.9%, which was 
higher than rural Victorian (31.3%), state (32.9%) or national (35.6%) averages 
(Brumby et al., 2011; Kilkkinen et al., 2007).    
 
     It has also been argued that, unlike farm men, farm women experience stress 
related to both the farm, and the impact of farming stressors on the social, 
financial and physical wellbeing of all family members (Fraser et al., 2005). Farm 
women in the USA have been found to have higher levels of stress, Depression 
and fatigue than farm men, with high workloads and role conflict as consistent 
explanatory themes (Gallagher & Delworth, 1993).  
 
     Apart from the lack of research with a definite focus on farm families, much of 
the currently available Australian research on rural population health is over 10 
years old. Since then, Australian farmers have experienced a 10 year drought, 
which was then followed by floods. Much is known about the link between mental 
health problems and acute weather disasters (such as cyclones or floods), however 
less is known about the effects of chronic climate-related disasters such as drought 
(Berry et al., 2008). Thus, older research may not be reflective of the current 
mental health experienced by Australian farmers. As the hardships of farming 
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lifestyle increase, the stress of property damage, lost income and debt will 
inevitably result in mental health problems for some (Berry et al., 2008).   
 
     Despite the suggestion that farmers may be at increased risk of mental health 
problems, research often shows that farmers self-report a lower prevalence of 
psychiatric morbidity than the general population (AIHW, 2008b). However, 
mortality rates from suicide are far greater for this cohort, reportedly being 
responsible for 1.7% of all deaths in Australia (AIHW, 2007). In regional and 
remote areas this proportion is 66% higher than in major cities and it is 
particularly elevated in males between the ages of 25 and 44 years (ABS, 2011), 
and higher still amongst farmers in both the United Kingdom and Australia.  
Research using descriptive and linear regression analysis of aggregated Australian 
mortality data from the period 1988 to 1997 found that of the 921 farm suicides 
identified, 67.4% were farm managers (including owners), with 97.3% of this 
group being males and 48.5% over the age of 55 years (Page & Fragar, 2002). The 
most common methods of suicide were firearms (51%), motor vehicle exhaust gas 
(12.3%) and hanging (16.4%), which collectively accounted for approximately 
81% of completed suicides amongst farm managers and labourers (Page & Fragar, 
2002). These suicide rates for farmers and farm managers are higher than those 
reported above for the wider rural population, and are believed to be associated 
with stressors such as financial or family problems and the administrative, 
legislative and production pressures of Australian agricultural processes and the 
rural economy (Page & Fragar, 2002).  
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     Research by Thomas et al. (2003) has found that farmers are also more likely 
to report that life was not worth living (OR 3.26, 95%, CI 1.51 to 7.02). Whilst the 
research by Thomas et al. (2003) was conducted in Britain amongst a 
representative cohort of 606 farmers, farm workers and family members, the 
comparison of farm family members and workers and rural and semi-rural 
householders highlights the possibility of different experiences, or cognitive 
processing of these experiences, between cohorts residing in the same 
geographical location. This may be attributed, in part, to some of the determinants 
of poorer health outcomes for farmers, which is discussed in further detail in this 
chapter.  
 
     Psychological autopsies conducted by  Malmberg, Simkin and Hawton (1999) 
on 84 farmers who had died by suicide in England and Wales found that rather 
than a reaction to an immediate crisis, suicide in famers was the end point of an 
accumulation of difficulties over time. It was also found that depressive disorder 
was the most frequently occurring mental illness associated with suicide, with 
physical illness and relationship, occupational and financial problems important 
and common factors in these deaths. Anecdotal evidence of these contributing 
factors commonly occurring in Australian farming populations is also noted by 
rural community health care workers, teachers and religious leaders (Department 
of Primary Industries, 2007). It is therefore important to further understand the 
factors that place greater stress on farming families, and how they affect their 
mental health and wellbeing. 
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3.4 Determinants of Poorer Health Outcomes 
     Whilst there is little research on the mental health of farm men and women, the 
available research has identified a number of possible factors that may be 
particularly associated with the mental health and wellbeing of farming families. 
These factors include drought and climate variability, increased workload, 
engagement in off-farm work, and economic pressures. 
 
3.4.1 Drought and Climate Variability 
     As stated earlier, farming is an inherently stressful occupation, which is only 
made more difficult in times of extreme weather events (Berry et al., 2008). Many 
farming families within Australia have been impacted by the effects of drought 
over the past few years, if not decades. For example, New South Wales (NSW) 
has been ‘drought-free’ for only four of the 30 years prior to 2007, with many new 
areas around Australia declared ‘exceptional circumstances’ areas between 2001 
and 2007 (ABS, 2008; Morrissey & Reser, 2007). Exceptional Circumstances 
(EC) due to drought is determined on the basis of six criteria, including 
meteorological conditions, agronomic and stock conditions, water supplies, 
environmental impacts, farm income levels, and the scale of the event. Figure 3 
(below) shows the changes in EC areas in Australia between 2000 and 2007.  
 
     It has been suggested by Wilson (2007) that as rural communities rely heavily 
on the success of agribusiness, drought places a particular stress on them. In 
trying to quantify the cost of drought on life satisfaction, it is estimated that the 
detrimental impact of drought in Spring equates to an AUD$18,000 annual 
reduction in mean rural household income (Carroll, Frijters & Shields, 2009).  
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The financial estimate in this research was calculated for only one spring drought 
in rural Australia and does not take into account the often chronic nature of 
drought, which can last for years. Lost income, damage to property and debt due 
to drought add more stressors which can accumulate and increase the likelihood 
and prevalence of mental health problems (Berry et al., 2008). The 
unpredictability of drought also often creates feelings of powerlessness (Sartore, 
Kelly, Stain, Albrecht & Higginbotham, 2008) and is commonly associated with 
higher levels of Anxiety and emotional distress amongst farm men and women 
when compared to those living in a drought-free city (Coelho, Adair & Mocellin, 
2004).  
 
 
 
 
 
 
 
 
 
 
 
 
 
     The presenting symptomatology associated with drought is most often related 
to failure and chronic loss, such as generalised Anxiety, helplessness-induced 
 
Figure 3. Exceptional Circumstances Areas 2000-02 to 2006-07 
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Depression, and ongoing emotional distress. A recent study surveying randomly 
selected adults from the Australian Electoral Roll measuring support networks and 
community attachment, recent stressors, and current health and functioning, found 
that 71.8% of farmers and farm workers in rural NSW reported high levels of 
perceived stress due to drought (Stain et al., 2008). This perceived stress was 
particularly associated with recent adverse life events, functional impairment and 
increased alcohol use.  
 
     In a report to NSW Agriculture on the social impacts of drought, it was noted 
that the poverty of farm families is more than relative deprivation in comparison 
with other Australians: there is also a psychological poverty, defined as a poverty 
of the spirit, that relates to increased workloads, lack of access to services, and a 
withdrawal from the community, which is exacerbated by a feeling that others do 
not understand what is currently being experienced (Alston & Kent, 2004). This 
report highlights a significant amount of stress amongst farming families which 
has resulted in increased mental illness and other stress related conditions. 
However, Alston & Kent (2004) alert readers to the difficulty in ascertaining 
whether these social impacts are drought-induced or related to ongoing structural 
adjustment within farming communities. 
 
     Alarmingly, a report by Berry et al. (2008) to the Garnaut Climate Change 
Review on the rural mental health impacts of climate change, predicts that regions 
in Australia previously considered to have low vulnerability and risk to adverse 
climate change will experience markedly larger downturns in agricultural 
productivity by 2030 than previously predicted. For those regions at high risk of 
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adverse climate changes, the effects on agriculture could be so great that grazing 
may not be feasible, thus excluding agriculture from many communities. This 
prediction and subsequent adverse mental health impacts that can be expected to 
arise highlight the necessity for both health and wellbeing education, and 
provision of services in rural communities, particularly amongst farm men and 
women, whose very livelihoods may be at stake. 
 
     Interestingly, the drought experienced by the farmers over the past ten years 
officially broke in a number of areas during the longitudinal research component 
of this study. Unfortunately, other natural disasters occurred including severe 
weather events that resulted in flooding, unseasonal rainfall that affected crops 
and/or livestock, cyclones and the biggest locust plague seen in decades 
(Department of Agriculture, Fisheries and Forestry, 2011).  Therefore, it could be 
concluded that the chronic nature of environmental stressors encountered by 
farmers was maintained during this time period.   
 
3.4.2 Economic Pressures 
      Economic hardship is of particular concern amongst farming Australians who 
are often asset rich and cash-flow poor (Berry et al., 2008). Specifically, the 
effects of these economic pressures on farming populations have been consistently 
identified as one of the major causes of stress, and they are associated with 
symptoms such as psychological dysfunction (any disruption in normal 
psychological functioning), cognitive impairment, Anxiety, physical 
aggressiveness, Depression, withdrawal, marriage problems, loss of temper, 
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increased substance use and suicidal ideation and completion (Fraser et al., 2005; 
Heflinger & Christens, 2006). 
 
     Research into the stress experiences of farm men in the United States of 
America (USA) who were owner operators (n=84) and had similar farming 
operations to Australian farmers, found that farmers had greater exposure to job-
related and financial events than non-farmers (n=295) (Swisher, Elder, Lorenz & 
Conger, 1998). These job-related and financial events were also the most 
significant predictors of Depression for farm men, as assessed by the Hopkins 
Symptom Checklist (SCL-90-R), six items from the positive affect sub-scale of 
the Mental Health Inventory, and the Psychiatric Epidemiology Research 
Interview (PERI) Life Events Scale.  
 
     As there is an abundance of research that has shown that social support, 
particularly family support, acts as a buffer to mental health problems, Johnson 
and Booth (1990) conducted a longitudinal study into the role of individual 
psychological distress in mediating the effect of economic decline on the erosion 
of family relations, (in particular, marital quality) on Nebraska farmers during the 
1980’s farm crisis in the USA. It was found that whilst the close relationship 
between the family unit and the economic unit of the farm were likely to serve as 
a barrier to marital instability, serious economic problems threaten and weaken 
the economic unit which in turn weakens the barrier to marital breakup. Thus, 
economic distress had a significant effect on marital communication and thoughts 
of divorce, and created personal psychological distress, which in turn influenced 
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marital quality over a 5 year period. It was also found that half of the effect of 
thinking about divorce was due to increased levels of Depression.  
 
3.4.3 Increased Workload and Engagement in Off-farm Work 
     Climate- and economic-related business stress is also associated with increased 
workloads which can, in turn, heighten risk factors such as social isolation, socio-
economic strain and family separation, well-established factors to unfavourable to 
mental health outcomes (Berry et al., 2008; Stain et al., 2008). Statistics show that 
59% of Australian farmers worked over 49 hours per week, with a median of 51 
hours per week, in comparison to 41 hours for all self-employed people in all 
occupations within Australia (ABS, 2003). As farming has become less profitable 
over the past 20 years, many farm families have found it necessary for members 
to undertake more on- and off-farm work to supplement and stabilise the family 
income (ABS, 2003; Fraser et al., 2005). Recent figures show that 81% of farm 
women currently undertake off-farm work, with this income source accounting for 
between 44% and 48% of the farming family’s income (ABS, 2003; Fraser et al., 
2005). 
 
     These changes in family roles and family separation can be difficult for 
farming families. For example, Gallagher & Delworth, (1993) suggest that there 
are three ‘shifts’ to a farm woman’s day: the first involves off-farm paid 
employment; the second shift includes child care and housework combined; and 
participation in farming operations such as managing and maintain the family 
farm comprises a third shift. Whilst women are more likely than men to move 
away from home for off-farm work, men have reported that staying behind to 
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work the farm increases their sense of not being able to escape and they feel the 
loss of companionship (Alston & Kent, 2004; Sartore et al., 2008). Although off-
farm work was often initially undertaken to reduce financial stress, a comparison 
of farm spouses (n=1067) in seven states of the USA found that families with 
women engaging in this survival strategy fared worse on several dimensions of 
family and economic functioning when compared with families that remain living 
and working on the farm together, including higher debt loads, longer hours in all 
production, less satisfaction with marital relationships, and lower levels of life 
satisfaction amongst husbands (Godwin, Draughn, Little & Marlowe, 1991). 
Increased workload responsibilities and role conflicts for farm men and farm 
women may in turn contribute to higher levels of Anxiety and emotional distress 
in farm women and increased Depression in farm men.  
 
3.4.3.1 Job Demand-Control (-Support) Model 
     The Job Demand-Control (-Support) (JDC(-S)) model (see Figure 4 below) is a 
theoretical framework aimed at describing the relationship between occupational 
stress and psychological distress. According to the strain hypothesis those 
workers in ‘high strain’ jobs, that is, workers with high (psychological) job 
demands in combination with low control (or decision latitude) are more likely to 
experience the most adverse psychological reactions, such as fatigue, Anxiety, 
Depression, and physical illness (Sanne, Mykletun, Dahl, Moen & Tell, 2005).   
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Figure 4. The Job Demand-Control(-Support) Model 
 
     The JDC(-S) model also recognises the importance of social support in 
buffering the negative effects of high strain, particularly when this support 
increases the control level above a certain threshold for the individual (known as 
the buffer hypothesis). The iso-strain hypothesis expands on these original 
hypotheses, by predicting that jobs characterised by high strain in combination 
with low support or social isolation have the most negative outcomes, such as 
Depression, Anxiety and stress (Sanne et al., 2005). Indeed, research has found 
that high demand, low support and low control, particularly when combined, are 
risk factors for both Depression and Anxiety. 
 
     In relation to farm men and farm women, the demands of the job are often 
high, as their work often becomes a 24 hour a day job. In addition to off-farm 
work that must be undertaken to ease economic pressures, there is the continual 
pressure to maintain their own farm. Consequently, farmers may perceive a low 
level of control over decisions as requirements surrounding crops or stock are 
often dependent on such factors such as climate and resource availability. Farm 
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men and women may also feel the effects of low support or social isolation as 
they may not be able to employ workers to assist them, or factors such as 
geographical isolation or a culture of stoicism makes them reluctant to seek 
assistance. Farm succession also places high demands on farm men and women: 
waiting for financial control and  being expected to do the work (high demand) 
with little or no financial control (low control) is especially complicated in a 
relationship that spans both an emotional one (marriage and family) and an 
economic one (the farm business). These high demands and sense of low control, 
in combination with social isolation or low support, may lead to farm men and 
women becoming vulnerable to psychological distress. 
 
3.5 Barriers to Help Seeking in Rural Areas 
      As previously mentioned, the increased incidence of health problems of rural 
residents may be problematic for a number of reasons including accessing health 
care services, not only because of the lack of availability of services within their 
community and large geographical distances between major regional centres, but 
also the perception of stigma associated with mental illness and a culture of 
stoicism. 
 
3.5.1 Isolation 
     With regards to mental health, decreased population density in rural 
populations can create a sense of psychological as well as physical isolation, 
which also poses a significant barrier to early identification of, and intervention 
for mental health problems (Heflinger & Christens, 2006). Wilson (2007) found 
that within the rural northern New South Wales population, people with a mental 
63 
 
illness are only likely to enter services after a longer period of untreated psychosis 
than their urban counterparts, with the number of clients treated for first-episode 
psychosis seven-fold than expected. Many studies have also found that rather than 
seeking assistance when they recognise personal psychological distress, people in 
rural communities will tend to conceal their distress through means such as self-
medicating with alcohol, and only access mental health services after a crisis 
occurs (Fraser et al., 2005; Philo, Parr & Burns, 2004; Wilson, 2007). Several 
other factors seem to be associated with decreased help-seeking behaviour. These 
include an absence of knowledge about mental illness, unavailability of providers 
and cost of care (Fox, Blank, Rovnyak & Barnett, 2001). These factors may 
further increase the sense of isolation in the event of psychological distress. 
 
3.5.2 Stigma 
     The perceived stigma associated with mental illness can contribute to 
reluctance of members of rural communities to access mental health services. 
Stigma can be defined as the co-occurrence of its components; that is, labelling, 
separation, stereotyping, discrimination and status loss (Link & Phelan, 2001). 
However, power must be exercised for stigmatization to occur. Due to heightened 
visibility associated with small communities, it has been suggested that people 
fear being stigmatised if they use mental health services (Fraser et al., 2005). A 
largely qualitative study on communities in Scotland’s remote and rural Highlands 
found that those with mental health problems tended to feel stigmatised and hid 
their problems, often for many years, before seeking help, and then often tried to 
conceal formal service use (Philo et al., 2004). Another study on psychological 
distress in rural America (N = 1487) also found that the size of the town lived in 
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was negatively correlated with the depressive symptoms shown by men and the 
level of stigma towards mental health care: the smaller the town lived in, the 
higher the level of both depressive symptoms and stigma attached to mental health 
issues (Hoyt, Conger, Valde & Weihs, 1997). Within Australia, interviews with 
22 key mental and general health professionals in rural South Australia found that 
mental health problems were associated with a high degree of stigma as people 
with mental health problems are allied with particular stereotypes and prejudices 
(Fuller, Edwards, Procter & Moss, 2000). In turn, this lead to an avoidance of 
mental health services, even when people recognised their distress.  
 
3.5.3 Stoicism 
     There are also stereotypical cultural beliefs regarding the stoicism of 
Australian rural communities; that they endure times of adversity with patience 
and indifference, without asking for help, and just ‘get on with it’. Research by 
Fuller et al. (2000) found a culture of stoical self-reliance and mistrust of outsiders 
within rural South Australian communities, particularly of mental health workers, 
contributed to people only seeking ‘outside’ help in dire necessity. In his research 
on mental illness in rural New South Wales, Wilson (2007) also found that this 
culture of stoicism, particularly for males, increases the reluctance to seek 
assistance in times of need lest it be seen as a sign of weakness. Rural families do 
not wish to be viewed as anomalous by their neighbours and the combination of 
increased risk of mental health issues and decreased willingness to seek help 
creates an environment that is ripe for the development and exacerbation of 
mental health problems.      
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3.6 Summary 
     In summary, the physical and mental health of those living in rural and remote 
Australia is significantly worse than that of their major city counterparts in a 
number of areas, and is associated with higher levels of mortality from 
preventable diseases and higher suicide rates. Unfortunately, much of the research 
fails to differentiate between those who simply reside in rural and remote 
communities, and those who work the land. However, inferences can be made 
based on the rural data in conjunction with the research on farmers. The 
combination of Australia’s prolonged drought and climate change, increased 
economic pressures necessitating off-farm work, and the current barriers to help-
seeking behaviours such as isolation, stigma and stoicism may increasingly 
jeopardise the health and wellbeing of many farm men and women.   
 
     If the HPA axis hypothesis previously discussed is correct, it would be 
expected that farm men and women, who may be enduring psychological distress 
related to the chronic nature of stressors associated with farm life, would also be 
experiencing detrimental physical health effects that could be measured via the 
metabolic syndrome factors. Thus, research is required to assess and review the 
current level of psychological functioning of Australian farm men and women as a 
distinctive cohort with unique challenges, and to determine if the prevalence of 
metabolic syndrome is significantly higher than that of the general population. 
However, from the research reviewed in Chapter 2, the relationship between 
metabolic syndrome and psychological distress is unclear. It has been suggested 
that psychological distress may be either a predictor or a consequence of 
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metabolic syndrome, or that there is no relationship between the two. This leads to 
the current study. 
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Chapter 4: The Current Study 
4.1 Introduction 
     The prevalence of metabolic syndrome is continuing to rise globally and is 
considered to be a major risk factor in the development of Type II diabetes and 
CVD. The burden of disease for diabetes alone is currently estimated to be 286 
billion International Dollars (ID) annually and is expected to risk to 396 billion ID 
by the year 2025. From a review of the research, it appears that the aetiology and 
pathogenesis of metabolic syndrome is an interaction between a number of factors 
including increased adipose fatty tissue, higher caloric diet, sedentary lifestyle, 
and a dysfunctional endocrine system possibly due to dysregulation of the HPA 
axis brought on by chronic stressors. Further, it is also unclear if gender 
differences in the prevalence and symptomatology of metabolic syndrome are 
associated with presentation and/or levels of psychological distress, or due to 
ethnicity, as suggested by previous research. Therefore, a greater understanding of 
the associations and interactions between Depression, Anxiety and Stress in the 
pathogenesis of metabolic syndrome is a research area worth pursuing. 
 
    Those living in rural and remote areas also have poorer physical health and 
health outcomes due to a number of environmental factors and barriers to health 
care and help-seeking behaviours. Due to the chronic nature of the stressors they 
endure, it could be expected that farm men and women would be experiencing 
higher levels of psychological distress than the general population. Consequently, 
if the HPA axis hypothesis is correct, it would also be expected that the 
prevalence of metabolic syndrome amongst this cohort would be higher than the 
general population and is perhaps related to the level of psychological distress 
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they are experiencing. Therefore, studying the physical and mental health 
interactions can provide direction for future research, health promotion and 
disease prevention interventions for this particularly under researched, at risk 
population.  
 
4.2 Aims of the Current Study 
     The current study was conducted in two phases, approximately one year apart. 
Study One was made up of a cross-sectional analysis from data collected at Time 
One. Study Two involved a longitudinal follow-up of participants in Study One.  
 
4.2.1 Study One 
     The first study in the current research aimed to analyse baseline data on the 
prevalence of metabolic syndrome and psychological distress (Depression, 
Anxiety and Stress) amongst farm men and women. These data were then 
compared with existing prevalence data from the general population. Based on the 
evidence of poorer health outcomes in rural areas, it was hypothesised that the 
prevalence of metabolic syndrome amongst farm men and women would be 
higher than that of the general population. Furthermore, based on the research 
findings related to unique environmental stressors, it was hypothesised that levels 
of Depression, Anxiety and Stress would be higher amongst farm men and women 
when compared with the general population norms. Based on previous research 
findings and the HPA axis dysregulation hypothesis, it was hypothesised that 
elevated levels of Depression and Stress would be significantly associated with 
metabolic syndrome, but that Anxiety would not.    
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     These proposed associations were further investigated at the level of the 
individual IDF criteria of metabolic syndrome (central obesity, raised 
triglycerides, reduced HDL cholesterol, raised blood pressure and raised fasting 
plasma glucose). Based on previous research findings it was hypothesised that 
waist circumference and elevated levels of triglycerides would be significantly 
associated with Depression, but that no factors would be significantly associated 
with Anxiety or Stress.  
 
    Based on previous research findings suggesting those with metabolic syndrome 
are more likely to have moderate to severe Depression, it was also hypothesised 
that there would be a significant association between Depression severity 
classification and the presence of metabolic syndrome. 
 
     Due to conflicting evidence surrounding gender differences, no hypotheses 
relating to gender differences in metabolic syndrome are proposed.  However, the 
study will allow this issue to be investigated. 
 
4.2.2 Study Two 
     The second study in the current research aimed to monitor both metabolic 
syndrome and psychological distress status over the course of approximately one 
year, and to assess the relationships between these variables over time. Due to 
conflicting evidence around the direction of these relationships, the current study 
aimed to investigate and clarify these relationships in three ways, with competing 
hypotheses being tested.  
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     Firstly, metabolic syndrome as a predictor of psychological distress was 
investigated. Based on previous research findings, it was hypothesised that those 
participants with metabolic syndrome at Time One would display increased 
Depression scores at Time Two, when compared to those without metabolic 
syndrome. Due to the inconsistency of the research findings, no predictions are 
made in relation to gender differences. 
 
      Secondly, psychological distress as a predictor of metabolic syndrome was 
explored. Given the association between Depression and metabolic syndrome in 
the longitudinal studies of Raikkonen et al. (2007), Vanhala et al. (2009) and 
Viinamaki et al. (2009), in which it was suggested that Depression may be a 
predictor of metabolic syndrome, it was hypothesised that higher levels of 
Depression at Time One would be associated with a positive metabolic syndrome 
status at Time Two. Furthermore, based on previous research findings and the 
HPA Axis hypothesis on the effects of chronic Stress, it was hypothesised that 
higher levels of Stress at Time One would be associated with a positive metabolic 
syndrome status at Time Two. Due to the inconsistency of research findings, no 
predictions were made in relation to gender.  
 
     Finally, the continuity of participants’ metabolic syndrome over time and 
possible relationships between Depression, Anxiety and Stress were also explored 
both prospectively and retrospectively. It was hypothesised that the maintenance 
or development of a positive metabolic syndrome status over time would be 
associated with higher levels of Depression at Time One, as previous research has 
suggested that Depression may be predictor of metabolic syndrome (Raikkonen et 
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al., 2007; Vanhala et al., 2009; Viinamaki et al., 2009). Furthermore, based on the 
longitudinal research by Akbaraly et al. (2009), Dunbar et al (2008) and Vanhala 
et al. (2009), it was hypothesised that those who maintained or developed 
metabolic syndrome would have higher levels of Depression at Time Two due to 
the cumulative effect of metabolic syndrome factors on Depression. Due to the 
unavailability of previous research findings, no predictions were made in relation 
to Anxiety or Stress.    
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  Chapter 5: Method 
5.1 Setting 
     Data were obtained from the Sustainable Farm Families (SFF) program, a 
health education and health promotion program specifically designed for, and 
delivered to, Australian farm men and farm women. Participants are recruited via 
agricultural industry groups, are aged over 18 years, and have worked on a farm 
for a minimum of five years (Brumby, Martin & Willder, 2006). It is unknown 
how many people were approached to participate as this was undertaken by 
Department of Agriculture and included newspaper advertisements, information at 
local agricultural shows and approaching people associated with local groups such 
as herd or pasture improvement groups. Therefore, response rates are unknown 
and unable to be documented due to the nature of these means. The program is 
delivered via a structured workshop each year for three consecutive years (two-
day in the first year, one-day in the subsequent years) and is designed to increase 
farm family’s health knowledge and skills, whilst supporting them to change their 
lifestyle and reduce risk behaviours (Sustainable Farm Families Program, 2011).  
It is facilitated by Registered Nurses (Division One) who also collect biological 
samples and other data for both individual and research purposes (see Appendices 
A and B). Nurses delivering the program attended training facilitated by SFF 
program coordinators, to ensure both sample and data collection adhered to 
protocol, and that delivery of the program was standardised across sites. 
 
     Baseline data (Time One) were collected from 21 different workshop locations 
between July 2009 and August 2010, dependent on when the program was run 
within the community. Follow-up data (Time Two) were then collected at the 
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same locations between July 2010 and August 2011. Individuals were assigned a 
code by the nurse delivering the program that could not be used to identify the 
individual, but would allow data for each individual to be collated over time. Data 
was then collated centrally by the National Centre for Farmer Health Data 
Manager in Hamilton, Victoria and data entered twice to ensure accuracy. De-
identified SFF data was provided for the current study from the National Centre of 
Farmer Health via an SPSS database.  
 
5.2 Participants 
     Participants in the current study were 368 farm men and farm women from 
across the following regions in the state of Victoria, Australia: Barwon South 
Western (n=94, 25.5%), Gippsland (n=40, 10.9%), Grampians (n=114, 31%), 
Hume (n=18, 4.9%) and Loddon Mallee (n=102, 27.7%). Figure 5 (below) 
provides a pictorial representation of these rural regions (Department of Health 
Victoria, 2011).  
 
 
Figure 5. Department of Health, Victoria - Rural Regions 
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5.2.1 Demographics 
     Demographic information was obtained from data collected from all 
participants at commencement of the SFF program and included age, sex, country 
of birth and Indigenous/non Indigenous status (see Appendix A). Participant ages 
ranged between 22 and 79 years, with a mean age of 51.5 years. Of the 
participants, 54.1% (n = 199) were male and 45.9% (n = 169) female.   
 
     Australia was nominated as the country of birth by 91% of participants (n = 
335). Of the remaining nine per cent, 2.2% did not respond to the question and the 
remaining 6.8% were born in the following countries: England (n = 3), New 
Zealand (n = 8), Canada (n = 1), USA (n = 1), Germany (n = 2), Netherlands (n = 
1), Scotland (n = 1), UK (n = 1), Other (n = 6). Two participants identified their 
status as Aboriginal, one participant identified as both Aboriginal and Torres 
Strait Islander.   
 
     Complete medical data and psychological data were available for 357 
participants at Time One (“Sample Time One”) and 234 participants at Time Two 
(“Sample Time Two”). Table 5 (below) provides details of the demographic 
characteristics of the total sample. The data was collected in various community 
locations, for example meeting rooms in Shire offices, where the programs were 
delivered. Due to the nature of participant recruitment and lack of available data, 
it is uncertain if the SFF participants are representative of the farming 
communities. 
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5.3 Materials 
5.3.1 Short Form of the Depression Anxiety and Stress Scale (DASS21) 
     The Short Form of the Depression, Anxiety and Stress Scale (DASS21) 
(Lovibond & Lovibond, 1995) was used to assess Depression, Anxiety and Stress 
(see Appendix G). This 21 item self-report measure contains three seven-item 
subscales that assess the core symptoms of these constructs.  Respondents use a 4-
point Likert scale to respond to items such as [over the last two weeks] “I couldn’t 
seem to experience any positive feeling at all” (Depression), “I was aware of 
dryness of my mouth” (Anxiety) and “I found it hard to wind down” (Stress).  
Responses range from 0 (did not apply to me) to 3 (applied to me very much or 
most of the time. For research and clinical purposes, the obtained scores from 
these subscales can be multiplied by two and compared to scores designed to 
characterise the degrees of severity relative to the population. Table 6 below 
outlines the guidelines for DASS severity ratings. 
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Table 5. 
Demographic Characteristics of Participants  
 Total 
sample 
(n=368) 
Sample  
Time One 
(n=357) 
Sample  
Time Two 
(n=234) 
Mean age (SD) 51.5 (11.8) 51.5 (11.8) 52.3 (11.8) 
Gender (%) 
Male 
Female 
 
199 (54.1) 
169 (45.9) 
 
193 (54.1) 
164 (45.9) 
 
132 (56.4) 
102 (43.6) 
Region of Victoria (%) 
Barwon South Western  
Gippsland 
Grampians 
Hume 
Loddon Mallee 
 
94    (25.5) 
40    (10.9) 
114  (31.0) 
18    (4.9) 
102  (27.7) 
 
89   (24.9) 
38   (10.6) 
111 (31.1) 
18   (5.0) 
101 (28.3) 
 
52 (22.2) 
25 (10.7) 
75 (32.1) 
13 (5.6) 
69 (29.5) 
Nominated Country of Birth  
Australia 
England 
New Zealand 
Canada 
USA 
Germany 
Netherlands 
Scotland 
UK 
Other 
No Response 
 
335  
3      
8      
1      
1      
2 
1      
1 
1 
6 
8 
 
326 
3 
8 
1 
1 
2 
1 
1 
1 
5 
8 
 
221 
1 
3 
1 
0 
0 
0 
1 
1 
4 
1 
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Table 6. 
DASS Severity Ratings 
Severity Label Depression Anxiety Stress 
Normal 0-9 0-7 0-14 
Mild 10-13 8-9 15-18 
Moderate 14-20 10-14 19-25 
Severe 12-27 15-19 26-33 
Extremely Severe 28+ 20+ 34 
 
Crawford et al. (2011) provide normative data for an Australian general adult 
population sample and report reliabilities of 0.90, 0.79 and 0.89 for the 
Depression, Anxiety and Stress scales respectively. In the current study, the 
baseline Cronbach alpha coefficient for the DASS21 Depression, Anxiety and 
Stress subscales were 0.85, 0.70 and 0.83 respectively. A small number of studies 
have investigated other psychometric properties of this version of the DASS. In 
clinical studies Antony, Bieling, Cox, Enns and Swinson (1998) replicated the 
factor structure using exploratory factor analysis, but using confirmatory factor 
analysis, Clara, Cox and Enns (2001) were unable to find a three-factor model that 
met all the fit criteria. Daza, Novy, Stanley and Averill (2002) reported similar 
difficulties in a study of an Hispanic sample with Anxiety disorders with a 
Spanish version of the DASS-21, despite finding support for a three factor model 
and sound internal reliabilities and discriminant and convergent validity. 
However, when they re-analysed the non-clinical data reported in their 2003 study 
using only the 21 items of the DASS-21 rather than the 42 items of the DASS, 
Henry and Crawford’s (2005) confirmatory factor analysis revealed that the model 
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with optimal fit had a quadripartite structure, which included a general factor of 
psychological distress in addition to the Depression, Anxiety, and stress factors. 
The internal reliability for the Depression subscale was 0.88, for the Anxiety 
subscale 0.82, and for the stress subscale 0.93. Although they did not report all of 
their findings related to the convergent and discriminant validity of the DASS-21, 
Henry and Crawford (2005) stated that their investigation indicated that, as for the 
full version of the DASS, the DASS-21 shows evidence good convergent and 
discriminant validity when compared with HADS and the Positive and Negative 
Affect Schedule (PANAS). They concluded that the purported DASS-21 
subscales are valid, but that each of them also assesses a more general dimension 
of psychological distress or negative affect. 
 
5.3.2 Health Conditions and Behaviours 
     Information about participants’ current health conditions and health behaviours 
was collected using the Victorian Department of Human Service Coordination 
Tools (Appendices E and F). These tools have their basis in health promotion 
literature and practice reviews, and incorporate key consumer information 
including medical, physical and social data that have been determined as useful in 
the determination of risk factors, further assessment and referrals. 
 
5.3.3 Metabolic Syndrome Factors 
     A range of health data and samples are collected by registered nurses on the 
first morning of the SFF program in each consecutive year (see Appendix B). 
Participants are required to fast for a minimum of ten hours before attending the 
first day of each workshop. Under ethical guidelines, health information and 
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biometric measurements are collected in a private and confidential manner. 
Measurements were collected and assessed as per guidelines of the Australian 
Government National Health and Medical Research Council (NHMRC) 
(NHMRC, 2011), including those variables associated with metabolic syndrome, 
such as fasting cholesterol and blood glucose, weight for height, waist-to-hip 
ratio, blood pressure and pulse. Blood pressure is measured twice, with both 
readings and an average of the two readings recorded. The average reading for 
both Systolic and Diastolic was used in analysis. In data analysis, those 
participants who were previously diagnosed with either hypertension and/or Type 
II diabetes were identified as meeting the IDF metabolic syndrome criteria as a 
previous diagnosis by this definition equates to meeting the criteria. 
 
5.4 Procedure 
     Ethics approval for the SFF program was obtained from the South West Health 
Care Ethics Committee (see Annex H).  
 
     Prior to the commencement of the first workshop, participants were mailed a 
package of documentation that included a Plain Language Statement (Appendix 
C) and a form consenting to the use of the data obtained from them to be used for 
research purposes (Appendix D). This package also included questionnaires 
recording demographic and health information (Appendices A, E, F). Participants 
were also asked to complete the DASS21 (Appendix G). All forms were returned 
prior to the workshop or handed to the program facilitator at the commencement 
of the workshop during the health assessment.  
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     The program commenced with a two-day workshop, followed by a second one-
day workshop approximately 12 months later and a further one-day workshop one 
year after that. Participants were required to fast for a minimum of ten hours 
before attending the first day of each workshop so that physical health 
assessments could be conducted on the first morning of each workshop. 
Assessment and collation of physical and psychosocial data and biometric 
measurements was undertaken in a private and confidential environment. The full 
SFF Physical Assessment Form can be viewed in Appendix B. Those participants 
who were identified as having results greater than acceptable levels as defined by 
NHMRC standards were referred for relevant further assessment or intervention.  
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Chapter 6: Results – Study One 
6.1 Demographics 
     Of a total of 368 participants in the SFF program at Time One, eleven were 
excluded from analyses due to missing metabolic syndrome factor and/or DASS 
data. The age distribution of the remaining participants is summarised in Table 7 
below. 
 
     Initial analyses assessed Time One gender differences in participants’ age and 
country of birth. There was no significant gender difference in mean age (t(355) = 
0.537, p = 0.59).  
 
Table 7.  
Age Distribution at Time One (N=357) 
Age Group (Years) n % 
18-24 3 0.8 
25-34 35 9.8 
35-44 63 17.6 
45-54 100 28.0 
55-64 110 30.8 
65+ 46 12.9 
 
 
 
 
 
82 
 
6.2 Health Conditions and Behaviours 
    Of those participants identified with existing health conditions at the 
commencement of the SFF program, nine had been previously diagnosed with 
Type II diabetes and 15 had been previously diagnosed with hypertension. As a 
previous diagnosis or specific treatment for raised triglycerides, reduced (HDL) 
cholesterol, raised blood pressure and raised fasting plasma glucose are to be 
considered when defining metabolic syndrome, these participants were controlled 
for in the analyses by manually coding them to reflect meeting these individual 
criteria of metabolic syndrome. 
 
     Participants reported their overall health in general to be ‘fair’ (n = 34), ‘good’ 
(n = 136), ‘very good’ (n = 157) or ‘excellent’ (n = 30). No participants reported 
their health as ‘poor’. When self-reporting how much their health interfered with 
their normal activities during the past four weeks, 63% of participants (n = 225) 
reported ‘not at all’, 26.1% of participants (n = 93) reported ‘slightly’, 6.2% (n = 
22) reported ‘moderately’ and 4.5% (n = 16) reported ‘quite a bit’.  There were no 
significant gender differences in the reporting of either overall health (χ2(3, 357) = 
1.94, p = 0.59), or interference with normal activities (χ2(3, 357) = 1.33, p = 0.72). 
 
     Seventy-five per cent of participants (n = 250) reported accumulating 30 
minutes or more of moderate intensity physical activity on most days of the week. 
However, significant gender differences were found, with males (n = 151, 78.2%) 
more likely than females (n = 99, 60.4%) to report ‘yes’ to achieving this level of 
activity (χ2(1, 357) = 13.5, p < 0.001). 
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6.3 Metabolic Syndrome Factors 
     In accordance with the IDF metabolic syndrome criteria, each participant was 
assessed to determine if they met the cut-off values for central obesity (defined as 
waist circumference), raised triglycerides, reduced HDL cholesterol, raised blood 
pressure and raised fasting plasma glucose (as previously described in detail in 
Chapter 1). The percentages of participants meeting the values for individual 
metabolic syndrome factors are presented in Table 8 below. 
 
6.3.1 Metabolic Syndrome Factors and Gender 
     A Chi-square test for independence (with Yates Continuity Correction) 
indicated a significant association between gender and the categorical variable of 
meeting the IDF waist circumference cut-off or not, χ2(1, 357) = 6.60, p = 0.007, 
phi = 0.14. A significantly higher proportion of females (78.7%) met the central 
obesity criteria for metabolic syndrome than males (65.8%). There was also an 
association between gender and the categorical variable of raised blood pressure, 
χ2(1, 357) = 9.35, p = 0.002, phi = -0.17, with a significantly higher proportion of 
males (69.9%) meeting the IDF criteria than females (53.7%). There were no 
significant gender differences in the categorical variables of raised triglycerides, 
(χ2(1, 357) = 2.46, p = 0.15, phi = 0.08), reduced HDL cholesterol (χ2(1, 357) = 
2.33, p = 0.10, phi = 0.09) or raised fasting plasma glucose (χ2(1, 357) = 0.19, p = 
0.67, phi = -0.03). Table 8 below also includes Chi-square tests and significance 
level for gender differences in these criteria.  
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Table 8.  
Frequency of Participants who met Individual IDF Metabolic Syndrome Factor 
Criteria and Gender Differences (N=357) 
Criteria All Participants Male 
(n=193) 
Female 
(n=164) 
Chi 
square 
p 
 n % n % n %   
Waist circumference 256 71.7 127 65.8 129 78.7 6.6 <0.01 
Raised triglycerides 72 20.2 33 17.1 39 23.8 2.06 0.15 
Reduced HDL 
cholesterol 
164 45.9 81 42.0 83 50.6 2.33 0.13 
Raised blood pressure 223 62.5 135 69.9 88 53.7 9.35 <0.01 
Raised fasting plasma 
glucose 
136 38.1 76 39.4 60 36.6 0.19 0.67 
 
6.4 Prevalence of Metabolic Syndrome 
     At the commencement of the SFF program (Time One), 139 (38.9%) of the 
357 participants were identified as meeting the IDF criteria for metabolic 
syndrome; that is, central obesity (as measured by waist circumference) plus at 
least two of the four remaining factors. A two independent proportion z-test found 
that the prevalence rate in the current study was significantly greater than that 
found by Cameron et al. (2007) in the Australian population (n = 3453, N = 
11,247), z = 3.31, p = <0.001, two-tailed. 
 
     Amongst participants in the current study, 35.8% (n = 69) of males and 42.7% 
(n = 70) of females met the criteria for metabolic syndrome. A Chi-square test for 
independence (with Yates Continuity Correction) indicated no significant 
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association between gender and metabolic syndrome (χ2(1, 357) = 1.51, p = 0.22, 
phi = 0.7).  
 
     Using results from previous research by Janus et al. (2007) on metabolic 
syndrome among rural men and women (without age adjustment), a two 
independent proportion z-test found that the prevalence rate amongst females was 
significantly greater in the current study than that found by Janus et al. (2007), in 
which IDF criteria prevalence 30.1% amongst females (n = 127, N = 423), z = 
2.914, p = 0.004, two-tailed. A two independent proportion z-test found no 
significant difference between the prevalence rate amongst males in the current 
study and that of Janus et al. (2007), (n = 129, N = 383), z = 0.49, p = 0.62, two-
tailed. 
 
     The association between metabolic syndrome and age group was also assessed. 
Participants were allocated to an age group according to their age at Time One. 
Table 9 below presents the prevalence data of metabolic syndrome by age group. 
A Chi-square test for independence indicated a significant association between 
metabolic syndrome status and age group (χ2(5, 357) = 23.45, p < 0.001, phi = 
0.26). Results indicate that the prevalence of metabolic syndrome increased 
progressively with age.   
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Table 9.  
Prevalence of Metabolic Syndrome by Age Group Time One 
Age Group 
(Years) 
No. of 
participants 
(N = 357) 
Prevalence 
(n = 137) 
Prevalence 
within Age 
Group 
% of Total 
Sample 
18-34 3 0 0 0 
25-34 35 6 17.1 1.7 
35-44 63 17 27.0 4.8 
45-54 100 39 39.0 10.9 
55-64 110 49 44.5 13.7 
65+ 46 28 60.9 7.8 
 
 
     These findings are consistent with those of previous research by Cameron et al. 
(2007) and Janus et al. (2007). Figure 6 (below) displays a comparison of 
previous research findings with the current results.  
 
Figure 6. Metabolic Syndrome Prevalence Data Comparison at Time One (%) 
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     As central obesity is central to the IDF definition of metabolic syndrome, all 
139 participants who were identified as meeting the criteria for metabolic 
syndrome diagnosis met this criteria. Amongst the other criteria, 86.3% of 
participants met criteria for raised blood pressure, 66.5% met the criteria for 
raised fasting plasma glucose, 58.3% met the criteria for reduced HDL 
cholesterol, and 34.5% met the criteria for raised triglycerides. No gender 
differences were found between males and females with metabolic syndrome 
amongst these criteria. Table 10 below outlines the frequency and percentages of 
metabolic syndrome criteria met by those with metabolic syndrome by gender.  
 
Table 10.  
Frequency of Factors for Participants with Metabolic Syndrome by Gender 
(n=139) 
IDF Metabolic 
Syndrome criteria 
Male 
(n=69) 
Female 
(n=70) 
Chi 
square  
p 
     n    %     n %   
Waist circumference 69 100 70 100 - - 
Raised triglycerides 20 29 28 40 1.86 0.17 
Reduced HDL 
cholesterol 
35 50.7 46 65.7 3.21 0.07 
Raised blood 
pressure 
63 91.3 57 81.4 2.87 0.09 
Raised fasting 
plasma glucose 
48 69.6 44 62.9 0.70 0.40 
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6.5 Depression, Anxiety and Stress  
     The DASS21 yields separate scores for Depression, Anxiety, and Stress. 
Obtained scores are then multiplied by two to provide a means of comparing with 
subscale clinical cut-off scores provided for the full 42-item DASS (Lovibond & 
Lovibond, 1995). Table 11 (below) summarises the range of scores, means and 
standard deviations for each of the constructs for participants at Time One by 
gender.  
 
6.5.1 Gender, Age Group and DASS Scores 
     Independent-samples t-tests were conducted to compare the Depression, 
Anxiety and Stress scores for males and females. There was a significant 
difference in Stress scores, with females (M = 8.78, SD = 6.69) scoring higher 
than males (M = 7.32, SD = 6.33, t (355) = -2.12, p = 0.03, two-tailed). The 
magnitude of the differences in the means (mean difference = -.95, 95% CI: -2.82 
to -0.10) was small (eta squared = .01). There was no significant difference 
between the Depression scores for males (M = 3.99, SD = 5.23) and females (M = 
4.94, SD = 5.62, t (355) = -1.65, p = 0.10, two-tailed). Likewise, there was no 
significant difference between Anxiety scores for males (M = 2.55, SD = 4.05) 
and females (M = 3.27, SD = 4.04, t (355) = -1.69, p = 0.09, two-tailed).  Table 11 
(below) summarises these analyses. According to Stevens (1996), when the 
sample size is large (e.g. 100 or more participants), power is ‘not an issue’. 
Therefore, it is unlikely that non-significant gender differences were due to 
sample size. 
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Table 11.  
DASS Subscale Range, Mean and Standard Deviations by Gender  
 Male (n = 193) Female (n = 164) Difference 
Subscale Range M SD Range  M SD t p 
Depression 0-28 3.99 5.23 0-28 4.94 5.62 -1.65 0.10 
Anxiety 0-30 2.55 4.05 0–20 3.27 4.04 -1.69 0.09 
Stress 0-28 7.32 6.33 0–28 8.78 6.69 -2.12 0.04 
 
     It was hypothesised that levels of Depression, Anxiety and Stress would be 
higher amongst farm men and women when compared with the general population 
norms. However, when compared with DASS results from an Australian general 
adult population sample (Crawford et al., 2011), the means and standard 
deviations were marginally lower for Depression (M = 5.02, SD = 7.54), Anxiety 
(M = 3.36, SD = 5.07) and Stress (M = 8.10, SD = 8.40). A further review of the 
article was undertaken and it was found that Crawford et al., (2011) did not use 
age-adjustment in their results and therefore, the comparison appears valid. 
 
     One-way between-groups analyses of variance were conducted to explore the 
relationship between participant age group and DASS subscale scores. 
Participants were allocated into an age group according to their age at Time One 
(see Table 7). The models were not significant for Depression (F(5, 356) = 1.92, p 
= 0.09), Anxiety (F(5, 356) = 0.16, p = 0.98), or Stress (F(5, 356) = 1.27, p = 
0.28). Table 12 below summarises these results.  
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Table 12.  
DASS Subscale Range, Mean, Standard Deviation by Age Group (N = 357). 
  Depression 
Subscale 
Anxiety Subscale Stress Subscale 
Group n Range M SD Range M SD Range M SD 
18-24 3 2-20 8.67 9.87 0-4 2.00 2.00 2-16 6.67 8.08 
25-34 35 0-22 5.67 5.03 0-10 2.51 2.58 0-22 9.71 6.78 
35-44 63 0-24 3.40 4.48 0-14 2.83 3.29 0-24 8.06 6.00 
45-54 100 0-28 5.14 6.05 0-28 3.12 4.39 0-28 8.41 7.13 
55-64 110 0-28 4.31 5.63 0-30 2.86 4.58 0-28 7.79 6.25 
65+ 46 0-18 3.35 4.30 0-20 2.83 4.08 0-20 6.26 6.15 
 
6.6 Metabolic Syndrome and DASS Subscale Scores 
     Three independent-samples t-tests were conducted to compare the Depression, 
Anxiety and Stress scores for those with metabolic syndrome and those without. 
A summary of these results can be found in Table 13 below. There was a 
significant difference between the Anxiety scores of those with metabolic 
syndrome (M = 3.44, SD = 4.66) and those without (M = 2.53, SD = 3.58; t 
(239.81) = -1.96, p = 0.05, two-tailed), with those meeting metabolic syndrome 
diagnostic criteria scoring higher. The magnitude of the differences in the means 
(mean difference = -0.91, 95% CI: -1.83 to 0.003) was small (eta squared = .01). 
There was no significant difference between the Depression scores of those with 
metabolic syndrome (M = 4.52, SD = 6.0) and those without (M = 4.37, SD = 
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5.04; t (256.7) = -.25, p = 0.81, two-tailed). Likewise, there was no significant 
difference in the Stress scores for those with metabolic syndrome (M = 8.22, SD = 
6.73) and those without (M = 7.85, SD = 6.41; t (355) = -0.52, p = 0.61, two-
tailed). 
 
Table 13.  
Metabolic Syndrome Status and DASS Subscale Scores. 
 With Metabolic 
Syndrome (n = 139) 
Without Metabolic 
Syndrome (n = 218) 
Difference 
Subscale M SD M SD t p 
Depression 4.52 6.01 4.37 5.04 -0.25 0.81 
Anxiety  3.44 4.66 2.53 3.58 -1.96 0.05 
Stress  8.22 6.73 7.85 6.41 -0.52 0.61 
 
     Three further independent-samples t-tests were conducted to compare the 
DASS subscale scores for males and females with metabolic syndrome. There was 
no significant differences found between Depression, Anxiety or Stress for males 
and females. Table 14 displays these results. 
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Table 14.  
DASS Subscale Scores for those with Metabolic Syndrome by Gender. 
 Males  (n = 69) Females (n = 70) Difference 
Subscale M SD M SD t p 
Depression  4.20 6.29 4.83 5.74 -0.61 0.54 
Anxiety  3.99 5.03 3.49 4.30 -0.12 0.90 
Stress  8.14 6.97 8.29 6.54 -0.12 0.90 
 
6.7. Relationship Between DASS Subscale Scores and Metabolic Syndrome 
Factors  
     The HPA Axis hypothesis  posits that cortisol levels, as regulated by the HPA 
axis, play an important role in lipid and glucose metabolism, with evidence of 
prolonged elevated levels leading to Type II diabetes, a redistribution of body fat 
(as characterised by central adiposity) and hypertension (Rosemond & Bjorntorp, 
2000). Psychological characteristics such as anger, hostility, Depression and 
Anxiety also influence the risk of developing CVD and diabetes (Goldbacher & 
Matthews, 2007; Weber-Hamann et al., 2002). Therefore, it could be expected 
that all of the metabolic syndrome factors would be significantly related to levels 
of Depression, Stress and Anxiety.  
 
     In line with this, previous studies by Akbaraly et al. (2009), Dunbar et al. 
(2008), Miettola et al. (2008), Muhntz et al. (2009), Richter et al. (1009), Skilton 
et al. (2007), Vanhala et al. (2008), and Vogelzangs et al. (2007) have found 
relationships between various metabolic syndrome factors and Depression.    
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     Therefore, correlation and multiple regression analyses were conducted to 
examine the relationship between the each of the Depression, Anxiety and Stress 
scores and the individual factors of metabolic syndrome criteria for both the total 
sample (N = 357) and the sample with metabolic syndrome (n = 139). The 
metabolic syndrome factor of raised blood pressure is separated into Systolic 
blood pressure (Systolic BP) and Diastolic blood pressure (Diastolic BP) as these 
are two separate physiological readings that are required to be separated for the 
purpose of analysis (as continuous variables). Tests for outliers, normality, 
linearity, homoscedasticity and independence of residuals indicated no violations 
of assumptions for each of the analyses. 
 
6.7.1 Depression Subscale      
     Correlation and multiple regression analyses were conducted to examine the 
relationship between Depression and metabolic syndrome factors for both the total 
sample and for the sample with metabolic syndrome. Table 15 displays the 
correlations between the variables for the total sample. Within the total sample, 
waist circumference and triglycerides are positively and significantly correlated 
with Depression. Raised fasting blood glucose is also positively, but not 
significantly, correlated with Depression. Reduced (HDL) cholesterol and both 
Systolic and Diastolic blood pressure are negatively, but not significantly 
correlated with Depression. These results indicate that, within the total sample, 
those participants experiencing higher levels of Depression tend to have a larger 
waist circumference and higher triglyceride levels.  
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Table 15.  
Pearson Correlations between Depression Scores and Metabolic Syndrome 
Factors for the Total Sample. 
Factor 1 2 3 4 5 6 7 
1. Depression Score - 0.15** 0.09* -0.03 -0.04 0.03 0.07 
2. Waist Circumference  - 0.09* -0.29** 0.30** 0.34** 0.22** 
3. Triglycerides   - 0.00 0.08 0.12* 0.06 
4. HDL Cholesterol    - -0.08 -0.10* -0.06 
5. Systolic Blood Pressure     - 0.70** 0.15* 
6. Diastolic Blood Pressure      - 0.03 
7. Blood Glucose        - 
* p < 0.05   ** p < 0.01    
 
     The multiple regression model for the total sample, with all six predictors, 
produced R2 = 0.043, F(6, 350) = 2.59, p = 0.018, explaining only 4.3% of the 
variance in Depression scores. Table 16 below summarises the descriptive 
statistics and analysis results by subscale. As can been seen in Table 16, waist 
circumference had a significant positive regression weight (1.9% of the variance, 
sr2 = 0.019, p = 0.008), whilst Systolic blood pressure had a significant negative 
regression weight (1.1% of the variance, sr2 = -0.011, p = 0.04), indicating that 
participants with higher waist circumference and lower Systolic blood pressure 
were more likely to have higher levels of Depression. Triglycerides, HDL 
cholesterol, Diastolic blood pressure and blood glucose did not contribute 
significantly to Depression scores within the total sample. 
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Table 16.  
Summary Statistics, Correlations and Results from the Depression Subscale 
Regression Analysis for the Total Sample 
 
 
Subscale 
 
 
Variable 
 
 
M 
 
 
SD 
 
Correlation 
with 
subscale 
Multiple regression 
weights 
ƅ β  sr2 
Depression 
(total 
sample) 
Depression 4.43 5.43     
Waist 94.77 12.30 0.15** 0.16** 0.07 0.19 
Triglycerides 1.28 1.06 0.09* 0.08 0.39 0.00 
HDL Cholesterol 1.14 0.42 -0.03 0.01 0.15 0.00 
 Systolic BP 132.72 16.78 -0.04 -0.15* -0.05 0.01 
 Diastolic BP 87.46 9.83 -0.03 0.08 0.04 0.00 
 Blood Glucose 5.40 0.78 0.07 0.05 0.34 0.00 
* p < 0.05   ** p < 0.01    
 
     Correlation and multiple regression analyses were then conducted to examine 
the relationship between Depression and metabolic syndrome factors in the 
sample with metabolic syndrome. Table 17 below displays the correlations 
between variables for the metabolic syndrome sample. 
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Table 17.  
Pearson Correlations between Depression Scores and Metabolic Syndrome 
Factors for Sample with Metabolic Syndrome. 
Factor 1 2 3 4 5 6 7 
1. Depression Score - 0.25** 0.11 -0.00 -0.07 0.07 0.17* 
2. Waist Circumference  - 0.05 -0.34** 0.08 0.24* 0.15* 
3. Triglycerides   - -0.06 -0.05 -0.02 -0.09 
4. HDL Cholesterol    - -0.07 -0.04 -0.18* 
5. Systolic Blood Pressure     - 0.60** 0.03 
6. Diastolic Blood Pressure      - 0.06 
7. Blood Glucose        - 
* p < 0.05   ** p < 0.01    
 
     Unlike the total sample, which indicated that participants with higher waist 
circumference and lower Systolic blood pressure were more likely to have higher 
levels of Depression, amongst the sample of participants with metabolic 
syndrome, waist circumference and fasting blood glucose were positively and 
significantly correlated with Depression scores. Triglycerides and Diastolic blood 
pressure were also positively, but not significantly, correlated with Depression. 
Reduced (HDL) cholesterol and Systolic blood pressure were negatively, but not 
significantly correlated with Depression.  
 
     The multiple regression model for the metabolic syndrome sample, with all six 
predictors, produced R2 = 0.121, F(6, 132) = 3.03, p = 0.008, explaining 12.1% of 
the variance in the model; almost three times more than that of the total sample 
(4.3%). As can been seen in Table 18, waist circumference (4.7% of the variance, 
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sr2 = 0.047, p = 0.008) and fasting plasma glucose (2.8% of the variance, sr2 = 
0.03, p = 0.04) had significant positive regression weights, indicating that, 
amongst participants with metabolic syndrome, those who have higher waist 
circumference and blood glucose levels were likely to have higher levels of 
Depression. Triglycerides, HDL cholesterol, Systolic and Diastolic blood pressure 
did not contribute to Depression amongst those with metabolic syndrome. 
 
Table 18.  
Summary Statistics, Correlations and Results from the Depression Subscale 
Regression Analysis for the Metabolic Syndrome Sample 
 
 
Subscale 
 
 
Variable 
 
 
M 
 
 
SD 
 
Correlation 
with 
subscale 
Multiple regression 
weights 
ƅ β  sr2 
Depression 
(Metabolic 
Syndrome 
Sample) 
Depression 4.52 6.01     
Waist 101.56 11.28 0.25** 0.24** 0.13 0.05 
Triglycerides 1.59 1.18 0.11 0.11 0.55 0.01 
HDL Cholesterol 1.20 0.43 <-0.01 -0.11 1.53 0.01 
Systolic BP 139.99 16.72 -0.07 -0.16 -0.06 0.01 
 Diastolic BP 87.98 9.21 0.07 0.12 0.08 0.00 
 Blood Glucose 5.76 0.88 0.17* 0.18* 1.20 0.03 
* p < 0.05   ** p < 0.01    
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6.7.2 Anxiety Subscale 
     Correlation and multiple regression analyses were also conducted to examine 
the relationship between Anxiety scores and the individual factors of metabolic 
syndrome criteria for both the total sample and also for the sample with metabolic 
syndrome. Table 19 displays the correlations between the variables for the total 
sample.  
 
     Within the total sample, waist circumference, Systolic and Diastolic blood 
pressure and blood glucose were positively and significantly correlated with 
Anxiety. Triglycerides were also positively, but not significantly, correlated with 
Anxiety. Reduced (HDL) cholesterol was negatively, but not significantly 
correlated with Anxiety in the total sample.  
 
Table 19.  
Pearson Correlations between Anxiety Scores and Metabolic Syndrome Factors 
for the Total Sample 
Factor 1 2 3 4 5 6 7 
1. Anxiety Score - 0.17** 0.05 -0.07 0.13* 0.14* 0.12* 
2. Waist Circumference  - 0.09* -0.29** 0.30** 0.34** 0.22** 
3. Triglycerides   - 0.00 0.08 0.12* 0.06 
4. HDL Cholesterol    - -0.08 -0.10* -0.06 
5. Systolic Blood Pressure     - 0.70** 0.15* 
6. Diastolic Blood Pressure      - 0.03 
7. Blood Glucose        - 
* p < 0.05   ** p < 0.01    
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     The multiple regression model for the total sample, with all six predictors, 
produced R2 = 0.048, F(6, 350) = 2.96, p = 0.008, explaining only 4.8% of the 
variance in the model. As can been seen in Table 20, waist circumference 
accounted for a significant proportion of variance in Anxiety scores (1.4% of the 
variance, sr2 = 0.014, p = 0.025), indicating that participants with higher waist 
circumference had higher levels of Anxiety. Triglycerides, HDL cholesterol, 
Systolic and Diastolic blood pressure and blood glucose did not contribute to 
Anxiety within the total sample. 
 
Table 20.  
Summary Statistics, Correlations and Results from the Anxiety Subscale 
Regression Analysis for the Total Sample 
 
 
Subscale 
 
 
Variable 
 
 
M 
 
 
SD 
 
Correlation 
with 
subscale 
Multiple 
regression weights 
 
ƅ β sr2 
Anxiety 
(total 
sample) 
Anxiety 2.88 4.06     
Waist 94.77 12.3
0
0.17** 0.13** 0.04 0.01 
Triglycerides 1.28 1.06 0.46 0.02 0.06 0.00 
HDL Cholesterol 1.14 0.42 <-0.01 0.05 0.46 0.01 
 Systolic BP 132.72 16.7
8
0.13* 0.02 <0.01 0.01 
 Diastolic BP 87.46 9.83 0.14* 0.08 0.03 0.00 
 Blood Glucose 5.40 0.78 0.17 0.43 0.08 0.00 
* p < 0.05   ** p < 0.01    
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     Correlation and multiple regression analyses were then conducted to examine 
the relationship between Anxiety and metabolic syndrome factors in the sample 
with metabolic syndrome. Table 21 below displays the correlations between 
variables for the metabolic syndrome sample.  
 
Table 21.  
Pearson Correlations between Anxiety Scores and Metabolic Syndrome Factors 
for Sample with Metabolic Syndrome 
Factor 1 2 3 4 5 6 7 
1. Anxiety Score - 0.25* -0.01 0.03 0.16* 0.13 0.17* 
2. Waist Circumference  - 0.05 -0.34** 0.08 0.24* 0.15* 
3. Triglycerides   - -0.06 -0.05 -0.02 -0.09 
4. HDL Cholesterol    - -0.07 -0.04 -0.18* 
5. Systolic Blood Pressure     - 0.60** 0.03 
6. Diastolic Blood Pressure      - 0.06 
7. Blood Glucose        - 
* p < 0.05   ** p < 0.01    
 
     Similar to the total sample, in which waist circumference, Systolic and 
Diastolic blood pressure and blood glucose were positively and significantly 
correlated with Anxiety, amongst the sample of participants with metabolic 
syndrome, waist circumference, Systolic blood pressure and fasting blood glucose 
were positively and significantly correlated with Anxiety. Reduced (HDL) 
cholesterol and Diastolic blood pressure were also positively, but not 
significantly, correlated with Anxiety. Triglyceride levels are negatively, but not 
significantly correlated with Anxiety.  
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     The multiple regression model for the metabolic syndrome sample, with all six 
predictors, produced R2 = 0.114, F(6, 132) = 2.83, p = 0.013, explaining 11.4% of 
the variance in Anxiety scores; almost two and a half times more than that of the 
total sample (4.8%). As can been seen in Table 22 (below), waist circumference 
(5% of the variance, sr2 = 0.05, p = 0.005) was the only factor to account for a 
significant proportion of the variance, indicating that, amongst participants with 
metabolic syndrome, those who have a higher waist circumference are more likely 
to experience higher levels of Anxiety. Triglycerides, HDL cholesterol, Systolic 
and Diastolic blood pressure and blood glucose levels did not contribute to 
Anxiety for those with metabolic syndrome.  
 
Table 22.  
Summary Statistics, Correlations and Results from the Anxiety Subscale 
Regression Analysis for the Metabolic Syndrome Sample 
 
 
Subscale 
 
 
Variable 
 
 
M 
 
 
SD 
 
Correlation 
with 
subscale 
Multiple 
regression weights 
 
ƅ β sr2 
Anxiety 
(Metabolic 
Syndrome 
Sample) 
Anxiety 3.44 4.66     
Waist 101.56 11.2
8
0.25** 0.26** 0.11 0.05 
Triglycerides 1.59 1.18 -0.01 <0.01 0.01 0.00 
HDL Cholesterol 1.20 0.43 <0.01 0.13 1.38 0.01 
Systolic BP 139.99 16.7
2
0.16 0.04 0.15 0.01 
 Diastolic BP 87.98 9.21 0.13 <0.01 <-0.01 0.00 
 Blood Glucose 5.76 0.88 0.17* 0.15 0.82 0.02 
* p < 0.05   ** p < 0.01    
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6.7.3. Stress Subscale 
     Correlation and multiple regression analyses were also conducted to examine 
the relationship between Stress subscale scores and the individual factors of 
metabolic syndrome criteria for both the total sample and also for the sample with 
metabolic syndrome. Table 23 displays the correlations between the variables for 
the total sample. 
 
     Within the total sample, there were no significant correlations found between 
the individual factors and Stress. Waist circumference, triglycerides and blood 
glucose levels were positively, but not significantly, correlated with Stress. 
Reduced (HDL) cholesterol and both Systolic and Diastolic blood pressure were 
negatively, but not significantly correlated with Stress in the total sample. 
 
Table 23.  
Pearson Correlations between Stress Scores and Metabolic Syndrome Factors for 
the Total Sample. 
Factor 1 2 3 4 5 6 7 
1. Stress Score - 0.04 0.05 -0.00 -0.08 -0.02 0.07 
2. Waist Circumference  - 0.09* -0.29** 0.30** 0.34** 0.22** 
3. Triglycerides   - 0.00 0.08 0.12* 0.06 
4. HDL Cholesterol    - -0.08 -0.10* -0.06 
5. Systolic Blood Pressure     - 0.70** 0.15* 
6. Diastolic Blood Pressure      - 0.03 
7. Blood Glucose        - 
* p < 0.05   ** p < 0.01    
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     The multiple regression model for the total sample, with all six predictors, 
produced R2 = 0.021, F(6, 350) = 1.25, p = 0.28, explaining only 2.1% of the 
variance in the Stress scores. As can been seen in Table 24 (below), Systolic 
blood pressure contributed significant unique variance (1.1% of the variance, sr2 = 
-0.107, p = 0.04), indicating that participants with lower Systolic blood pressure 
were likely to have higher levels of Stress. This result is counter-intuitive to the 
medical literature and may be due to biased self-reporting of stress, or the 
suppression effect of another unknown variable. Waist circumference, 
triglycerides, HDL cholesterol, Diastolic blood pressure and blood glucose did not 
contribute to Stress scores for the total sample. 
 
Table 24.  
Summary Statistics, Correlations and Results from the Stress Subscale Regression 
Analysis for the Total Sample 
 
 
Subscale 
 
 
Variable 
 
 
M 
 
 
SD 
 
Correlation 
with 
subscale 
Multiple 
regression weights 
 
ƅ β sr2 
Stress 
(total 
sample) 
Stress 7.99 6.53     
Waist 94.77 12.30 0.04 0.05 0.03 0.00 
Triglycerides 1.28 1.06 0.05 0.05 0.30 0.00 
HDL Cholesterol 1.14 0.42 <0.01 0.01 0.19 0.00 
 Systolic BP 132.72 16.78 -0.07 -0.15* -0.06 0.01 
 Diastolic BP 87.46 9.83 -0.02 0.07 0.04 0.00 
 Blood Glucose 5.40 0.78 0.07 0.08 0.65 0.00 
* p < 0.05 
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     Correlation and multiple regression analyses where then conducted on the 
metabolic syndrome sample to examine the relationship between Stress and 
individual factors of metabolic syndrome. Table 25 displays the correlations 
between variables for those participants with metabolic syndrome      
 
Table 25.  
Pearson Correlations between Stress Scores and Metabolic Syndrome Factors for 
Sample with Metabolic Syndrome 
Factor 1 2 3 4 5 6 7 
1. Stress Score - 0.10 -0.01 0.01 -0.08 0.02 0.06 
2. Waist Circumference  - 0.05 -0.34** 0.08 0.24* 0.15* 
3. Triglycerides   - -0.06 -0.05 -0.02 -0.09 
4. HDL Cholesterol    - -0.07 -0.04 -0.18* 
5. Systolic Blood Pressure     - 0.60** 0.03 
6. Diastolic Blood Pressure      - 0.06 
7. Blood Glucose        - 
* p < 0.05   ** p < 0.01    
 
     As with the total sample, there were no significant correlations within the 
sample of participants with metabolic syndrome between Stress and any of the 
metabolic syndrome factors. Waist circumference, reduced (HDL) cholesterol, 
Diastolic blood pressure and fasting blood glucose were positively, but not 
significantly, correlated with Stress. Triglycerides and Systolic blood pressure 
were negatively, but not significantly, correlated with Stress. 
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     The multiple regression model for the metabolic syndrome sample, with all six 
predictors, produced R2 = 0.027, F(6, 132) = 0.60, p = 0.73, explaining only 2.7% 
of the variance in the model. This is a very similar result to that of the total sample 
(2.1%). As can been seen in Table 26 (below), metabolic syndrome factors did not 
contribute to Stress. 
 
Table 26.  
Summary Statistics, Correlations and Results from the Stress Subscale Regression 
Analysis for Metabolic Syndrome Sample 
 
 
Subscale 
 
 
Variable 
 
 
M 
 
 
SD 
 
Correlation 
with 
subscale 
Multiple 
regression weights 
 
ƅ β sr2 
Stress 
(Metabolic 
Syndrome 
Sample) 
Stress 8.22 6.73     
Waist 101.56 11.28 0.10 0.09 0.06 0.00 
Triglycerides 1.59 1.18 -0.01 -0.02 -0.09 0.00 
HDL Cholesterol 1.20 0.43 0.01 0.05 0.69 0.00 
Systolic BP 139.99 16.72 -0.08 -0.14 -0.06 0.01 
 Diastolic BP 87.98 9.21 0.02 0.09 0.07 0.00 
 Blood Glucose 5.76 0.88 0.06 0.06 0.47 0.00 
* p < 0.05   
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6.8 Metabolic Syndrome and DASS Severity 
     As previous research by Richter et al. (2007) has found a relationship between 
the severity of Depression and metabolic syndrome status, analyses were 
conducted to explore any relationships. Mann-Whitney U Tests found that there 
was no significant difference in the Depression, Anxiety or Stress severity ratings 
between those who had metabolic syndrome and those who did not. Table 27 
summarises the descriptive statistics and analysis results for the above.  
 
Table 27.  
Differences between those with Metabolic Syndrome and those without on DASS 
Subscale Severity Ratings 
  
With Metabolic 
Syndrome  
(n = 139) 
Without 
Metabolic 
Syndrome  
(n = 218) 
   
Subscale Md Md U z p 
Depression Severity 2 2 14382 -1.21 0.23 
Anxiety Severity 2 2 14173 -1.88 0.60 
Stress Severity 8 6 14056 -1.46 0.14 
 
6.9 Summary of Study One Results 
     Results from this study show that in relation to metabolic syndrome factors, a 
significantly higher proportion of females met the IDF central obesity criteria than 
males, whilst a significantly higher proportion of males met the IDF blood 
pressure level criteria. The prevalence of metabolic syndrome in the current study 
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was significantly greater than previously reported in the Australian population, as 
hypothesised. When compared to previous research results from rural Australian 
men and women, a significantly higher prevalence of metabolic syndrome was 
found amongst females but not males. Within the whole sample females reported 
higher levels of Stress than males, however there were no significant differences 
between genders on DASS subscale scores for participants with metabolic 
syndrome. Larger waist circumference accounted for significant amount of 
variance in Depression and Anxiety for both the total sample and for those with 
metabolic syndrome. Raised fasting plasma glucose was also significantly related 
to Depression in the metabolic syndrome sub-sample.    
 
     In summary, it appears that those with metabolic syndrome have higher levels 
of Anxiety than those who do not, and that both waist circumference and raised 
fasting plasma glucose are related to Depression in those with metabolic 
syndrome. These findings present a mixed picture of the relationship between 
metabolic syndrome and Depression and Anxiety and may be due to issues 
surrounding psychological self-report measures, particularly within a cohort of 
farm men and women for reasons discussed earlier. However, following the 
participants over time, as has been done in Study Two, and also analysing the 
relationships between the continuity of an individual’s metabolic syndrome status 
and Depression and Anxiety scores, may assist in providing a better understanding 
of relationships between metabolic syndrome and Depression, Anxiety and Stress.      
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Chapter 7: Results – Study Two 
     The HPA axis hypothesis posits that there is a relationship between 
psychological distress and metabolic syndrome. However, due to a lack of 
longitudinal research, it is unclear as to whether Depression, Anxiety and/or 
Stress will influence metabolic syndrome status over time, or if metabolic 
syndrome status influences levels of Depression, Anxiety and/or Stress over time. 
As Sustainable Farm Families Program participants are health screened on an 
annual basis for three years as a part of the program, this regime provides an ideal 
opportunity to determine the direction of the relationship between Depression, 
Stress and Anxiety and metabolic syndrome.  
 
7.1 Participants 
     Of the total sample from Time One of 357 participants, 250 (70%) returned at 
Time Two to undertake the program, thirteen participants (3.6%) returned 
paperwork but did not attend the program, and 94 participants (26.3%) did not 
return paperwork or participate. Of the 250 participants who did return, 15 cases 
were removed from the analyses due to incomplete data and a further case was 
removed due to pregnancy interfering with valid data (i.e. waist measurement), 
leaving a total of 234 cases with valid data. Demographic information for this 
reduced sample is provided in Table 5 (Chapter 5) for those 234 cases identified 
as “Sample Time Two”. 
 
     A Mann-Whitney U Test revealed no significant difference at Time One 
between those who returned to the program and those who did not on self-
reported overall general health (U = 13194, z = -0.22, p = 0.83), and self-reported 
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health interference with normal activities during the past four weeks (U = 12186, z 
= -1.40, p = 0.16). A Mann-Whitney U Test also revealed there were no 
significant differences between those who returned at Time Two and those who 
did not, on Time One data relating to Weight (U = 13018, z = -0.4, p = 0.69), 
waist measurement (U = 13365, z = -0.01, p = 0.99), Blood Glucose Level (U = 
12839, z = -0.60, p = 0.55), HDL Cholesterol level (U = 11923, z = -1.63, p = 
0.10), Triglyceride level (U = 12117, z = -1.43, p =0.15), Systolic blood pressure 
(U = 12439, z = -1.05, p = 0.29) and Diastolic blood pressure (U = 13320, z = -
0.06, p = 0.95). A Chi-square test for independence (with Yates Continuity 
Correction) indicated no significant association between gender and attrition, χ2(1, 
357) = 1.02, p = 0.31, phi = 0.26.  
 
7.2 Demographics 
     The sample for analysis at Time Two (n = 234) had a mean age of 52.3 years 
(SD = 11.8) and ranged between 24 and 80 years. There was no significant gender 
difference in mean age (t(232) = 0.91, p = 0.24).  
 
7.3 Metabolic Syndrome 
     At Time Two, 103 (44%) of the total 234 participants (43.2% of males, 45.1% 
of females) were identified as meeting the criteria for metabolic syndrome (versus 
38.9% in Study One). A two independent proportion z-test found that the 
prevalence rate in the current study was significantly greater than that found by 
Cameron et al. (2007) in the Australian population (n = 3453, N = 11,247), z = 
4.36, p <0.001, two-tailed.  
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     Of those who met the criteria for metabolic syndrome in the current study, 
55.3% were male, and 44.7% were female. A Chi-square test for independence 
(with Yates Continuity Correction) indicated that this gender difference was not 
significant (χ2(1, n=234) = 0.03, p = 0.87, phi = 0.02). At Time One these figures 
were 49.6% and 50.4% for males and females respectively. Using results from 
previous research by Janus et al. (2007) on metabolic syndrome among rural men 
and women, a two independent proportion z-test found that prevalence rates were 
significantly greater in the current study than those found by Janus et al. (2007)  
among males (z = 1.96, p = 0.05, two-tailed) and females (z = 2.91, p = 0.003, 
two-tailed.  
 
7.3.1 Metabolic Syndrome and Age 
     The association between metabolic syndrome and age group was also assessed. 
Participants were allocated into an age group based on their age at Time Two. 
Table 28 below presents the prevalence of those with metabolic syndrome by age 
group. Results indicate that the prevalence of metabolic syndrome progressively 
increases with age.  
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Table 28.  
Prevalence of Metabolic Syndrome by Age Group at Time Two 
Age Group 
(Years) 
No. of 
participants 
(N=234) 
Prevalence 
(n=103) 
Prevalence 
within  
Age Group 
%  
% of Total 
Sample 
18-34 1 0 0 0 
25-34 23 8 34.8 3.4 
35-44 38 11 28.9 4.7 
45-54 61 25 41.0 10.7 
55-64 78 39 50.0 16.7 
65+ 33 20 60.6 8.5 
 
 
     The above results are similar in trend to those found in Time One, as well as 
those of previous research discussed in Chapter 1. A greater proportion of 
participants in the 25-34 year old age group had metabolic syndrome in the Time 
Two sample, however cannot be judged as significant as the number of 
participants is too small. Figure 7 below is a visual comparison of the prevalence 
results of both Times One and Two of the current study and those of Cameron et 
al. (2007) and Janus et al. (2007), however it should be noted that the number of 
participants between Times One and Two in the current study varied greatly.   
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Figure 7. Metabolic Syndrome Prevalence Data Comparison Times One  
and Two (%) 
 
7.4 Depression, Anxiety and Stress Scale Scores 
     A summary of the range of scores, means, and standard deviations for each of 
the mood constructs for participants at Times One and Two by gender, can be 
seen in Table 29 below.  
 
     An independent-samples t-test was conducted to compare the Depression, 
Anxiety and Stress scores for males and females at Time Two. There was a 
significant difference in Depression scores for males (M = 3.68, SD = 3.84) and 
females (M = 5.22, SD = 6.22; t (158.54) = -2.19, p = 0.03, two-tailed), with 
females scoring higher than males. The magnitude of the differences in the means 
(mean difference = -1.53, 95%CI: -2.92 to -0.15) was small (eta squared = 0.02). 
There was also a significant difference in Stress scores for males (M = 6.55, SD = 
6.08) and females (M = 8.84, SD = 6.87; t (232) = -2.71, p = 0.007, two-tailed), 
with females again scoring higher than males. The magnitude of the differences in 
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the means (mean difference = -2.30, 95%CI: -3.97 to -0.63) was small (eta 
squared = 0.03). There was no significant gender difference in Anxiety scores.  
 
     These results were very different to those at Time One (N = 357) (see Table 29 
below) in both the range of the scores, and gender differences, as at Time One 
only Stress was found to be significantly different between genders. Therefore, 
paired-samples (repeated) t-tests were conducted on the Time Two sample, by 
gender, to evaluate any differences in the means on DASS subscale scores 
between Times One and Two. No statistically significant differences were found 
for males. However, it was found that the females within the Time Two sample 
had a statistically significant decrease in Anxiety from Time One (M = 3.42, SD = 
3.67) to Time Two (M = 2.53, SD = 3.47), t (101) = 2.69, p = 0.008 (two tailed). 
The mean decrease in Anxiety score was 0.89 with a 95% confidence interval 
ranging from 0.23 to 1.55. The Eta squared statistic (0.06) indicated a moderate 
effect size.  
 
7.4.1 Metabolic Syndrome and DASS Scores 
     Independent-samples t-tests were conducted to compare the Depression, 
Anxiety and Stress scores at Time Two for those with metabolic syndrome and 
those without. In this cross-sectional analysis, those meeting metabolic syndrome 
diagnostic criteria scored higher on Depression (M = 5.42, SD = 6.35) than those 
without the syndrome (M = 3.51, SD = 3.56; t(151.47) = -2.73, p = 0.007, two-
tailed). The magnitude of the differences in the means (mean difference = -1.91, 
95%CI: -3.29 to -0.53) was small (Eta squared = 0.03). There was no significant 
difference in Anxiety scores for those with metabolic syndrome (M = 2.72, SD = 
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3.45) and those without (M = 2.18, SD = 2.92; t (199.50) = -0.34, p = 0.21, two-
tailed). Likewise, where was no significant difference in Stress scores for those 
with metabolic syndrome (M = 8.10, SD = 7.33) and those without (M = 7.11, SD 
= 5.81; t (232) = -1.14, p = 0.25, two-tailed). These results were different from 
those of Time One, at which time those with metabolic syndrome scored higher 
on Anxiety. 
 
Table 29. 
Summary Statistics of DASS Subscale Scores at Times One and Two by Gender 
and Differences over Time (N = 234) 
Subscale Time One Time Two   
Males  Range M SD Range  M SD t p 
Depression 0-24 3.89 4.70 0-14 3.68 3.84 0.54 0.59 
Anxiety 0-12 2.32 2.93 0-16 2.33 2.93 -0.07 0.95 
Stress 0-28 7.07 6.08 0-40 6.55 6.08 1.06 0.30 
Females         
Depression 0-28 4.96 5.66 0-38 5.22 6.22 -0.48 0.64 
Anxiety 0-20 3.42 3.67 0-16 2.53 3.47 2.69 <0.01 
Stress 0-26 9.10 6.56 0-40 8.84 6.87 0.46 0.65 
 
7.5 Relationships between Metabolic Syndrome Status and DASS Scores Over 
Time 
     Analyses were then conducted to determine if a predictive relationship could 
be found between Time One metabolic syndrome status and Time Two DASS 
115 
 
subscale scores, or Time One DASS subscale scores and Time Two metabolic 
syndrome status. 
 
7.5.1 Relationship between Time One Metabolic Syndrome Status and Time Two 
DASS Scores 
     Three separate correlations and hierarchical multiple regression analyses were 
conducted to examine the relationship between Time One metabolic syndrome 
status and Time Two DASS subscale scores, whilst controlling for the relevant 
Time One DASS subscale scores. The dependent variable in each analysis was 
Time Two Depression score, Anxiety score or Stress score. The independent 
variables were the corresponding Time One DASS subscale score and Time One 
metabolic syndrome status. Preliminary analyses were conducted to ensure no 
violation of the assumptions of normality, linearity, multicollinearity and 
homoscedasticity. Table 30 below displays the partial correlations. As to be 
expected, there were strong, positive partial correlations between Time One and 
Time Two Depression scores (r = 0.54, p < 0.001), Anxiety scores (r = 0.57, p 
<0.001) and Stress scores (r = 0.62, p < 0.001). However, there were no 
significant correlations between either Time One or Time Two DASS subscale 
scores and Time One metabolic syndrome.   
 
     In the regression analysis for Depression, Time One Depression score was 
entered at Step One, explaining 29% of the variance in Time Two Depression. 
After entry of Time One metabolic syndrome status at Step Two, the total 
variance explained by the model as a whole was 29.1%, F(2,231) = 47.47, p < 
0.001. Time One metabolic syndrome status explained less that 0.01% of the 
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Table 30.  
Partial Correlations between Time One Metabolic Syndrome Status and Times 
One and Two DASS Subscale Scores 
Variable 1 2 3 
1. Time One Depression 
2. Time Two Depression 
3. Time One Metabolic Syndrome 
Status 
- 
- 
- 
0.54 
- 
- 
0.01 
-0.02 
- 
1. Time One Anxiety 
2. Time Two Anxiety 
3. Time One Metabolic Syndrome 
Status 
- 
- 
- 
0.57 
- 
- 
0.08 
0.01 
- 
1. Time One Stress 
2. Time Two Stress 
3. Time One Metabolic Syndrome 
Status 
- 
- 
- 
0.62 
- 
- 
<0.01 
-0.03 
- 
 
 
variance in Depression scores at Time Two, after controlling for Time One 
Depression scores, R squared change = 0.001, F change (1, 231) = 0.25, p = 0.62. 
In the final model, Time One Depression was statistically significant, (beta = 
0.54, p < 0.001) whilst Time One metabolic syndrome status was not (beta = -
0.03, p = 0.62).  
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     In the regression analysis for Anxiety, Time One Anxiety score was entered at 
Step One, explaining 32.4% of the variance in Time Two Anxiety. After entry of 
Time One metabolic syndrome status at Step Two, the total variance explained by 
the model as a whole was 32.5%, F(2,231) = 55.52, p < 0.001. Time One 
metabolic syndrome status explained less that 0.01% of the variance in Anxiety 
scores at Time Two, after controlling for Time One Anxiety scores, R squared 
change = 0.001, F change (1, 231) = 0.39, p = 0.54. In the final model, Time One 
Anxiety was statistically significant, (beta = 0.57, p < 0.001) whilst Time One 
metabolic syndrome status was not (beta = -0.03, p = 0.54).  
  
    In the regression analysis for Stress, Time One Stress score was entered at Step 
One, explaining 38.2% of the variance in Time Two Stress. After entry of Time 
One metabolic syndrome status at Step Two, the total variance explained by the 
model as a whole was 38.3%, F(2,231) = 71.69, p < 0.001. Time One metabolic 
syndrome status explained less that 0.01% of the variance in Stress scores at Time 
Two, after controlling for Time One Stress scores, R squared change = 0.001, F 
change (1, 231) = 0.29, p = 0.59. In the final model, Time One Stress was 
statistically significant, (beta = 0.62, p < 0.001) whilst Time One metabolic 
syndrome status was not (beta = -0.03, p = 0.59).  
 
     Overall, these results indicate that metabolic syndrome status at Time One did 
not make a unique contribution to Depression, Stress or Anxiety at Time Two, 
once the relevant Time One mood state had been accounted for. Thus, the causal 
relationship between mood and metabolic syndrome is not in this direction. 
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7.5.2 Relationship between Time One DASS Scores and Time Two Metabolic 
Syndrome Status 
     A one-way between-groups multivariate analysis of variance was performed to 
investigate whether Time Two metabolic syndrome status was associated with 
DASS subtest scores at Time One. Three dependent variables were used: 
Depression score, Anxiety score and Stress score. The independent variable was 
Time Two metabolic syndrome status. Preliminary assumption testing was 
conducted, to check for normality, linearity, univariate and multivariate outliers, 
homogeneity of variance-covariance matrices, and multicollinearity, with a 
violation of homogeneity of variance noted in Levene’s test of equality of error 
variances. As recommended by Howell (2007), although this was significant, an 
inspection of the variance for each of the groups found that the largest variance 
was no more than four times the smallest, and therefore the results were likely to 
be valid.  
 
     There was a statistically significant difference between those who had 
metabolic syndrome at Time Two  and those who did not on the combined 
dependent variables, F (3, 230) = 3.318, p = 0.021; Wilks’ Lambda = 0.96; partial 
eta squared = 0.04. When the results for the dependent variables were considered 
separately, the two variables to reach statistical significance were Anxiety (F(1, 
232) = 7.21, p = 0.008, partial Eta squared = 0.03) and Depression (F(1,232) = 
6.59, p = 0.01, partial Eta squared = 0.27). An inspection of the mean scores 
indicated that those with metabolic syndrome at Time Two reported higher Time 
One levels of Anxiety (M = 3.45 vs 2.29) and Depression (M = 5.32 vs 3.60).  
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     These results indicate that participants with metabolic syndrome at Time Two 
were more likely to have had higher levels of Depression and Anxiety at Time 
One, and suggest a causal contribution in this direction. 
 
7.6 Continuity of Metabolic Syndrome Status and DASS scores 
     A perusal of the results at Time One when compared to those at Time Two 
indicates some noticeable differences in the relationship between metabolic 
syndrome status and Depression and Anxiety. At Time One, participants with 
metabolic syndrome were significantly higher on Anxiety only, whereas at Time 
Two, participants with metabolic syndrome were significantly higher on 
Depression. There was also a relationship found between metabolic syndrome 
status at Time Two and higher levels of Depression and Anxiety at Time One.  
 
    Given the above results, analyses were conducted to investigate how the DASS 
variables were associated with the continuity of participants’ metabolic syndrome 
status over time. The sample was divided into four groups according their 
metabolic syndrome status at both Time One and Time Two. Table 31 below 
outlines these groups and the number of participants who either maintained or 
changed their metabolic syndrome status over time. There is a limitation to using 
categorical variables as individuals who are on the borderline can easily tip either 
way, however in the treatment setting, practitioners would be using such 
categories to assist in determining metabolic syndrome status. 
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7.6.1 Time One DASS scores and Continuity of Metabolic Syndrome Status  
     A one-way between-groups multivariate analysis of variance was performed to 
investigate Time One DASS subtest scores in relation to the continuity of 
metabolic syndrome status. Three dependant variables were used: Depression 
score, Anxiety score and Stress score at Time One. The independent variable was 
continuity of metabolic syndrome status. Preliminary assumption testing was 
conducted to check for normality, linearity, univariate and multivariate outliers, 
homogeneity of variance-covariance matrices, and multicollinearity, with a 
violation of homogeneity of variance noted in Levene’s test of equality of error 
variances. As recommended by Howell (2007), although this was significant, an 
inspection of the variance for each of the groups found that the largest variance 
was no more than four times the smallest, and therefore the results were likely to 
be valid.  
 
Table 31. 
Continuity of Metabolic Syndrome Status over Time (N = 234) 
Metabolic 
Syndrome Status 
Time Two  
Positive 
Time Two  
Negative 
Total 
Time One Positive 58 28 86 
Time One Negative 45 103 148 
Total 103 131 234 
 
     There was no statistically significant difference between metabolic syndrome 
status groups on the combined dependent variables of Depression, Stress and 
Anxiety at Time One, F (9, 555) = 1.42, p = 0.18; Wilks’ Lambda = 0.95; partial 
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Eta squared = 0.02. However, when the results for the dependent variables were 
considered separately, there was a statistically significant difference in Anxiety, F 
(3, 555) = 3.01, p = 0.03, partial Eta squared = 0.4. An inspection of the mean 
scores indicated that those participants with metabolic syndrome at both Time 
One and Two reported slightly higher levels of Anxiety at Time One (M = 3.76, 
SD = 3.62) than those who did not have metabolic syndrome at Time One but 
developed it by Time Two (M = 3.04, SD = 4.08); those who had metabolic 
syndrome at Time One, but not Time Two (M = 1.86, SD = 2.61); and those who 
did not have metabolic syndrome at either Time One or Time Two (M = 2.41, SD 
= 2.76). Therefore, those participants who maintained a positive metabolic 
syndrome status over time had higher levels of Anxiety at Time One when 
compared with the other three continuity of metabolic syndrome groups. 
 
7.6.2 Continuity of Metabolic Syndrome Status and DASS scores at Time Two 
     A one-way between-groups analysis of variance was conducted to explore the 
relationship between continuity of metabolic syndrome and Depression at Time 
Two (see Table 32, Figure 8). There was a statistically significant effect: F (3, 
230) = 3.55, p = 0.02. The effect size, calculated using eta squared, was 0.04 was 
small to medium. Post-hoc comparisons using the Tukey HSD test indicated that 
the mean score for those who had no metabolic syndrome at Time One, but 
developed metabolic syndrome at Time Two (M = 6.09, SD = 6.84) was 
significantly higher than those who had metabolic syndrome at Time One, and no 
metabolic syndrome at Time Two (M = 2.79, SD = 3.19), and those who did not 
have metabolic syndrome at either time point (M = 3.71, SD = 3.65).  
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     To investigate whether group's scores changed differentially, a one-way 
analysis of covariance (ANCOVA) was then conducted to compare scores on the 
Depression subscale of the DASS21 at Time Two for the different metabolic 
syndrome status groups, whilst controlling for Depression subscale scores at Time 
One. A significant effect was found, F (3, 230) = 3.84, p = 0.01, partial Eta  
squared 0.05).  
 
Table 32.  
Descriptive Statistics for Continuity of Metabolic Syndrome Status and 
Depression Scores  
  Depression Score 
Time One 
Depression 
Score Time Two 
Metabolic Syndrome Status n M SD M SD 
Metabolic Syndrome positive at Times 
One and Two 
58 5.28 6.41 4.90 5.95 
No Metabolic Syndrome Time One, 
Metabolic Syndrome Time Two 
45 5.38 6.44 6.09 6.83 
Metabolic Syndrome Time One, No 
Metabolic Syndrome Time Two 
28 2.71 3.90 2.79 3.19 
No Metabolic Syndrome at Times One or 
Two 
103 3.84 3.72 3.71 3.65 
 
     Post-Hoc comparisons using the Tukey HSD test indicated that, there was a 
significant difference in the changes in Depression scores of those who 
maintained their positive metabolic syndrome status over time and those who had 
metabolic syndrome at Time One then no metabolic syndrome at Time Two 
(mean difference = 2.34, p = 0.02, 95% CI 0.34 to 4.33). In looking at Table 32 
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and Figure 8 it appears that the change in those who maintained metabolic 
syndrome was toward becoming less depressed, whereas those whose metabolic 
syndrome resolved changed minimally.   
 
 
Figure 8. Continuity of Metabolic Syndrome Group and Mean Depression Scores 
at Times One and Two 
 
    Similarly, after controlling for Time One Depression scores, those who did not 
have metabolic syndrome at Time One but developed it by Time Two had a 
greater change in Depression scores than those who had metabolic syndrome at 
Time One then no metabolic syndrome at Time Two (mean difference = 2.98, p = 
0.005, 95% CI 0.90 to 5.07), and those who did not have metabolic syndrome at 
either time. The magnitude of the changes in the scores of the Time Two positive 
metabolic status groups was not different, although in opposite directions.  
 
      Similarly, an ANOVA was conducted to explore the relationship between 
metabolic syndrome status and Anxiety scores at Time Two (see Table 33, Figure 
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9 below). There was no statistically significant effect: F (3, 230) = 0.62, p = 0.60.  
An ANCOVA controlling for Anxiety scores at Time One also found no 
significant effect, F (3, 230) = 2.0, p = 0.12; partial Eta squared = 0.025, and 
indicate that any changes in Anxiety score were consistent across groups.  
 
Table 33.  
Descriptive Statistics for Continuity of Metabolic Syndrome Status and Anxiety 
Scores  
  Anxiety Score 
Time One 
Anxiety  Score  
Time Two 
Metabolic Syndrome Status n M SD M SD 
Metabolic Syndrome positive at 
Times One and Two 
58 3.76 3.62 2.72 3.49 
No Metabolic Syndrome Time One, 
Metabolic Syndrome Time Two 
45 3.04 4.08 2.71 3.44 
Metabolic Syndrome Time One, No 
Metabolic Syndrome Time Two 
28 1.86 2.61 1.93 2.34 
No Metabolic Syndrome at Times 
One or Two 
103 2.41 2.76 2.25 3.06 
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Figure 9. Continuity of Metabolic Syndrome Group and Mean Anxiety Scores at 
Times One and Two 
 
     Finally, an ANOVA was conducted to explore the relationship between 
metabolic syndrome status and Stress scores at Time Two (see Table 34, Figure 
10 below). There was no statistically significant effect: F (3, 230) = 0.69, p = 
0.56.  An ANCOVA controlling for Stress scores at Time One also found no 
significant effect, F (3, 230) = 0.77, p = 0.51; partial Eta squared = 0.01, and 
indicate that any changes in Stress score were consistent across groups.  
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Table 34.  
Descriptive Statistics for Continuity of Metabolic Syndrome Status and Stress 
Scores  
  Stress Score  
Time One 
Stress  Score  
Time Two 
Metabolic Syndrome Status n M SD M SD 
Metabolic Syndrome positive at 
Times One and Two 
58 8.66 6.52 7.69 6.87 
No Metabolic Syndrome Time One, 
Metabolic Syndrome Time Two 
45 8.31 7.63 8.62 7.93 
Metabolic Syndrome Time One, No 
Metabolic Syndrome Time Two 
28 6.57 6.23 6.57 4.83 
No Metabolic Syndrome at Times 
One or Two 
103 7.78 5.70 7.26 6.06 
 
 
Figure 10. Continuity of Metabolic Syndrome Group and Mean Stress Scores at 
Times One and Two 
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7.7 Summary of Study Two Results 
     Results from this study indicate that the prevalence of metabolic syndrome 
progressively increases with age, which supports both the findings at Time One 
and that of previous research.   
 
     Cross-sectional analyses at Time Two found that, in relation to DASS subscale 
scores and gender, females scored significantly higher on both Depression and 
Stress than males at Time Two, whilst the Anxiety levels of females had also 
significantly decreased from Time One to Time Two. Those participants with 
metabolic syndrome at Time Two scored higher on Depression at Time Two than 
those without metabolic syndrome.  
 
     Longitudinal analyses found that Time One metabolic syndrome status was not 
associated with Depression, Anxiety or Stress at Time Two, however higher 
levels of Anxiety and Depression at Time One were associated with a positive 
metabolic syndrome status at Time Two. Analyses of the continuity of 
participants’ metabolic syndrome over time found that the development of a 
positive metabolic syndrome status over time was associated with higher levels of 
Depression, and that those participants who maintained a positive metabolic 
syndrome status over time had higher levels of Anxiety at Time One than the 
other three groups.  
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Chapter 8: Discussion 
     This thesis was concerned with the relationship between metabolic syndrome 
and mental health. As discussed in the introductory chapters, metabolic syndrome 
is a clustering of metabolic, anthropometric and haemodynamic abnormalities 
that, when occurring together, significantly increase the risk of morbidity and 
mortality from Type II diabetes and CVD. It appears that the aetiology and 
pathogenesis of metabolic syndrome is an interaction between a number of factors 
including increased adipose fatty tissue, higher caloric diet, sedentary lifestyle and 
a dysfunctional endocrine system; possibly due to dysregulation of the HPA axis 
brought on by chronic stressors.  
 
     The differences in intervention results may be explained by the HPA axis 
pathology conceptualisation, and suggests that psychological factors may be 
placing additional stress on an endocrine system that is shared with the biological 
indicators of metabolic syndrome. A greater understanding of the interrelationship 
between psychological and biological risk factors in the aetiology and 
pathogenesis of metabolic syndrome may inform interventions, which are 
currently aimed at reducing only physical symptomatology.  
 
     The studies reported in this thesis were conducted with farm men and women, 
who generally have poorer physical health and health outcomes than their urban 
counterparts due to a number of environmental factors and barriers to health care 
and help seeking behaviours. Due to the chronic nature of the stressors they 
endure, it could be expected that farm men and women would also be 
experiencing higher levels of psychological distress than the general population.  
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     Consequently, if the HPA axis hypothesis is correct, it would also be expected 
that the prevalence of metabolic syndrome amongst this cohort would be higher 
than the general population and possibly related to the level of psychological 
distress they are experiencing. Therefore, studying the physical and mental health 
interactions can provide direction for future research, health promotion and 
disease prevention interventions for this particularly under researched, at risk 
population.  
 
     Whilst it would be pragmatic to suggest a causal relationship between 
metabolic syndrome and mood disorders, the evidence at present suggests that, 
whilst there are associations between these factors, there is currently no consensus 
on direction or causation. However, awareness of symptoms of psychological 
distress could be important in the clinical management of metabolic syndrome, 
and vice versa.  
      
     At Time One, based on the evidence of poorer health outcomes in rural areas, 
it was hypothesised that the prevalence of metabolic syndrome amongst farm men 
and women would be higher than that of the general population. Furthermore, 
based on the research findings related to unique environmental stressors, it was 
hypothesised that levels of Depression, Anxiety and Stress would be higher 
amongst farm men and women when compared with the general population 
norms. Based on previous research findings and the HPA axis dysregulation 
hypothesis, it was hypothesised that elevated levels of Depression and Stress 
would be significantly associated with metabolic syndrome, but that Anxiety 
would not. Based on previous research findings it was hypothesised that waist 
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circumference and elevated levels of triglycerides would be significantly 
associated with Depression, but that no factors would be significantly associated 
with Anxiety or Stress. Based on previous research findings suggesting those with 
metabolic syndrome are more likely to have moderate to severe Depression, it was 
also hypothesised that there would be a significant association between 
Depression severity classification and the presence of metabolic syndrome. Due to 
conflicting evidence surrounding gender differences, no hypotheses relating to 
gender differences in metabolic syndrome were proposed.   
 
     At Time Two, based on previous research findings, it was hypothesised that 
those participants with metabolic syndrome at Time One would display increased 
Depression scores at Time Two, when compared to those without metabolic 
syndrome. Due to the inconsistency of the research findings, no predictions were 
made in relation to gender difference. It was also hypothesised that higher levels 
of Depression at Time One would be associated with a positive metabolic 
syndrome status at Time Two. Furthermore, based on previous research findings 
and the HPA Axis hypothesis on the effects of chronic Stress, it was hypothesised 
that higher levels of Stress at Time One would be associated with a positive 
metabolic syndrome status at Time Two. Due to the inconsistency of research 
findings, no predictions were made in relation to gender.  
 
     Finally, the continuity of participants’ metabolic syndrome over time and 
possible relationships between Depression, Anxiety and Stress were also explored 
both prospectively and retrospectively. It was hypothesised that the maintenance 
or development of a positive metabolic syndrome status over time would be 
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associated with higher levels of Depression at Time One. Furthermore, it was 
hypothesised that those who maintained or developed metabolic syndrome would 
have higher levels of Depression at Time Two due to the cumulative effect of 
metabolic syndrome factors on Depression. Due to the unavailability of previous 
research findings, no predictions were made in relation to Anxiety or Stress.   
 
     These hypotheses will be discussed in this chapter in relation to the analyses. 
 
8.1 Mental Health of Participants 
     When comparing the baseline DASS results from the current study at Time 
One with results from an Australian general adult population sample (Crawford et 
al., 2011), the means and standard deviations were similar for Depression. In fact, 
the mean scores were marginally lower in the current study than those previously 
reported by Crawford et al. (2011) from the general population. This does not 
support the hypothesis that farm men and farm women experience elevated levels 
of Depression, Anxiety and Stress due to prolonged stressors.  
 
     Previous research on Australian farm men and farm women that has shown a 
higher incidence of psychological distress (Brumby et al., 2011) has used the 
Kessler 10 as the measure. The K10 is particularly designed to monitor population 
prevalence and trends and to identify community cases of non-specific 
psychological distress, whilst the DASS has been designed to measure the three 
related negative emotional states of Depression, Anxiety and Tension/Stress 
(Kessler et al., 2002; Lovibond & Lovibond, 1995). Other research has used such 
measures as the Hospital Anxiety and Depression Scale (HADS), which was 
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developed for, and validated on, medical patients and excludes many of the 
somatic symptoms of Depression that overlap with physical problems such as 
fatigue, sleep disturbance, psychomotor changes and loss of appetite and weight. 
Amongst the literature, this is one of the first studies to use the DASS21 
specifically on farm men and farm women. 
 
     Lovibond and Lovibond (1995) also note that the DASS, like other self-report 
measures, is transparent and it is possible for respondents to disguise their 
symptoms. When the DASS has been used in previous research on regional and 
rural Australian communities, it has not distinguished between farmers and non-
farmers. As discussed in Chapter 3, previous research by Thomas et al. (2003) has 
found that whilst farmers self-report a lower prevalence of psychiatric morbidity, 
they were more likely to report thinking that life is not worth living; a question 
that is not asked on the DASS21. A culture of stoicism and perceived stigma 
associated with mental illness amongst farm men and women may also lead to a 
lower self-reporting of symptoms. Alternatively, farm men and women, whilst 
experiencing many environmental and economic stressors, may enjoy a high level 
of social support which acts as a buffer to mental health problems (Johnson & 
Booth, 1990). Future research could perhaps explore differences in reporting by 
farm men and women based on self-report questionnaires and the questions asked 
to determine which self-report scale is more able to capture Depression, Anxiety 
and related constructs, and validated against a measure such as the Structured 
Clinical Interview for DSM Disorders.   
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     As the study was conducted over two time periods in consecutive years, 
‘vulnerable episodes’ of psychological distress in life course epidemiology were 
neither discussed or able to be measured given the measures used and the data 
provided. Future longitudinal research should consider this inclusion to determine 
the effects of these episodes on results. 
 
8.2 Physical Health of Participants 
     In the current studies, 38.9% of participants met the criteria for metabolic 
syndrome at Time One, and 44% met the criteria at Time Two. These prevalence 
rates were significantly higher at both times than Australian prevalence rates 
reported by Cameron et al. (2007) (30.7%).  For females, the prevalence rate at 
each time point was higher than that for females from a rural population in South 
Australia reported by Janus et al. (2007). For males, the prevalence rate was 
higher than that reported by Janus et al. only at Time Two. As the measures used 
were objective, it can confidently be stated that Australian men and women in 
farming communities are at higher risk of developing metabolic syndrome. Whilst 
28 participants reduced their symptoms between Times One and Two so they no 
longer had metabolic syndrome, 45 new incidences of metabolic syndrome were 
seen at Time Two.  
 
     The apparently higher rates of metabolic syndrome amongst farm men and 
women may reflect the reduction in physical activity levels due to increased 
mechanisation, less livestock, decreased farming production, and fewer 
recreational activities. Indeed, farm men and women anecdotally report that their 
level of physical activity is seasonal, spasmodic, unplanned or non-existent 
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(Brumby, Willder & Martin, 2010). However, each of the metabolic syndrome 
factors is responsive to lifestyle changes (Riediger & Clara, 2011). Given the 
abundance of evidence on the benefits of physical activity in improving physical 
health outcomes, interventions aimed at increasing physical activity to at least the 
minimum current recommended levels should reduce the burden of disease 
associated with metabolic syndrome in farming communities. However, the 
challenge will be in developing novel interventions to increase physical activity. 
As a part of their program, the SFF facilitators work in conjunction with their 
participants to develop ways of increasing incidental and physical activity as a 
part of their farming family life. The program also now offers short video clips via 
its internet site to demonstrate ways in which farm men and women are able to 
incorporate these activities into their daily lives. However, as these interventions 
are currently limited to program participants, it may also be possible to promote 
such activities through local newspapers (including agricultural specific 
newspapers), rural television stations or agricultural shows to capture a wider 
audience. 
 
     When prevalence rates were broken down by age group, the findings from the 
current studies were consistent with previous research, with metabolic syndrome 
prevalence steadily increasing by age group at a rate of 10 to 15% with each 
increasing 10 year age bracket. One difference was observed at Time Two in the 
current study, with a greater proportion of those participants in the 25-34 year age 
bracket having metabolic syndrome that the 35-44 year age group. It is not clear 
why this result occurred, although one possible explanation is that the number of 
participants in that age group decreased from 35 at Time One to 23 at Time Two, 
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whilst the number of participants with metabolic syndrome increased from six to 
eight between Times One and Two, thereby increasing the prevalence proportion. 
Therefore, caution should be taken when drawing any conclusions from this 
result. Interestingly, in regards to metabolic syndrome prevalence rates increasing 
by age group, amongst the literature reviewed, no study provided a conclusive 
explanation as to why this occurs. However, obesity prevalence increases with 
age, whilst basal metabolic rate as well as lean body mass decreases with age. 
Increasing prevalence rates with age may also be due to secondary ageing; that is, 
the preventable changes that occur in some people that are the result of health 
habits, disease or environmental influences that have a cumulative effect over 
time (Bee & Bjorklund, 2004) For example, risk factors for Coronary heart 
disease (CHD) such as high-fat diets, tobacco use, physical inactivity, obesity and 
high blood pressure, are cumulative in nature and the more risk factors one has, 
the higher the chance of developing CHD through adulthood (Bee & Bjorklund, 
2004). Further research is required to determine factors that may influence age 
related prevalence rates in metabolic syndrome.  
 
     Previous research has reported inconsistent results regarding gender 
differences in the prevalence of metabolic syndrome; therefore gender differences 
were not hypothesised. A review of the literature also found that previous gender 
differences, if any, appear to be related to ethnicity, as discussed in Chapter 3. The 
current study found no difference in prevalence rates between genders at either 
Times One and Two. This suggests that both farm men and farm women are at 
equal risk of developing metabolic syndrome. It may be that both farm men and 
farm women are more likely to have a similar diet or physical activity level than 
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their rural or metropolitan counterparts. For example, those living and working on 
the farm together may eat the same meals at the same times and share the 
workload on the farm. One limitation of this study was the inability to pair 
participants to their partner or those living within the same residence due to de-
identification of the database. Future research should include the ability to 
examine proximal relationships to determine similarities in metabolic syndrome 
status as well as environmental influences such as diet, physical activity levels, 
and socioeconomic status.  
 
     Study One also determined the most commonly occurring factors of metabolic 
syndrome amongst farm men and women. As central obesity is mandatory to the 
IDF criteria, all metabolic syndrome positive participants met this. It was found 
that the next most commonly occurring factor amongst both genders was raised 
blood pressure, with 91.3% and 81.4% of men and women meeting this 
respectively. The next most commonly occurring factor was raised fasting plasma 
glucose for males (69.6%) and reduced HDL cholesterol for females (65.7%). The 
reverse relationship occurred for the third most commonly occurring factor, with 
62.9% of females meeting the criteria for raised fasting plasma glucose and 50.7% 
of males meeting the criteria for reduced HDL cholesterol. Raised triglyceride 
levels were found in 29% and 40% of men and women respectively.  
 
     These results are concerning for this population as it has been found that 
hypertensive patients with metabolic syndrome have a two-fold greater risk of 
cardiovascular incidents compared to those without metabolic syndrome 
(Vyssoulis et al., 2010). Likewise, reduced HDL cholesterol levels increase the 
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risk of CVD as the body is not able to as effectively clear the artery walls from 
cholesterol deposits and take them to the liver, where they are processed and then 
excreted from the body (Nevid et al., 1998). Raised triglyceride levels indicate a 
high level of dietary fat in the bloodstream, derived from carbohydrates and fats, 
and also increase the risk of heart disease as they are often connected with high 
blood cholesterol and central obesity. Raised fasting plasma glucose levels 
increase the risk of Type II diabetes as the pancreas is required to produce more 
insulin to assist in the circulation of glucose through the blood stream.  
 
     It has been suggested that patterns of environmental influences affecting 
hypertension, reduced levels of HDL cholesterol, raised fasting plasma glucose 
levels and raised triglyceride levels include a lack of regular exercise, lack of 
stress control, lack of proper diet, and smoking (Nevid et al., 1998). Although age 
can be a factor in the body’s ability to take up glucose from the bloodstream, these 
metabolic risk factors can be reduced by adopting healthier lifestyle habits 
including regular aerobic exercise, diets low in saturated fats, controlling stress, 
and avoiding smoking and excessive drinking (Nevid et al., 1998). Therefore, the 
prevalence of metabolic syndrome and individual risk within the current sample 
could be significantly reduced through relatively simple and inexpensive 
therapeutic lifestyle changes including diet and exercise.   
 
8.3 Relationship Between Mental Health and Metabolic Syndrome 
     Over the past decade there has been a paradigm shift in research that has 
resulted in an increasing focus on associations between mental health problems 
(particularly Depression) and the component factors of metabolic syndrome. 
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Indeed, there is a growing body of evidence to suggest the co-occurrence of 
metabolic syndrome and Depression. Based on the HPA axis dysregulation 
hypothesis, metabolic networks mediate both homeostasis and allostasis. 
Disturbances within these networks have been implicated in the pathogenesis, and 
also recovery from, depressive disorders. When compared with other studies 
reviewed, research conducted in rural regions of Australia (Dunbar et al., 2008) 
suggests that those living within rural areas are at increased risk of the co-
occurrence of metabolic syndrome and Depression.   
 
     The current research explored psychological factors associated with metabolic 
syndrome in two ways: firstly, through a cross-sectional study (Time One) on a 
total of 357 participants, 139 of which met the criteria of metabolic syndrome; and 
secondly through a longitudinal study (Time Two) on participants returning to the 
SFF program the following year (N = 234), 103 whom met the criteria for 
metabolic syndrome.  
 
8.3.1 Study One 
     Based on previous research findings, it was hypothesised that the constructs of 
Depression and Stress would be related to the presence of metabolic syndrome, 
whilst Anxiety would not. However, contrary to these expectations, comparisons 
of DASS subscale scores amongst those with and without metabolic syndrome at 
Time One revealed that those with metabolic syndrome scored significantly 
higher on Anxiety, whilst Depression and Stress were not related. These findings 
are partially consistent with those of Raikkonen et al. (2002), who found that trait 
Anxiety was significantly related to metabolic syndrome amongst middle-aged 
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women. Yet Raikkonen et al. (2002) also found women with metabolic syndrome 
to be higher in Depression, tension and anger scores relative to those without 
metabolic syndrome. These findings are also inconsistent with previous research 
by Skilton et al. (2007), who found that Depression, but not Anxiety was related 
to metabolic syndrome amongst men and women when using the HADS to 
measure Anxiety and Depression. Likewise, research by Dunbar et al. (2008) also 
found that Depression, but not Anxiety was related to metabolic syndrome when 
using the HADS.  
 
     The results from the Study One in relation to Depression and metabolic 
syndrome were not consistent with previous research findings. However, as 
discussed in Chapter 2, much of the research reviewed used the HADS as a 
measure of Depression and excludes many of the somatic symptoms of 
Depression that overlap with physical problems such as fatigue, sleep disturbance, 
and psychomotor changes. A culture of stoicism and stigma related to mental 
illness may have also contributed to a reluctance to self-report higher scores on 
the Depression subscale of the DASS; the HADS questions may possess more 
face validity in rural populations due to more socially acceptable phrasing of the 
questions for this cohort. The DASS also fails to ask about suicidality, which has 
been shown to be more widely reported by farmers than other psychiatric 
symptoms (Thomas et al., 2003).  
 
     It was also hypothesised that amongst the individual factors of metabolic 
syndrome, higher waist circumference and reduced HDL Cholesterol would be 
independently associated with Depression (Dunbar et al., 2008). Analysis of the 
140 
 
individual factors in the current study at Time One found that only waist 
circumference and blood glucose levels were able to explain any unique variance 
in Depression, whilst no individual factors significantly contributed to Anxiety or 
Stress. These findings are partially consistent with those of Muhtz et al. (2009) in 
that whilst Depression was not related to metabolic syndrome as an entity 
amongst men or women separately, women with depressive symptoms had a 
larger waist circumference, higher fasting blood glucose, diastolic blood pressure 
and lower HDL cholesterol than those without Depressive symptoms. One 
possible explanation for the findings from the current study is the relationship 
between psychological distress and the subsequent detrimental effects on positive 
health behaviours. These detrimental effects include an increase in harmful 
behaviours and poor compliance to treatment regimens which, like metabolic 
syndrome, are also associated with insulin resistance and increased central 
adiposity (Goldbacher & Matthews, 2007; Reaven, 1993). 
 
     Based on previous findings by Viinamaki et al., (2009) and Vanhala et al., 
(2009) who found relationships between Depression severity and metabolic 
syndrome, the hypothesis that moderate to severe levels of Depression would be 
associated with the presence of metabolic syndrome was not supported in the 
current study. This again may have been due to the low self-reporting of 
depressive symptoms on the DASS21, in which the severity ranged between 
normal to moderate levels only at both Times.  
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8.3.2 Study Two 
     The main interest of Study Two was the relationships between Depression, 
Anxiety, and Stress, and metabolic syndrome over time. These relationships are 
particularly important in determining how psychological risk factors are related to 
metabolic syndrome, and assist in targeting interventions that expand on 
therapeutic changes in lifestyle. The data allowed the exploration of these 
relationships in three ways: firstly, prospective analyses of baseline metabolic 
status at Time One and follow-up mental health status at Time Two; secondly, 
retrospective analyses of Time Two metabolic status and possible mental health 
factor differences at baseline (Time One); and finally, analyses of whether mental 
health factors were associated with the emergence, resolution or continuation of 
metabolic syndrome over time.    
 
8.3.2.1 Prospective Analyses for Time One Metabolic Syndrome 
     The hypothesis that those participants with metabolic syndrome at Time One 
would display an increase in Depression scores at Time Two when compared to 
those without metabolic syndrome was not supported. A review of the previous 
research finding that supports a predictive relationship (Akbaraly et al., 2009) 
shows that the follow-up studies were conducted at three and six year intervals. 
Thus, the one year period between Times One and Two in the current study may 
not have been a sufficient amount time to explore this relationship and compare to 
these previous results. As they also found no bidirectional associations, Akbaraly 
et al. (2009) suggest that depressive symptoms may be a consequence rather than 
a cause of metabolic syndrome. This notion of Depression as a consequence of 
metabolic syndrome shall be discussed in further detail when exploring the 
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relationship between continuity of metabolic syndrome status and Depression 
amongst participants.  
 
8.3.2.2 Retrospective Analyses from Time Two Metabolic Syndrome 
     The hypothesis that higher levels of Depression would be found at Time One 
for those with metabolic syndrome at Time Two than those without metabolic 
syndrome at Time Two was supported. This finding is consistent with those of 
Raikkonen et al. (2007), Vanhala et al. (2009), and Viinamaki et al. (2009).  Thus, 
depression may be a precursor of metabolic syndrome as well as a comorbid 
condition, as found at Time Two. 
 
     The hypothesis that Time Two metabolic status would be associated with 
higher levels of Stress at Time One was not supported. This finding mirrors that 
of Raikkonen et al. (2002) who reported perceived stress was not associated with 
metabolic syndrome amongst middle-aged women at baseline or follow-up seven 
years later. However, previous research has reported that frequent feelings of 
anger, tension, chronic stress and psychological distress were predictive of later 
metabolic syndrome (Raikkonen et al., 2002; Vitaliano et al., 2002).  This raises a 
question about the way Stress was assessed in the current study.  The DASS21 
measures perceived Stress within the past four weeks, and may not have been the 
most appropriate measure for examining the chronic stressors which farm men 
and farm women experience. Future research should contemplate using measures 
of chronic stress, along with personal and social resources. One possibility is the 
Perceived Stress Reactivity Scale (SRS), which measures general perceived stress 
reactivity across a number of life domains (Schlotz, Yim, Zoccola, Jansen & 
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Schulz, 2011). The use of an objective measurement of Stress, such as cortisol 
levels, should also be considered as another method of measuring stress in this 
population who are known to underreport psychological symptoms. 
 
     No prediction was made in relation to Anxiety due to the unavailability of 
previous research findings; however those with a positive metabolic syndrome 
status at Time Two also reported higher levels of Anxiety at Time One than those 
without metabolic syndrome.  Interestingly, at Time Two Anxiety levels were no 
longer significantly different between those with metabolic syndrome and those 
without, as they had been at Time One. This may have been associated with a 
significant decrease in Anxiety scores amongst females between Times One and 
Two. This decrease may have been due, in part, to participants of the SFF 
program receiving an intervention in the form of psychoeducation about 
Depression, Anxiety and Stress, and learning skills to assist in the management of 
these conditions.  
 
8.3.2.3 Continuity of Metabolic Syndrome and Mental Health at Time One and 
Time Two 
     The investigation of the relationships between continuity, resolution or 
emergence of metabolic syndrome and mental health at Time One and Time Two 
allowed the above findings to be unpacked further.  
 
     The initial analyses indicated that those with metabolic syndrome at Time One 
had higher Anxiety at that time, and that those with metabolic syndrome at Time 
Two had higher Anxiety at Time One than those without the syndrome at Time 
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Two.  However, when continuity of metabolic syndrome was investigated, only 
those who had maintained a positive metabolic status had reported higher levels of 
Anxiety at Time One when compared to participants who did not have metabolic 
syndrome at both times, had developed metabolic syndrome at Time Two, or had 
metabolic syndrome at Time One but did not meet the criteria at Time Two. 
Importantly, the group that developed metabolic syndrome by Time Two did not 
have a higher Anxiety score than other groups at Time One, and did not show a 
significant relative increase in their Anxiety scores by Time Two. In fact the 
Anxiety levels of all groups did not differ at Time 2. Given that it is unknown 
how long the stable positive metabolic syndrome group had met criteria, it is 
possible that the elevated Anxiety at baseline for this group could have developed 
after the onset of the condition, and was yet to develop in the new metabolic 
syndrome group.  Overall, there is no evidence that elevated Anxiety preceded the 
syndrome. 
 
     The initial analyses above showed no cross-sectional association between 
metabolic syndrome and Depression at Time One, nor a relationship between 
metabolic syndrome at Time One and Depression at Time Two. However, 
retrospective analysis found that those with metabolic syndrome at Time Two had 
higher levels of Depression at Time One than those without metabolic syndrome. 
They also had higher levels of Depression at Time Two than those without 
metabolic syndrome, suggesting a causal or maintaining role for depression could 
exist. 
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     When stability of metabolic syndrome was investigated, it was found that 
compared with participants who did not have metabolic syndrome at both times or 
who had metabolic syndrome at Time One but did not meet the criteria at Time 
Two, those participants who either maintained or developed metabolic syndrome 
had elevated Depression scores at Time One.  This is consistent with the above.  
Those who had developed metabolic syndrome now had higher scores than those 
who did not. However, those whose metabolic syndrome status was stable did not 
differ from the other groups.  When investigating relative change in depression 
scores over time by controlling for Time One depression scores in the ANOVA, 
both Time Two positive metabolic syndrome groups had significantly higher 
changes in scores than the other groups. The stable group's scores decreased, 
while the emergent metabolic groups' scores increased.  In combination, these 
findings suggest Depression is associated with the emergence of metabolic 
syndrome, with there being no evidence to the contrary.  While it may be co-
morbid, it association may weaken over time.   
 
     These findings support the HPA axis hypothesis that psychological distress, in 
particular the construct of Depression, is a plausible underlying factor in both the 
development and maintenance of metabolic syndrome. It is interesting to note that 
Depression was not associated with metabolic syndrome status at Time One, yet 
increased waist circumference and raised fasting plasma glucose were factors 
associated with increased levels of Depression at Time One. However, Time One 
elevated Depression scores were related to Time Two metabolic syndrome status, 
which in turn was related to Time Two elevated Depression scores for those who 
developed metabolic syndrome at Time Two.  
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     It has been suggested by Akbaraly et al. (2009) that perhaps there is an obesity-
depression relationship, in which abnormal lipids and central obesity constitute 
risk factors for Depression, as overweight and obese individuals experience 
stigma and devaluation which may cause them to suffer from lower self-esteem 
and higher levels of Depression. Depressive symptoms at Time One may also 
have affected participants’ health behaviours, such as weight management and 
physical activity levels, which appear to be the cornerstone in any attempt to 
reduce risk factors associated with metabolic syndrome.  
 
8.4 Implications for Metabolic Syndrome Interventions 
     Overall, the results of the current study demonstrates that Australian farm men 
and women may be at greater risk of metabolic syndrome than both the general or 
rural populations. It also appears that Depression is associated in the development 
of metabolic syndrome, whilst both Depression and Anxiety are associated in the 
maintenance of metabolic syndrome amongst farm men and farm women. 
Previous research by McIntyre et al. (2007) found a number of shared abnormal 
metabolic process overlaps between Major Depressive Disorder and Type II 
diabetes and conceptualised a basis for testing metabolic influence and therapies 
for mood disorders. From the results of the current study, it would appear that 
there is an interrelationship between the two, which provides further support of 
the HPA axis dysregulation hypothesis and the need to assess both the mental and 
physical health of farm men and women for better health outcomes.   
 
     This interrelation also highlights the need to address both the physical and 
mental health of farm men and farm women for decreasing the risk of 
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cardiovascular disease, Type II diabetes and achieving optimal wellbeing. As 
Depression, Anxiety and metabolic syndrome are associated with an increased 
risk in developing a number of physical illnesses, early detection of depressive 
and anxious symptomatology in individuals is important in the clinical 
management of those who are at risk of developing or maintaining metabolic 
syndrome.  
 
8.5 Limitations and Recommendations for Future Research 
     The current research aimed to determine relationships between Depression, 
Anxiety and Stress in the pathogenesis of metabolic syndrome among farm men 
and women. It was designed to examine the current physical and psychological 
symptoms associated with metabolic syndrome and Depression, Anxiety and 
Stress and to examine predictive relationships between these constructs 
longitudinally to identify associations that could provide direction for future 
research, health promotion and disease prevention interventions for this 
particularly under researched, at risk cohort.  
 
     Prior to the current project, the prevalence of metabolic syndrome amongst 
farm men and women was unknown. Relationships between Depression, Anxiety 
and Stress and metabolic syndrome in this unique cohort had also not been 
examined. This is also the first study to measure the continuity of metabolic 
syndrome status over time in an attempt to determine prospective and 
retrospective associations. This study has been able to demonstrate farm men and 
women are at an apparently elevated risk of developing metabolic syndrome than 
the general population and that Depression is involved in the development of 
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metabolic syndrome, whilst both Depression and Anxiety are involved in the 
maintenance of metabolic syndrome within this population. However, it should be 
noted that the majority of participants did not report elevated levels of Depression, 
Anxiety or Stress when compared with population norms. Despite efforts to 
further the research knowledge in this area, there were shortcomings and 
limitations to the current project. Combined with future recommendations, the 
limitations of the current study are discussed below.  
 
     A major limitation of the current study was the intervention provided through 
the Sustainable Farm Families program and environmental events that occurred in 
between Times One and Two. This may have confounded results as both physical 
and mental health issues were addressed by two ways. Firstly, education was 
provided at the first workshop in relation to cardiovascular disease, nutrition, diet, 
and stress. Participants also participated in exercises including stress management, 
how to read food labels, supermarket tours and how to choose healthier options, 
and exercise re-enforcement. At the end of each topic, participants were also 
asked to develop an action plan and set goals for the following year to facilitate a 
commitment to address identified priorities in the development and maintenance 
of good health. Secondly, each participant’s physical evaluation results were 
discussed during Individual Health Assessments to identify priority issues, and 
referrals were made to the appropriate services if required. Whilst the objective 
data in the current study was able to be adjusted to reflect IDF metabolic 
syndrome criteria, including specific treatments for lipid abnormalities or previous 
diagnosis of hypertension or Type II diabetes, external interventions relating to 
mental health between the two time periods were unable to be controlled.  
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     Another limitation of the study was the de-identification of the data used. This 
did not allow the current study to explore possible similarities between metabolic 
syndrome factors and status as well as Depression, Anxiety and Stress amongst 
participants who reside together. Both the research reviewed and the findings 
from the current study suggest the development of metabolic syndrome may be 
individualistic and dependent on a number of environmental and genetic 
influences. It could be expected that those participants living on and working the 
same property may have similar results on these measures due to a number of 
shared personal and environmental influences or experiences such as dietary 
intake, physical activity and the effects of economic, social or weather events on 
the farm. Furthermore, as twin studies have shown high concordance rates in 
relation to metabolic syndrome risk factors (Poulsen et al., 2001), genetic links 
between participants should also be considered. Future research should consider 
the ability to match participants based on their place of residence and also any 
genetic relationships to gain a greater understanding of the impacts of various 
influences in the pathogenesis of metabolic syndrome and its factors.  
 
     A further limitation of the current study includes the collection of biological 
samples across a number of locations by a number of Nurses using different 
equipment in each location, although this has been minimised by the use of the 
same equipment on each participant over the time periods.  
 
     The method of recruiting participants through media advertising and promotion 
of the program through various agriculture groups may also have resulted in a 
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sample that is not representative of the farming population. Future research needs 
to both determine what a representative farming population is, and conduct a 
study that matches these parameters.   
 
     A final limitation of the current study was the inability to measure the cortisol 
levels of participants. As the functions of cortisol include the regulation of blood 
sugar levels and stress, and levels can be affected by physical, emotional or 
environmental stressors, future research should consider measuring cortisol levels 
to further investigate the HPA axis dysregulation hypothesis.   
 
8.6 Conclusion 
     Given the individual and societal burden of cardiovascular disease, Type II 
diabetes and mental illness, research efforts to reduce metabolic syndrome and its 
individual risk factors is important. The greater the effort to understand, intervene 
and improve the physical and mental health of those at risk of developing these, 
the better the outcomes for individuals and society. In particular, when 
considering both the determinants of poorer health outcomes and barriers to help-
seeking for farm men and women, supporting efforts towards better health 
outcomes for this under-researched and under-serviced population has financial, 
emotional and social implications for individuals, families, populations and the 
Australian economy.  
 
     The elevated results from this study demonstrate that Australian farm men and 
women are at risk of developing metabolic syndrome and that Depression is 
associated with the development of metabolic syndrome, whilst both Depression 
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and Anxiety are associated with the maintenance of metabolic syndrome. These 
findings provide further support for the HPA axis dysregulation hypothesis of 
metabolic syndrome and suggest that psychological evaluation should be an 
integral part of assessment of metabolic syndrome. However, it appears that a 
multi-factorial approach to aetiology and pathogenesis is required for intervention 
and treatment. As both physical activity and good dietary habits are known to 
have positive effects on physical health and also mood states, farm men and 
women should continue to be evaluated, educated and encouraged to improve 
both physical and mental health and wellbeing.  
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